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ABSTRACT 
Chronic Total Occlusions (CTOs) are fibrous and calcified atherosclerotic lesions 
which completely occlude the artery. They are difficult to treat with standard 
dilation procedures as they cannot be traversed easily. Their treatment is also 
associated with a high risk of arterial perforation. Low frequency ultrasonic 
vibrations delivered via wire waveguides represent a minimally invasive 
treatment for CTOs and other tissue ablation applications. These devices 
typically operate at 20–50 kHz delivering wire waveguide distal tip amplitudes 
of vibration of 0-60 µm. The diseased tissue is ablated or disrupted by repetitive 
direct mechanical contact and cavitation. This research assesses the 
susceptibility of arterial tissue to perforation and residual damage under the 
action of ultrasonically energised wire waveguides. Using Finite Element 
Analysis (FEA), a linear acoustic model of the wire waveguide distal tips can 
predict the pressures for a range of operating parameters typically used for 
these devices. High mesh densities (140 EPW) were required to solve the entire 
acoustic field, including complex wave interactions. The FEA model was used to 
aid in the further design and modification of an ultrasonic apparatus and wire 
waveguide (0–34.3 µm at 22.5 kHz). Using a test rig, the effects of distal tip 
amplitudes of vibration, feedrate and angled entry on the perforation forces, 
energy and temperature were measured. The perforation forces reduced (≈ 
60%, 6.13 N - 2.46 N mean) when the wire waveguide was energised at low 
amplitudes of vibrations (< 27.8 µm). There were no significant change in tissue 
perforation forces above this or when the waveguide was operating above the 
cavitation threshold. Histological analysis also showed tissue removal. While 
this knowledge is useful in the prediction and avoidance of perforations during 
CTO operations; it is also envisaged that this information can aid in the design 
and development of generic ultrasonic wire waveguide tissue cutting tools. 
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1 
CHAPTER  
1 INTRODUCTION 
 
1.1 Catheter delivered ultrasonic wire waveguides in cardiovascular 
treatments 
Cardiovascular surgery has benefited from the advances in Minimally 
Invasive Surgery (MIS) and it is now possible to perform some surgical 
interventions on an outpatient basis without the use of traumatic open thoracic 
surgery. There is a rapid development and refinement of surgical instruments 
used in this surgical field, in particular MIS has seen unprecedented success in 
Percutaneous Transluminal Interventions (PTI), delivering dilation devices 
(balloon and stent) and other cutting tools to an atherosclerotic lesion site for 
restoring antegrade blood flow to the artery.  
However, totally blocked arteries known as Chronic Total Occlusions 
(CTOs) can be identified in approximately 16% of all patients undergoing 
angioplasty. They pose a significant challenge to standard minimally invasive 
interventional techniques that require a guidewire to cross the lesion prior to 
placement of dilation devices. The ability of a guidewire to cross the lesion 
appears to be critical to the outcome of standard dilation procedures; a key 
success indicator in 80% of all cases [1]. This problem has led to an impetus in 
the development of new devices for unblocking CTOs. 
 
2 
Catheter delivered external transducer systems which deliver ultrasonic 
vibrations via a wire waveguide can be applied in cardiovascular treatments for 
thrombus dissolution and for ablation and disruption of hard fibrous calcified 
atherosclerotic tissues, such as CTOs [2, 3]. This method is reported to 
selectively remove both inelastic diseased tissue and thrombus through a 
combination of direct contact and cavitation, with minimal disruption to the 
surrounding healthy elastic arterial wall, as shown in Figure 1-1. These systems 
use long slender shafts for navigating the vascular system but typically 
terminate with an enlarged distal tip (1.1 – 2.0 mm diameter) [2, 4, 5]. Because 
the wire waveguides typically vibrate in the low ultrasonic frequency range (20-
50 kHz), they are also often referred to as high frequency mechanical vibrations. 
The wire waveguide distal tip vibrations commonly used are approximately 0 - 
60 µm in amplitude [2, 5-8].  
 
Cavitation
Direct 
Contact
Pressure 
Waves
Cap Cap
Plaque
Artery wall
Wire Waveguide Catheter
20-50 kHz, 0-60 µm
 
Figure 1-1 : Ultrasonic wire waveguide recanalising a CTO. 
 
 
 
3 
In 2005 and 2007, a device using high frequency mechanical vibrations (≈ 
20 kHz) delivered via a wire waveguide was approved for use in the 
recanalisation of CTOs, in Europe and the United States, respectively [9, 10].  
Calcifications and fibrous tissue formation is commonly present in CTOs 
and they are associated with an increased potential for arterial wall perforation 
during treatment with traditional devices when compared to sub-totally 
occluded vessels. This may be a result of the distal section of the guidewire or 
subsequent device being deflected by the hard diseased lesion cap toward the 
surrounding healthy elastic artery wall or by entering a false lumen [11, 12]. 
 
1.2 Research aim and objectives 
Most work to date using catheter delivered external transducer systems 
which deliver ultrasonic vibrations via a wire waveguide has focused on end 
clinical outcomes, such as, thrombus dissolution, hard fibrous and calcified 
atherosclerotic tissue ablation and removal.  
Minimally invasive cardiovascular devices operate close to healthy 
vascular tissue and may be associated with a risk of tissue damage or 
perforation of the surrounding soft healthy arterial wall. While the literature 
discusses the ability of high frequency mechanical waveguides to selectivity 
ablate and disrupt diseased tissues, its effects on soft vascular wall tissue have 
not yet been quantified. No work has been done assessing the resistance of such 
soft tissue to perforation or cutting using these devices despite the fact this may 
be of benefit in minimising the risk of perforation during CTO procedures. In 
addition, greater knowledge of this technology in soft tissue perforation may 
4 
lead to the development of generic soft tissue cutting tools which can be used in 
MIS and other applications.  
Using an ultrasonic wire waveguide apparatus, modified as part of this 
work, the effects of high frequency mechanical vibrations transmitted through 
wire waveguides on porcine vascular tissue perforation forces, using clinically 
relevant operating parameters and conditions, is examined. 
 
1.2.1 Aim 
The specific aim of this research is to: 
 
“To determine if the ultrasonically energised wire waveguide permits perforation 
of soft arterial tissue at lower forces, introducing a risk of arterial perforation 
during CTO recanalisation.” 
 
1.2.2 Objectives 
This research was realised by conducting a number of parallel but related 
studies: 
 
i. Numerical analysis of wire waveguide distal tip acoustic conditions. 
ii. Ultrasonic apparatus modification and test rig design and development 
for tissue testing. 
iii. Tissue testing using the ultrasonic apparatus and test rig. 
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1.2.2.1 Numerical analysis of wire waveguide distal tip acoustic 
conditions 
A method of modelling the acoustic conditions surrounding the wire 
waveguide distal tip is presented as part of this work, using linear acoustic fluid-
structure Finite Element Analysis (FEA) (ANSYS). This method is then used as a 
design tool to aid in the selection of ultrasonic apparatus operating parameters 
for a tissue testing programme. 
 
1.2.2.2 Ultrasonic wire waveguide apparatus and test rig for tissue testing 
A wire waveguide ultrasonic apparatus, developed previously, is modified 
for a suite of soft tissue tests [13]. A test rig is designed and developed to 
accommodate this ultrasonic apparatus, which can advance the ultrasonic 
apparatus towards tissue samples in a controlled manner (feedrate and entry 
angle). A tissue-wire waveguide force measurement system is also developed. 
The acoustic field is measured using a hydrophone and a cavitation detection 
system. Temperature sensing equipment (embedded thermocouples) is also 
included in the test rig development. A data acquisition system interfaces with a 
PC and allows for measurement and recording of the above. 
 
1.2.2.3 Tissue testing using the ultrasonic apparatus and test rig 
The characterised ultrasonic apparatus is then used to test the perforation 
forces using ultrasonically vibrating wire waveguide on soft tissue ablation and 
disruption over a range of distal tip amplitudes of vibration, both above and 
below the cavitation threshold. The tissue tests are conducted in three phases. 
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In an effort to more closely mimic surgical in vivo conditions the effects of 
feedrate and angled entry to the tissue on the perforation forces are examined. 
The temperature increase in the tissue is also measured. Finally a histological 
analysis is used to assess tissue perforation and damage mechanisms. 
 
1.3  Organisation of thesis 
 
Chapter 2 
This review focuses on the use of an ultrasonic wire waveguide device for 
thrombolysis and angioplasty, with specific applications to CTOs. Experimental 
and clinical data on device configuration and operating parameters are then 
compiled. This chapter is a more comprehensive analysis of the state of the art 
of therapeutic ultrasound and ultrasonic cutting tools for tissue cutting and 
ablating applications. This review investigates the evolution of this energy 
delivery, examining both past and present applications and potential future 
trends.  The design requirements for tissue testing using an in-house ultrasonic 
apparatus, as part of this research, will be extracted from the literature review. 
This review also highlights the lack of experimental knowledge and quantitative 
data in wire waveguide ablation and disruption of soft tissue.  
 
Chapter 3 
This chapter outlines a methodology for predicting the acoustic pressures 
generated by an ultrasonically vibrating wire waveguide in a fluid, both directly 
at the wire waveguide distal tip and the entire acoustic field. Verification of the 
model is achieved through a mesh convergence and sensitivity analysis and 
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comparison with analytical solutions. The accuracy of the model for a range of 
typical operating parameters is determined. This method is then validated by 
comparing the predicted results of the acoustic field with that of experimental 
results conducted by others representing a wire waveguide in a peripheral 
artery.  
A number of wire waveguide distal tips are modelled for a range of 
amplitudes of vibrations. Using a cavitation pressure threshold, it was then 
possible to predict the amplitudes of vibration required to cause cavitation. 
Spatially, the cavitation region for a range of wire waveguide distal geometries 
could also be determined. 
 
Chapter 4 
The requirements for an ultrasonic apparatus for this research 
programme are outlined here. An existing design of an ultrasonic apparatus 
developed and manufactured previously is refined and improved upon so that it 
is suitable for a tissue testing programme. The characterisation methods of the 
ultrasonic apparatus are also outlined, verifying some of the major design 
requirements. A test rig and sensing equipment used for this research are also 
outlined. An approach for examining the force profile of the wire waveguide-
tissue interaction using a cantilever beam arrangement is proposed. Using a 
miniature hydrophone and an ultrasonic B-mode diagnostic scanner, Passive 
Cavitation Detection (PCD) for the acoustic field generated by the vibrating wire 
waveguide is also conducted. 
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Chapter 5 
Tissue testing using the characterised ultrasonic apparatus and test rig is 
presented here. The testing was conducted in three phases.  
i. Phase one was an initial pilot study to determine the effects of 
ultrasonic activation of the wire waveguides on perforation forces. 
These preliminary tests showed that the ultrasonic apparatus and 
test rig was capable of performing tissue tests. The effects of 
amplitude of vibration on the maximum perforation forces were 
investigated. Based on these results, phase two and phase three 
tissue tests were then designed.  
ii. Phase two tissue testing involved a closer examination and analysis 
of the perforation forces and energies using improved wire 
waveguides. The effects of cavitation on perforation forces and 
energies were also investigated here.  
iii. Finally, phase three tissue testing is intended to be closer to 
conditions encountered in vivo, such as angled entry perforation 
and perforation over a range of feedrates. The temperature rise is 
also recorded for a range of feedrates and amplitudes of vibrations. 
 
Chapter 6  
Finally, the major findings and conclusions for the entire research 
programme are presented here. A summary of results and potential future 
research and recommendations are also presented. 
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1.4 Contributions 
The following methods and results represent a novel contribution in the 
emerging field of ultrasonic soft tissue ablation and disruption using wire 
waveguides.  The contributions of this thesis are: 
 
1. This thesis contains an experimental study of ultrasonically energised wire 
waveguides on arterial tissue perforation. A study of this type has not been 
conducted before. These results are relevant to wire waveguide 
application in CTOs and are important in establishing suitable operating 
parameters, end effector designs and in guiding surgical technique. This is 
realised through the presentation and analysis of: 
 
 Force profile data of soft arterial tissue perforation using ultrasonically 
vibrating wire waveguides with clinically relevant operating parameters. 
 Perforation initiation force, perforation initiation energy, the total 
perforation energy. 
 Effects of angled entry, feedrates and amplitudes of vibration on 
perforation forces and temperature increase, similar to conditions 
encountered in vivo. 
 Histological examination of tissues perforated with ultrasonically 
vibrating wire waveguides. 
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2. A computational numerical method capable of predicting the pressures in 
the acoustic field surrounding the ultrasonically vibrating wire waveguide. 
This model may be used as a tool for designing ultrasonic wire waveguide 
devices. This methodology includes: 
 
 Verification of the model by performing mesh density analysis and 
comparison with accepted analytical solutions for a range of clinically 
relevant operating parameters. 
 Validation of the model against experimental measurements from the 
literature of an ultrasonic wire waveguide operating in simulated in vivo 
conditions (peripheral artery). 
 Presentation of predicted pressure profiles, using this validated model, 
for a range of distal tip geometries and amplitudes of vibration. 
 Operation parameters required to cause cavitation can, therefore, be 
predicted with the inclusion of a cavitation threshold parameter. The 
extent of the cavitation region in the medium can also be predicted. 
 
3. A method of designing and developing an experimental test rig with an 
integrated ultrasonic wire waveguide apparatus, including: 
 
 A method of measuring the perforation forces and temperatures in the 
soft tissue using a custom cantilever force measurement device.  
 A method of experimentally measuring cavitation for these devices using 
a Passive Cavitation Detection (PCD) via a hydrophone and B-mode 
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ultrasonic scanner, thus establishing an inertial cavitation threshold for 
the medium (water) at a typical frequency used for these devices. 
 A method of manufacturing wire waveguides which can deliver 
amplitudes of vibration and transmit for sufficient periods of time for 
tissue ablation and disruption. 
 
1.4.1 Publications 
1.4.1.1 International refereed journals 
 
 A Linear Finite Element Acoustic Fluid-Structure Model of Ultrasonic 
Angioplasty in vivo. Mark P. Wylie, Garrett McGuinness and Graham 
Gavin. International Journal of Numerical Methods in Biomedical 
Engineering. Volume 26, Issue 7, pages 828 – 842, July 2010. 
 
 Ablation of Chronic Total Occlusions using Kilohertz-Frequency 
Mechanical Vibrations in Minimally Invasive Angioplasty Procedures. 
G.B. McGuinness, Mark P. Wylie, G.P. Gavin. Critical Reviews in 
Biomedical Engineering. Volume 38, Issue 6, pages 511 – 531, July 2010. 
 
 Increased Susceptibility of Arterial Tissue to Wire Perforation with the 
Application of High Frequency Mechanical Vibrations.  
Mark P. Wylie, Garrett B. McGuinness and Graham P. Gavin. IEEE 
Transactions on Biomedical Engineering. Manuscript accepted December 
2011. DOI 10.1109/TBME.2012.2184286 
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1.4.1.2 Conference proceedings 
 
 Numerical Investigation of the Effects of Ultrasonic Angioplasty: Thermal 
Heating and Acoustic Streaming.  
Mark P. Wylie, Garrett McGuinness and Graham Gavin. Northern Ireland 
Biomedical Engineering Society Conference, Belfast, Northern Ireland, 
March, 2008. Conference abstract. 
 
 A Numerical Acoustic Fluid-Structure in Vivo Model of Ultrasonic 
Angioplasty in a Peripheral Artery.  
Mark P. Wylie, Garrett McGuinness and Graham Gavin. Conference on 
Computational & Mathematical Biomedical Engineering, Swansea, UK, 
June, 2009. Conference paper. 
 
 Ultrasonic Angioplasty: Assessing the Risk of Arterial Perforation.  
Mark P. Wylie, Garrett McGuinness and Graham Gavin. UK Society for 
Biomaterials Conference, Belfast, Northern Ireland, July, 2009. Conference 
paper. 
 
 Therapeutic Ultrasound Angioplasty: The Risk of Arterial Perforation. An 
In Vitro Study.   
Mark P. Wylie, Garrett McGuinness and Graham Gavin. IEEE Engineering 
in Medicine Conference, Minneapolis, USA, September, 2009. Conference 
paper. 
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 Perforation of Arterial Tissue using Low Frequency Ultrasound Delivered 
via NiTi Waveguides.  
Mark P. Wylie, Garrett McGuinness and Graham Gavin. Bioengineering In 
Ireland Conference, Galway, Ireland, January, 2011. Conference abstract. 
 
 Soft Tissue Cutting with Ultrasonic Mechanical Waveguides.  
Mark. P. Wylie, Garrett McGuinness and Graham. P. Gavin. International 
Congress on Ultrasonics, Gdansk, Poland, September, 2011. Conference 
paper. 
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CHAPTER 
2 LITERATURE REVIEW 
2.1 The cardiovascular system and cardiovascular disease 
The cardiovascular system comprises of the heart, its connecting blood 
vessels and the lymphatic system. The purpose of the cardiovascular system is 
to distribute nutrients, gases and hormones throughout the body [14]. It 
actively regulates flow velocity and pressure by dilation and contraction of the 
vessels.  
Cardiovascular disease encompasses a number of disorders which 
generally act to inhibit the performance of the cardiovascular system by means 
of blood flow reduction through the arterial vessels. Narrowing of the artery 
lumen not only reduces blood flow but also increases the risk of blood clot 
formation due to a substantial decrease in the lumens cross sectional area. 
Narrowing of the lumen can be attributed to a cardiovascular disease of the 
artery known as atherosclerosis. Indeed, most cardiovascular diseases are a 
direct result of an underlying atherosclerotic condition of the arteries [15].  
 
2.1.1 The artery and atherosclerosis 
The arterial wall can be thought to comprise of at least 3 distinct layers; 
the tunica intima, tunica media and tunica adventitia. The intima, or inner wall, 
is the thinnest layer and consists of a sheath of endothelial cells. They provide a 
low resistance to blood flow in the artery and prevent adhesion to the arterial 
wall.  
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The media contains many elastic fibres (elastin), smooth muscle cells and 
some collagen fibrils depending on its location in the vascular system [16].   The 
elastin allows for elastic material behaviour while the collagen provides the load 
bearing structural strength [17].  Typically, there are only a few collagenous 
fibres in the media [17].  The adventitia contains many dispersed collagenous 
fibres and is surrounded by tough perivascular connective tissue.  The 
mechanical properties of healthy arterial tissue are comparable to that of 
rubber [18]. They display creep under constant load and stress relaxation under 
constant extension but stiffen once physiological strain range level has been 
exceeded. 
Atherosclerosis is a gradual chronic cardiovascular disease of the arteries 
which is specifically localised to the intima of the artery [15]. It creates an 
obstruction to blood flow in the artery and is the most common cause of acute 
myocardial infarction [19]. Atherosclerosis can affect the large and medium 
sized muscular arteries (such as coronary, iliac and femoral) and also large 
elastic arteries (such as the aorta) [15]. It is thought that narrowing of the 
lumen from atherosclerosis is a result of the inflammatory response from the 
repeated injury of the endothelial cells which line the inner intima [20].  
This lesion manifests itself first as a thin fatty streak on the arterial wall. 
With time, the lesion can become fibrous and calcified [21]. Advanced stages of 
this disease are known to include fibrocalcific tissue with calcified caps, hence 
the name, atherosclerosis, which comes from the Greek word athero, meaning 
gruel or paste [22].  
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The properties of atherosclerotic lesions vary depending on the 
pathogenesis of the lesion. Some studies have examined the mechanical 
properties of the various types of atherosclerotic lesions and elucidate to the 
fact that there is a large variability in the properties of lesion types from patient 
to patient and also specific anatomical location [23]. Early stages of the disease 
are often softer than normal arterial tissue [24] and exhibit time dependent 
behaviour under constant mechanical loading (i.e. viscoelastic behaviour) [25]. 
As time progresses, the lesion can become harder and more brittle, as a result of 
fibrous plaque and calcification formation [26]. Maher et al. has conducted 
studies on the tensile and compressive strength of fresh human carotid 
atherosclerotic plaques, concluding also that calcified plaque material is the 
stiffest lesion tissue type while echolucent plaques were the least stiff [23].  
 
2.1.2 Treatments for atherosclerotic lesions 
There are pharmacological approaches such as vasodilators and beta 
blockers which help to relieve some symptoms of atherosclerosis. The 
vasodilators stimulate the smooth muscle cells which act to enlarge the lumen 
[27]. Other drugs that are also administered include antihypertensive drugs and 
lipid lowering drugs. Examples include thiazide diuretics, beta blockers, 
angiotensin converting enzyme inhibitors, calcium channel blockers, aspirin, 
metformin and insulin [28]. Beyond a certain degree of severity, atherosclerotic 
lesions require a surgical intervention and are commonly treated by minimally 
invasive Percutaneous Transluminal Intervention (PTI). The most common 
dilation procedure is the balloon and stent which was conceived in the early 
1970s.  
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2.1.3 Minimally invasive surgical techniques 
Minimally Invasive Surgical (MIS) techniques for treatment of 
atherosclerotic lesions first require the use of intravascular catheters and 
guidewires. The guidewires are applied percutaneously to the vascular system. 
This method of delivery, if successful, has a significant reduction in trauma 
when compared to conventional open thoracic surgery. The majority of current 
guidewires have a main shaft diameter of 0.35 mm or less [29]. They are 
manoeuvred through the vessel to explore the lesion site and act as a rail for the 
follow up surgical device. They may fall under two classifications [30]. 
 
i. Non-hydrophilic – Lower frictional resistance, better manoeuvrability.  
ii. Hydrophilic – Most suited to provide tactile feedback. 
 
Guidewires can be used to probe the lesion site, examining if there is a 
viable path through the lumen. They can be classified according to their stiffness 
(soft, intermediate and stiff). Soft guidewires are typically used for advancement 
of the catheter and crossing occlusions of small lumens. Intermediate 
guidewires are used in tortuous vessels or recently occluded vessels and stiff 
wires are used for advancing through totally occluded lesions [29]. 
Atherosclerotic lesions which can be successfully traversed by a guidewire can 
then be treated by the standard balloon and stent. For the lesions which cannot 
be traversed, an armoury of alternative less well established methods are 
available [31-34]. The premise behind the majority of these devices is to 
unblock the artery to a state whereby it can be traversed and then treated by a 
secondary follow up device, such as the balloon and stent.  
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2.1.3.1 Balloon and stent 
For balloon dilation procedures, initially a guidewire is fed to the lesion 
location and traverses the blockage. X-ray and ultrasound diagnostic imaging 
systems are often employed to guide the balloon into position; contrast media is 
also often used. The angioplasty balloon is inflated which dilates the artery by 
mechanical strain. This may be a stand-alone procedure but more often will be 
accompanied by a metal structure known as a stent (90% of the time [35]). The 
stent is left in the artery to support the arterial wall and to tack the diseased 
material back from the arterial flow path.  An illustration of the procedure is 
shown in Figure 2-1. This procedure has a high success rate for common lesion 
types. 
 
 
Figure 2-1: Balloon and stent procedure [36]. 
 
 
Coronary artery Balloon and stent 
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2.1.4 Complications associated with common PTI 
Although the balloon and stent is a highly accepted form of intervention 
there are some limitations. Success rates are lesion specific [37] and damage of 
the surrounding healthy artery may also occur. In some cases, emergency 
surgery is required. More advanced lesions can be unstable and potentially 
hazardous.  
 
2.1.4.1 Eccentric lesions  
The lesion is considered eccentric when it fails to involve the entire inner 
artery circumference [38], as shown below in Figure 2-2. Eccentric lesions are 
more predominant with early stages of lesion formation. In a study conducted 
by Mintz et al., 55% of all atherosclerotic lesions examined by angiography were 
eccentric [38]. The eccentric lesions may yield sub optimal results if the balloon 
is to expand stretching and damaging the healthy arterial wall while failing to 
alter the plaque impinging on the lumen [37].  
 
 
 
 
 
 
 
Figure 2-2 : Eccentric atherosclerotic lesion, H&E stain [39]. 
Artery wall 
Atherosclerotic 
lesion 
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2.1.4.2 Restenosis 
As a result of the surrounding healthy arterial tissue being strained from 
balloon inflation, the patient may suffer from a restenosis of the artery. This is 
effectively an inflammatory response of the healthy arterial tissue. This is the 
formation of scar tissue which can cause inflammation of the arterial wall thus 
reducing the blood flow once again. It can occur within the first 6 months after 
surgery, and has up to a 40 % chance of occurring after balloon angioplasty [40] 
cited in [41]. Stents can act to reduce restenosis but 25% of all patients with 
stent implantations still suffer from restenosis [41]. 
 
2.1.5 Chronic Total Occlusions (CTOs) 
Advanced stages of atherosclerosis may result in a complete blockage of 
the lumen, otherwise known as Chronic Total Occlusions (CTOs). CTOs are 
defined as occlusions of the artery which are more than one month old [42]. 
They are also classified as having a length of occlusion greater than 15 mm [43]. 
Depending on their duration, they broadly consist of various degrees of fibro-
athermanous plaque and thrombus [42, 43].  
 
2.1.5.1 Traversing the lesion 
Early stage atherosclerotic lesions can be treated by PTI, such as balloon 
and stent. However, CTOs are challenging as they do not lend themselves to 
being accessed and traversed by the guidewire, as can be seen in Figure 2-3. 
Guidewire access and ability to cross the lesion is critical to the success of 
standard dilation procedures and has been reported to be the key success 
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indicator in 80% of cases [1]. Forcing the guidewire may only cause deflection 
towards the artery wall or into adjoining bifurcations. Excessive force may also 
cause the plaque to fracture, creating large segments of broken plaque in the 
artery lumen. 
 
 
Figure 2-3: Guidewire encounter with a CTO [44]. 
 
2.1.5.2 Increased risk of arterial wall perforation 
CTOs are often difficult to engage safely with minimally invasive 
procedures and are associated with an increased potential for arterial wall 
perforation during treatment with traditional devices when compared to sub-
totally occluded vessels. This may be a result of the distal section of the 
guidewire or subsequent device being deflected by the hard diseased lesion cap 
toward the surrounding healthy elastic artery wall or by entering a false lumen 
[11, 12]. A schematic of this occurrence is shown in Figure 2-4. Dissection of the 
coronary arteries with proximal vessel occlusion due to aggressive wiring and 
guide catheter techniques are also reported with CTOs engagement ([45] cited 
CTO blockage and 
wire waveguide. 
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in [11]). For these reasons CTOs are the number one cause for coronary artery 
bypass graft (CABG) surgery referral [43]. Because of this high risk surgery 
(CABG), an increasing number of vascular specialists are employing a 
percutaneous intervention-first policy for the treatment of CTOs [34]. 
 
 
Figure 2-4 : Wire waveguide and guidewire encountering an atherosclerotic 
lesion and being deflected towards artery wall. 
 
2.1.6 Devices and techniques for CTOs 
Problematic atherosclerotic lesions, such as CTOs, traditionally required 
by-pass graft surgery, in most cases open thoracic surgery. This treatment can 
now be attempted by Minimally Invasive Surgery (MIS). There are MIS devices 
on the market that are specifically designed to target various lesion types and 
CTOs. Traditional dilation treatments are often attempted first by stiffer 
guidewires. Some devices specifically for CTOs have been successfully approved 
in the USA by the Food and Drug Administration (FDA) and also in the European 
Union (EU). These include the Safe Cross guidewire and FrontRunner catheter 
which operates using radio frequency energy, and the POLAR™ (Path Of Least 
Arterial Resistance) low frequency vibrational device which delivers lateral 
Catheter and wire waveguide 
Lesion 
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movements at the distal end of standard guidewires in the frequency range of 
16 – 100 Hz [1, 46]. A device known as the Silverhawk™ Plaque Excision system 
has been approved in both the US and the EU for use in debulking of coronary 
and peripheral atherosclerotic lesions. This device removes plaque using a small 
rotating blade at the distal end of a catheter. This device is passed along the 
lesion length a number of times, removing and capturing the removed plaque 
with each pass [47]. 
Rotational drilling devices for atherosclerotic lesions were developed in 
mid 1980’s [48]. Some of these devices and recent designs for treating CTOs 
include the Rotablator and multi-wire crushing techniques [43, 49]. The 
Rotablator consists of a thin elastic wire, the distal end of which has the form of 
a burr. The proximal end is connected to a rotating drill and spun at speeds of 
3000 revolutions per minute. This acts to clear the lumen by displacing the 
atherosclerotic material against the artery wall [48].  
Slower speed rotary drilling machines have also been introduced and 
tested, an example of this is the WildCat by Avinger, which is specifically aimed 
towards Peripheral Artery Disease (PAD) [50]. LASER angioplasty is another 
technique used to unblock arteries. The device is advanced though the artery to 
the site of blockage. This operates by emitting pulsating beams of light which act 
to vaporise the plaque [51]. The first LASER device, the Excimer LASER, was 
approved in 1992 by the FDA. The device, however, is relatively costly [52]. 
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2.1.6.1 Catheter delivered external ultrasound transducer wire 
waveguide treatment of CTOs  
The use of low frequency, high power ultrasonic energy transmitted via 
wire waveguides has been proposed as a method to treat CTOs.  Because of their 
low ultrasonic frequency of operation, these devices are also often described as 
high frequency mechanical vibrations or high frequency drilling [53].  Complex 
conditions exist at the wire waveguide distal tip and its interface with the 
surrounding tissue. This is due to the combined effects of ultrasound exposure 
and the dynamics of high frequency cyclic loading of the diseased tissue. One 
benefit of the ultrasonic treatment over other plaque removal devices such as 
the Silverhawk™ and Rotoblator is the preferential removal of the diseased 
tissue. 
The first device of this type using high frequency mechanical vibrations 
(20 kHz) transmitted through wire waveguides for atherosclerotic lesion 
ablation and disruption has been approved in both the EU (2005) [9] and also 
by the FDA (2007) [10]. This device was intended to facilitate intra-lumen 
placement of conventional guidewires beyond peripheral artery CTOs. This is 
known as the CROSSERTM system and was approved based on substantial 
equivalence to that of a radiofrequency device (Intraluminal Therapeutics (ILT) 
Safe-Cross System) which is also used for CTO unblocking [54].  
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2.1.7 Summary of atherosclerosis and its treatments 
 
 Atherosclerosis is a cardiovascular disease which inhibits blood flow 
through the artery. The lesion is soft initially but may become hard and 
calcified over time. Complete blockages are known as CTOs, they can 
comprise of fibrous tissue and calcifications.  
 Atherosclerotic lesions are typically treated by a balloon and stent. 
However, their success relies on the ability to cross the lesion. CTOs are 
difficult or impossible to transverse and are, therefore, associated with 
complications, such as, increased risk of arterial perforation. They are 
the number one cause for coronary artery by-pass surgery referral.  
 New devices and techniques have been developed as alternative 
therapies for problematic lesions such as CTOs. One such technique uses 
high frequency mechanical vibrations (≈ 20 kHz) transmitted via wire 
waveguides to unblock the stenosed artery.  
 The first clinical device, the CROSSERTM, which uses high frequency 
mechanical vibration delivered via a wire waveguide has been approved 
(EU and FDA) for use in the treatment of CTOs. The effects of the 
CROSSERTM on the surrounding soft arterial tissue have not yet been 
published. 
 The soft tissue properties and subsequent response to the low frequency 
ultrasound is not known.  Soft arterial tissues properties may change as a 
result of strain (physiological strain range) rendering the tissue more 
stiff. 
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2.2 Therapeutic ultrasound in medicine 
Ultrasound in medicine can be generated by exploiting the piezoelectric 
effect of certain crystalline materials. These materials have the ability to change 
shape when a voltage is applied and vice-versa. Ultrasound generation produces 
sound waves at a frequency above the upper human hearing threshold (≈20 
KHz) which propagate by longitudinal motion in compression/refraction cycles. 
In medicine, two principal forms of ultrasound energy can be used.  
 
i. High-frequency low intensity ultrasonic waves in the megahertz range 
which for ultrasonic imaging. 
ii. High intensity ultrasound at generally lower frequencies which can be 
used to ablate and disrupt hard materials or emulsify soft tissues and fat.  
 
The latter of the two describes what is commonly known today as therapeutic 
ultrasound. The use of therapeutic ultrasound for clinical treatments is an 
emerging technology. The premise behind this technology is the selective 
disruption of tissue types on the basis of their mechanical properties and their 
response to the ultrasonic energy.  
Its effectiveness and high success rates for a range of medical procedures  
[55] had led researchers to examine its uses in other areas and treatments. In 
order to understand the origins of the application of ultrasonically energised 
wire waveguides for cardiovascular tissue disruption and ablation, one must 
first describe the general trend of evolution from the early therapeutic 
ultrasonic devices. For this reason, the development of therapeutic ultrasonic 
devices is discussed in this section. 
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2.2.1 Classification of therapeutic ultrasonic devices 
Therapeutic ultrasonic devices can be broadly classified according to 
frequency of operation, acoustic intensity range and delivery method. For this 
review, the devices are classified according to delivery method. The device used 
for this research would belong in the percutaneous catheter delivered external 
transducer system category but has similarities with some external transducer 
tipped cutting devices. The delivery methods include: 
 
i. Transcutaneous delivered external transducer systems. 
ii. Ultrasonic tissue cutting and drilling devices. 
iii. Percutaneous catheter delivered external transducer systems. 
 
2.2.1.1 Transcutaneous delivered external transducer systems 
This describes the application of ultrasound generated by an 
extracorporeal transducer. This is a non-invasive means which couples the 
transducer directly to the body via ultrasonic transmission fluid or gel. The 
ultrasound is then focused to the target tissue to achieve the desired effect. 
 
2.2.1.1.1 High Intensity Focused Ultrasound (HIFU) 
HIFU primarily utilises cavitation as a mean of ablation or coagulation 
necrosis. Secondary ablation effects through heating are also observed [56]. 
This is an area of therapeutic ultrasound which is generating a lot of momentum 
not only for hard tissue ablation but also for soft tissue ablation using short but 
high intensity ultrasonic pulses (histotripsy). 
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2.2.1.1.2 Histotripsy 
This therapy uses focused ultrasound to fractionate soft tissue through 
controlled tissue cavitation.  Tests using histotripsy as a means of non-invasive 
thrombolysis have been conducted by Maxwell et al. Their results show effective 
thrombolysis only when cavitation was present. It was also observed that fluid 
flow generated by a cavitation cloud can attract, trap and further break down 
clot fragments [57]. 
 
2.2.1.1.3 Lithotripsy 
Lithotripsy is also a form of extracorporeal HIFU. Shockwave lithotripsy is 
a procedure for treatment of kidney stones, a schematic of this procedure is 
shown in Figure 2-5. It uses a focused acoustic pulse to ablate the kidney stone.  
X-ray
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Figure 2-5 : Lithotripsy of a kidney stone. 
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2.2.1.2 Ultrasonic tissue cutting and drilling devices 
2.2.1.2.1 Chisels and drills on hard tissue (bone)  
Much work has been done in the area of ultrasonic bone cutting and 
removal. It is because of its success in this field that it has also expanded into 
other applications of mineralised tissue removal using probes, such as dentistry. 
The effectiveness of mineralised tissue removal using therapeutic ultrasound is 
described by Volkov in 1974 who used 25-30 kHz longitudinal mechanical 
vibrations to drive saws and scalpels when cutting bone [58]. In other work by 
Cardoni et al., they examined a low frequency ultrasonic cutting tool for cutting 
bone which operates in the frequency range of 20-100 kHz [59]. They report 
that the benefits of using this device over conventional cutting scalpels include 
the reduction of swarf, reduced reaction forces and more precise cutting which 
is otherwise not achievable with other high speed rotational devices. 
Khambay and Walmsley examined the effects of feedrate on the cutting 
forces when using an ultrasonically vibrating cutting tool on bone [60]. Using a 
harmonic chisel, the effect of feedrate on the cutting depth of bovine bone was 
examined. Results show that when the feedrate increases there is a 
corresponding increase in the downward force which is followed by a decrease 
in the force at feedrates greater than 56 mm/min. The depth of the cut increases 
up to a feedrate of 56 mm/min after which it decreases. They also report the 
effects of angle of approach to the bone with the cutting device, stating that both 
the longitudinal and downward forces do not change when the rake angle 
changes from 0 degrees to 10 degrees. The downward force decreases when the 
rake angle increases from 10 degrees to 20 degrees [60]. 
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2.2.1.2.2 Phaco-emulsification  
Phaco-emulsification refers to a procedure for removing ocular cataracts 
whereby the eyes internal lens is emulsified by a low frequency ultrasonic 
probe. This procedure was developed by Charles Kelmen who took inspiration 
after seeing this form of energy being used in dentistry [61]. A conventional 
phaco tip vibrates at ultrasonic frequencies typically between 25 KHz and 62 
KHz [62]. 
For this procedure, heating of the distal tip and surrounding medium can 
be substantial and is considered an unwanted adverse effect. Therefore, the 
distal tip must be irrigated by coolant to prevent thermal damage within the 
eye. Cavitation effects using these devices can generate even more heat [62].  
Phaco-emulsification is now known to cause collateral damage to the 
cornea and efforts are being made to reduce ultrasonic powers below the 
intensities required to cause cavitation [63]. Therefore, recent advances in this 
technology (SonicWave) propose the use of sonic frequencies (40-400 Hz) to 
eliminate or mitigate the effects of ultrasonic cavitation and heating  during this 
procedure [64]. 
 
2.2.1.2.3 Scalpels and incisors on soft tissue 
One of the first studies using an ultrasonically vibrated scalpel was 
documented as early as 1979 by Hodgens who describes the evolution of this 
device as being a descendant of the Cavitron-Kilmen Phaco-emulsfier [65]. He 
proffers that the potential value of this device, as well as ablation and dissection, 
is the reduction of blood loss during surgery from thermal cauterisation. This 
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scalpel operates by delivering amplitudes of vibration of 150 µm to the distal 
scalpel tip. Today, a number of ultrasonic incisors and scalpels are commercially 
available. 
 
i. UltraCision 
Koch et al. performed tests using an ultrasonic scalpel (UltraCision) on a 
suite of soft porcine tissues which operated at 55 kHz and produced amplitudes 
of vibration between 10 - 50 µm [66]. Heating of the tissue at 1.0 mm from the 
cutting interface of above 40 0C was measured. However, it was stated that 
perfusion of blood through the tissue reduced the heat efficiently at distances 
greater than 5.0 mm from the distal tip [66]. 
 
ii. Harmonic Ace  
More recently, the application of a double sided scalpel (i.e. an incisor) has 
been developed and is gaining acceptance across the world in endoscopic 
surgery for dividing systematic vessels [67]. The design of the incisors typically 
includes a sharp blade distal tip which is ultrasonically vibrated coupled to a 
small narrow blade jaw which acts to clamp the tissue, see Figure 2-6 . The jaw 
is typically not ultrasonically vibrated. The Harmonic Ace ® (Ethicon Endo-
Surgery Inc, Cincinnati, Ohio) is a good example of an ultrasonically energised 
shearing device.  
The Harmonic Ace ® is FDA approved for use in dividing any vessels 5.0 
mm or less in diameter [68]. In clinical tests using this device by Tanaka, its 
efficiency for shearing and sealing pulmonary vessels in clinical trials is 
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described [69].  Ethicon Endo-surgery also boasts an arsenal of different but 
similar products using this technology.  They all operate at 55.5 kHz. 
 
 
Figure 2-6: Harmonic ACE from Takana [69]. 
iii. LOTUS 
The LOTUS ultrasonic scalpel also performs a similar function to the 
Harmonic Ace but instead of longitudinal vibrations at the distal tip there is 
torsional vibration which oscillates around an arc. It also operates at a lower 
frequency of 36 kHz [70]. 
 
2.2.1.3 Percutaneous catheter delivered external ultrasonic transducer 
systems 
Using small incisions in the skin it is possible to apply ultrasonic wire 
waveguides through a catheter which is inserted percutaneously. It is currently 
only used in the delivery of a wire waveguide to the vascular system for surgery. 
The catheter and wire waveguide are passed through an insertion made in the 
artery to the lesion site, as shown in Figure 2-7 . The catheter is typically used to 
Non-ultrasonically 
vibrating jaw 
Ultrasonically 
vibrating jaw 
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guide the wire waveguide through the vascular system to lesion site. The 
transducer is external to the body but acts to transmit the energy through the 
wire waveguide to the distal tip. 
 
2.2.1.3.1 Ultrasonic wire waveguide delivery for thrombolysis and 
angioplasty 
In cardiovascular applications, this form of therapy has been applied for 
soft thrombus dissolution (thrombolysis) and hard brittle atherosclerotic tissue 
removal. It relies on the transmission of high frequency mechanical vibrations 
(low ultrasonic frequency range (20-50 kHz)) via wire waveguides. The 
waveguides must be able to transmit the energy through lengths of wire which 
are sufficiently long to navigate the arterial system and to reach the lesion site 
(≈ 1600 mm) [13]. 
 
 
Figure 2-7 : Wire waveguide delivered through a catheter to lesion site. 
Administer MIS device via 
catheter 
Lesion site 
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They must also be sufficiently small in diameter so as to be flexible enough to 
pass through some of the smaller arteries in the body, such as the coronary 
arteries. Diameters typically range from 0.35- 2.0 mm [2, 5, 13]. In most cases, a 
large ball tip is also attached to the distal end to cause cavitation and create a 
larger lumen. Reports of ball tips in the region of 2.0 – 2.5 mm are also 
described [2, 5, 7, 71].  
The wire waveguide can be fed to the lesion site through a catheter, 
energised and pushed through the lesion, removing tissue in the process and 
making a viable path to restore blood flow or allowing the vessel to be dilated 
further by a follow up device. Some early prototypes of these devices were 
designed and tested but were of little practical use because of their small wire 
waveguide lengths [2, 71-73]. Over time, through constant refinement of design, 
some of the more difficult design challenges were overcome and these problems 
were addressed. 
 
2.2.1.3.2 Device configuration 
The first practical devices for ultrasonic angioplasty in vivo were 
developed in the late 1980’s.  These devices generally comprise of three sub-
systems. External generator (A), ultrasonic transducer (B) and a horn or 
transmission wire (C) are typically used. The generator delivers AC power input 
to the piezoelectric transducer; this converts the electrical energy to high 
frequency mechanical vibrations and is often amplified by using an acoustic 
horn. These are solid metal tapered rods that can be coupled to the distal end of 
the transducer. A flexible ultrasound transmission wire waveguide is often 
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coupled directly to the acoustic horn. Figure 2-8 shows this arrangement used 
by Rosenschein et al. [6]. 
A similar arrangement is also shown by Siegel et al. [74]. Their system was 
powered by a Blackstone Lithotripsy generator. This was then coupled to a 
transducer. Siegel’s wire waveguide was ensheathed in a catheter which 
provided saline irrigation for cooling to the distal wire waveguide tip, their 
system schematic is shown in Figure 2-9.  Both Rosenschein’s and Siegel’s 
systems operate in the low 20 kHz frequency range. 
 
 
Figure 2-8 : Prototype of ultrasonic angioplasty device by Rosenschein et al. [6]. 
  
 
Figure 2-9 : Diagram of the ultrasonic device used for arterial plaque ablation by 
Seigel et al. [74].  
A 
B 
C 
Transducer Wire waveguide and catheter 
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The FDA and EU approved medical device for CTO recanalisation is very 
similar in many respects to these early devices. The CROSSER™ Catheter System 
consists of a re-usable electronic generator, a high-frequency transducer and a 
single-use CROSSER™ CTO recanalisation catheter (wire waveguide, length 
1200- 1460 mm, 1.1 – 1.5 mm distal tip outer diameter [75]). An optional saline 
flush system, the FlowmateTM Injector is also available. According to the 
manufactures specifications, the recanalisation catheter operates at 20 kHz at a 
stroke depth of approximately 20 µm [44]. The complete system is shown in 
Figure 2-10. 
 
 
 
Figure 2-10 : The CROSSER™ Catheter System [44]. 
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Ultrasonic 
generator 
Recanalisation 
catheter 
Flowmate 
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Detailed literature on the manufacturing and design of these devices is 
sparse. Patents are available which illustrate the mechanics behind the design 
but do not outline the manufacturing methods or a means to achieve similar 
devices [76-78]. Some of the design aspects involved in producing these 
ultrasonic devices is described by Gavin [13]. Gavin describes the use of an 
adapted BransonTM sonifier to achieve similar wire waveguide distal tip 
conditions to that used in the approved clinical and experimental devices. 
Gavin’s work focused on the characterisation of the ultrasonic apparatus with 
particular emphasis on the wire waveguide and its connection methods to the 
acoustic horn. Gavin’s ultrasonic apparatus was modified and used as part of 
this research programme for tissue testing. The modifications are described in 
further detail in Chapter 4. 
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2.2.2 Summary of therapeutic ultrasound and wire waveguide devices 
 
 Therapeutic ultrasound generally operates in the low acoustic frequency 
range (20 - 100 kHz) but at much higher acoustic intensities to that of 
ultrasonic diagnostic imaging devices. Therapeutic ultrasound is 
generally used where selective tissue ablation and disruption is required.  
 Therapeutic ultrasonic devices in medicine can be classified according to 
their method of delivery :  
 
i. Transcutaneous delivered external transducer,  
ii. Ultrasonic tissue cutting devices and  
iii. Percutaneous catheter delivered external transducer systems. 
 
 Transcutaneous devices (such as HIFU) are non-invasive and are 
designed to generate cavitation at the tissue target site and generally 
operate at acoustic intensities many orders of magnitude greater than 
that of the other therapeutic delivery methods.   
 Ultrasonic tissue cutting devices generally operate at frequencies below 
100 kHz and are used for hard/soft tissue ablation and disruption. 
Benefits of using these devices over traditional non-ultrasonic devices 
include reduced cutting forces, increased tissue removal rates and more 
precise cutting. Feedrate has also been shown to have an impact on 
tissue removal rates.  
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 The UltraCision ultrasonic scalpel has been tested on cutting of porcine 
tissue with amplitudes of vibration between 10 -50 µm at 55 kHz. They 
report heating above 40 0C but state that perfusion of the blood reduces 
this temperature efficiently 5.0 mm from the distal tip. 
 In phaco-emulsification, heating is described as being generated from the 
phaco tip. This may be due by internal friction of the vibrating probe. 
Fine et al. also describe additional heating caused by cavitation during 
phaco-emulsification [62]. 
 Percutaneous catheter delivered external transducer systems include the 
use of ultrasonically vibrating wire waveguides for ablation and 
disruption of cardiovascular tissues, with a specific clinical application of 
CTO ablation. The use of ultrasonically vibrating wire waveguides in 
cardiovascular treatments has been coined as “ultrasonic angioplasty” in 
some forums. It is also known as high frequency mechanical vibrating 
wire waveguide delivery. 
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2.3 Ablation and disruption mechanisms using wire waveguides  
At the distal tip of the wire waveguide, both hard diseased tissue and 
thrombus are thought to be disrupted by a number of mechanisms; primarily 
direct mechanical ablation and cavitation and, to a lesser extent, acoustic 
streaming and pressure wave components [79]. In this section, the ablation and 
disruption mechanisms which are encountered using ultrasonic wire waveguide 
devices will be discussed. Figure 2-11 below illustrates the mechanisms which 
are responsible for the disruption and ablation of the tissue. 
 
Ablation and disruption mechanisms
Pressure wave 
components
Attenuation Mechanical 
(direct contact)
Sinusoidal 
pressure field
Cavitation
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streaming
Heating
Friction
Impact ablation/
disruption
 
Figure 2-11: Ablation and disruption mechanisms. 
 
2.3.1 Mechanical contact disruption and ablation 
Mechanical contact ablation caused by the vibrating wire waveguide distal 
tip impacting the diseased atherosclerotic lesion in the artery is thought to play 
a critical role in material disruption and removal [80]. High frequency cyclic 
impacting of the tissue and wire waveguide can cause the tissue to fail. Indeed, 
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recent studies using the CROSSERTM system describe ablation mechanisms as a 
result of high frequency mechanical vibrations [81]. In soft tissue, Cimino and 
Bond suggest that the primary ablation mechanisms associated with tissue 
removal is predominantly related to direct mechanical impact of the acoustic 
horn, acoustic streaming and pressure wave components [82]. 
From the perspective of micromachining engineering materials, the key 
variable for effective ultrasonic cutting devices by mechanical disruption is 
amplitude of vibration at the cutting tip [83]. The removal rate also increases 
with frequency and is dependent on the size of the end probe area [82]. In 
brittle material removal, the ablated particles may also create a slurry at the 
distal wire tip, which may contribute to further tissue removal. The 
concentration of the slurry (particulate) at the tip has an effect on removal rate, 
raising the concentration of this tends to increase the removal rate [84]. 
 
2.3.2 Cavitation 
Cavitation generated by the wire waveguide distal tip case occurs on the 
negative half of the acoustic cycle. As the wire waveguide is vibrating, it is 
causing high pressures at the amplitude maxima and low pressure at the 
amplitude minima. These low pressures can cause the rapid expansion of 
bubbles (dissolved gas coming out of solution). Following this, on the positive 
half of the cycle, the bubbles then collapse. It is during this phase that the 
disruptive effects of cavitation occur. Cavitation is usually considered to be an 
undesirable erosive effect in diagnostic ultrasound but deemed to be a crucial 
mechanism in both ultrasonic ablation of CTOs and ultrasonic thrombolysis [3, 
7, 85-87].  The two main types of ultrasonic cavitation are:  
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i. Stable cavitation, where the radius of the cavitation bubbles oscillates 
around an equilibrium value over a considerable number of acoustic 
cycles without the generation of bubble collapse [88] and  
ii. Inertial cavitation, where the bubble rapidly grows and collapses a 
number of times over a single acoustic cycle, and is commonly associated 
with damage mechanisms [89].  
 
Cavitation is a threshold phenomenon [90]. The acoustic pressure threshold for 
inertial cavitation is much higher than that for stable cavitation. There is a 
considerable amount of information in the literature on cavitation thresholds 
[91-94]. These thresholds are sensitive to temperature, dissolved gasses and are 
frequency dependent.  
For therapeutic ultrasound, the frequencies of interest typically range 
from 20-50 kHz [13] because the intensity required to produce cavitation rises 
rapidly above frequencies of 100 kHz [92]. Nyborg also describes the onset of 
cavitation for water, in the frequency range of 20-50 kHz [91]. With suitable gas 
nuclei present, above pressure amplitudes in the range of 0.1 - 0.2 MPa, inertial 
cavitation threshold is observed. The inertial cavitation for degassed water at 
room temperature, recorded by Perkins, is shown in Figure 2-12 [92]. For the 
frequency range typically used in therapeutic ultrasound (20 – 50 kHz), the 
inertial cavitation threshold is given as approximately 6 – 8 W/cm2. 
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Figure 2-12: Inertial cavitation threshold for degassed water from Perkins [92]. 
 
2.3.2.1 Cavitation detection 
Critical to the understanding and evaluation of these devices is the ability 
to detect the onset of cavitation. Cavitation can be observed to some degree by 
the naked eye. When using small diameter wire waveguides (and hence small 
localised cavitation regions) in often inaccessible locations near tissue, other 
methods must be employed. The event of cavitation can be examined indirectly 
by its effects on the surrounding environment: 
 
i. A simple technique is the use of an aluminium foil (pitting method). Here 
the heterogeneous cavitation causes pitting on the thin foil section (≈ 20 
µm thickness) and can been seen by the naked eye. Experiments using 
this method have been conducted by Tezel et al. at 20 KHz [95].  
 
20-50 kHz 
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ii. Cavitation can be actively measured by using chemiluminescence of 
luminol. The cavitation bubbles in this case collapse creating radicals 
which oxidise luminol and emit a weak blue light [96]. 
iii. Cavitation also acts as a secondary sound source and can, therefore, be 
measured passively by analysing the acoustic frequency profile 
generated by the device using a hydrophone; this is known as Passive 
Cavitation Detection (PCD). The method is outlined in the ANSI Bubble 
Detection and Cavitation Monitoring Report [97] and is practiced by 
others [94] [93, 98, 99]. This will be discussed in further detail in the 
methodology section. 
 
It is also possible to visualise cavitation by using an ultrasonic diagnostic 
imaging device.  Cavitations can be identified in the ultrasound image display as 
highly echogenic microbubbles. This technique was employed by Rosenschein et 
al. who used a 7.5 MHz multi-element linear array ultrasound imaging 
transducer positioned at the wall of an arterial phantom [87].  
 
2.3.3 Attenuation of the ultrasound 
Attenuation of the acoustic energy describes all mechanisms which 
remove energy from the ultrasonic wave. This includes scattering and 
absorption, where the absorption relates to the amount of energy which is 
absorbed by the medium and converted into heat. In acoustics, the attenuation 
coefficient may be expressed in units of NPm-1 or dBm-1 and are frequency 
dependent [100]. Attenuation coefficients are non-linear and are only 
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approximations limited to a finite frequency range, as can be seen in Figure 2-13 
(note x-axis in MHz units).  
 
 
Figure 2-13: Experimental mean results for the attenuation coefficient as a 
function of frequency [101]. 
2.3.3.1 Heating 
The generation of heat when using ultrasonic angioplasty devices is 
commonly reported [102, 103]. The thermal response from ultrasonically 
vibrating cutting tools on tissue (bone) has been described in similar 
applications (chisel) by Cardoni et al. The thermal increase has been 
decomposed into two contributing factors.  
 
i. Absorption of the ultrasonic energy (i.e. attenuation). 
ii. Friction between cutting tool and the tissue [59].   
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It has been suggested that when using ultrasonic angioplasty devices, the 
thermal injury to the tissues may be the result of conduction from the wire 
waveguide. This is caused by ultrasonic energy being converted to heat as it is 
transmitted through the waveguide to the tissue [87].  Siegel et al. describe the 
temperature increase at the probe distal tip (2.3 - 3.0 mm diameter) when using 
ultrasonic angioplasty on canine arteries at a frequency of 20 kHz. Five minutes 
of constant duty ultrasound produced a temperature increase from 22 to 50 0C 
at probe tip. 50% duty for the same duration produced only an 8 0C temperature 
rise [102]. Hartnell et al. also report similar temperature increases. Tests were 
conducted in vitro studies using 1.6 mm mushroomed tipped wire waveguides 
for thrombus ablation. For 15 minutes of activation and at an ambient 
temperature of 37 0C, an intra-luminal temperature rise of 9 0C and a wall 
temperature increase of 15 0C were measured [103].  
The generally accepted safe limit for heating blood for short periods of 
time is 41 0C, after which cell death ensues [104], so irrigation at the distal tip is 
common. Efforts to combat heating have been made by integrating a saline flush 
into the system [72]. This also has the additional benefit flushing away ablated 
debris. 
 
2.3.3.2 Acoustic streaming 
Any medium or object in the path of an ultrasonic beam which absorbs 
some of the energy of the beam, will experience a force due to the change in 
momentum carried by the beam [100]. This is caused by the momentum  loss of 
the acoustic beam by attenuation  being taken up by the momentum of the fluid 
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mass, thus conservation of momentum is fulfilled [105]. The result of this is 
known as radiation force, but originally, this was coined as “Quartz Wind” 
because it was emitted from a quartz piezoelectric transducer [106]. The 
radiation force acts on the fluid medium and gives rise to a dipole streaming 
regime, known as acoustic streaming [107]. 
Acoustic streaming is commonly treated as a second order mathematical 
function, which means that the streaming speeds are proportional to the square 
of the source amplitude [106]. The streaming velocity is also a function of 
frequency [105]. The fluid flow from acoustic streaming gives rise to shear 
forces within the fluid which may cause cell and tissue damage [108], the extent 
of which is still unknown. Acoustic streaming has also been shown to enhance 
thermal convection thus reducing the localised heating effects by ultrasound 
[109] and [110] cited in [111].  
The effects of acoustic streaming on material ablation are not yet known 
and it may have a greater effect on highly viscous thrombus rather than hard 
calcified plaques. In work by Lauer et al., the affects of 1 MHz intermittent 
ultrasound on thrombus was examined. They concluded that acoustic streaming 
alone, without cavitation effects, was responsible for the increased thrombolysis 
[112].  
 
2.3.4 Failure of soft tissues by therapeutic ultrasound  
Although these ultrasonic devices are generally aimed towards diseased 
atherosclerotic hard tissue ablation and disruption and thrombolysis, there is a 
lack of clarity on the effects that this energy has on the soft healthy arterial wall. 
In other fields of therapeutic ultrasound, there is evidence to suggest that soft 
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tissue may be failing due to a combination of mechanisms such as soft tissue 
fragmentation, mechanical and thermal ablation (whereby the water content of 
the soft tissue is lowered as a result of thermal absorption rendering tissue 
susceptible to brittle failure) or fibre bundle de-striation [82, 113]. 
Fundamentally, the question of whether soft tissue is removed by ablation or 
fibres are torn and separated at the powers reported in ultrasonic therapy still 
remains unanswered.   
 
2.3.5 Other considerations for failure of soft tissues  
Relevant to this research is the quantification of the fracture and failure 
of soft tissues by non-ultrasonically energised cutting and perforating devices. 
Combining the knowledge of both fields (non-ultrasonic and ultrasonic) may 
help to give a better insight to the overall mechanics of soft tissue perforation 
when using ultrasound transmitted via wire waveguides. This section describes 
non-ultrasonic devices only. 
A number of authors have presented work on perforation and cutting of 
soft tissues with standard needles and scalpels and have established methods 
for quantifying the energy needed to achieve this. McCarthy et al. [114] 
investigated the cutting of soft tissues with scalpels with the goal of establishing 
a ‘blade sharpness index’ for describing scalpels and other such implements. To 
quantify the cutting process, the force profile for the cut was measured and 
using the indentation distance into the tissue (δi), it was possible to calculate 
energy or work done. They describe cut initiation energy, Ei, required to initiate 
a cut in soft tissues, given in Equation 1 and illustrated in Figure 2-14. Given 
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that tissue deforms initially to some penetration depth, δi, under loading prior to 
failure, Ei, is defined as: 
 
Ei = ∫δi F dx                                                        Equation 1
     
                                                                               
δi
 
Figure 2-14 : Needle insertion into tissue by McCarthy et al. [114]. 
The force profile for needle insertion phases into human liver and kidney 
has been examined experimentally by Mahvash and Hayward. An experiment 
was designed to measure the force profile for a needle insertion into the tissue. 
They decompose the force profile into four phases, as shown in Figure 2-15 
[115] cited in [116].  They describe the force profile as composing of: 
 
i. Deformation – Initial deformation from contact with tissue. 
ii. Steady state penetration – Energy threshold breached and crack initiates.  
iii. Relaxation – Desired force achieved and force relaxes as a result of 
viscoelastic properties of the material. 
iv. Extraction phase – Force due to the released stored elastic strain energy 
and friction. 
F 
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Figure 2-15: Needle insertion phases (force profile) into a human liver from 
Mahvash and Hayward [115]. 
Azar and Hayward [116] also describe the use of a general energy balance 
equation to describe all phases of the initial tissue deformation and perforation 
of porcine liver tissue during a needle insertion. Allowing for the investigation 
of the cut initiation energy and also the work done during insertion of the 
needle, accounting for friction, wedging and fracture work. Some work has been 
conducted on the effects of feedrate on the perforation forces of a needle into 
soft liver tissue. The feedrates range from 2 – 10 mm/sec and show an increase 
in perforation forces with increasing feedrates [117]. 
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2.3.6 Summary of ablation and disruption mechanisms 
 
 Cavitation, direct mechanical impact, acoustic streaming and other 
pressure wave components are described as ablation and disruption 
mechanisms for both ultrasonic thrombolysis and atherosclerotic 
plaques.  It is not yet known the degree or contribution of which the 
mechanisms have on diseased tissue failure or indeed healthy soft tissue 
damage and perforation. 
 Failure due to mechanical contact of the wire waveguide and tissue may 
be caused by the action of high frequency cyclic impacts on the tissue, 
pulverising and breaking down the brittle tissue or straining, moving and 
cutting of the soft tissue fibres. 
 Non-contact tissue disruption and ablation may be related to inertial 
cavitation in the acoustic medium in regions close to or on the target 
tissue. Softer thrombus may be broken down by shear forces created by 
high streaming velocities.  
 Cavitation thresholds for the low ultrasonic frequency range used in 
cathether delivered external transducer wire waveguide systems for 
water range from 0.1 MPa to - 0.2 MPa [91]. For a frequency of 22.5 kHz 
with acoustic properties of water with suitable gas nuclei this is 
approximately 2-3 W/cm2. For degassed water this may be as high as ≈ 6 
– 8 W/cm2. 
 Attenuation coefficients and cavitation thresholds are non-linear and 
dependent on the fundamental frequency of operation. There is a paucity 
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of information for these coefficients in the literature for the frequencies 
(and acoustic mediums) used in ultrasonic angioplasty. 
 Heating of diseased and surrounding healthy tissue may be caused by a 
number of factors, including attenuation of the ultrasonic wave, frictional 
heating of the wire waveguide-tissue interaction and internal friction 
heating of the vibrating wire waveguide or tool. Heating when using 
ultrasonic angioplasty devices may cause thermal damage. These effects 
can be mitigated by using irrigation via the catheter. This may also act to 
flush away ablated debris. 
 This research is focused on soft tissue failure due to high frequency 
vibrating wire waveguides at similar operating conditions to that used 
for unblocking CTOs and thrombolysis.  
 Soft tissue perforation for a range of feedrates (2 – 10 mm/sec) using a 
needle show that increasing feedrates results in increased perforation 
force.  
 Techniques which were used for analysing soft tissue failure using 
cutting forces and tissue indentation distances by standard non-
ultrasonic cutting tools, such as needles are adopted for this research in 
assessing the perforation energies of the wire waveguide and tissue.  
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2.4 Experiences using catheter delivered external transducer wire 
waveguide delivery in cardiovascular applications. 
 
2.4.1 In vitro 
In 1965,  Anschuetz and Bernard first suggested that this form of 
ultrasonic energy has potential to be applied to atherosclerotic plaque 
irradiation [118]. In the same year, Lane and Mino ablated  human coronary 
atherosclerotic plaques post mortem [119] cited in [120]. This heralded the 
beginning of studies into the use of low frequency ultrasound to disrupt 
atherosclerotic lesions. These initial studies concluded that ultrasonic energy 
transmitted through flexible wire waveguides can offer effective treatment for 
the disruption of atherosclerotic lesions.  
 
2.4.1.1 Ultrasonic thrombolysis 
Relatively low frequency (26.5 KHz) ultrasonic waves transmitted via 
small diameter waveguides were first used to ablate an occluding thrombus in 
vitro by Trubenstein et al. in 1976 using a probe 21-29 cm in length [73] cited in 
[120]. Bige et al. also examined the use of ultrasound at 27 kHz for thrombolysis 
[121]. They voiced their concern that the ablated fragments can cause new 
thrombus formation. However, in a study performed by Philippe et al. , who 
analysed fragment size after thrombolysis, they found that 90% of the 
fragments to be less than 10µm [122]. 
 
54 
2.4.1.2 Plaque disruption and ablation 
The low frequency operation of these devices began to be the standard for 
any experimental work carried out. There are a number of reasons behind this. 
Suchkova et al. demonstrated greater acceleration in fibrinolysis using 
frequencies in the mid-kilohertz rather than in the megahertz range [123].  
As far as safety is concerned, Siegel et al. reports that the microscopic 
particulate debris generated during plaque ablation are small and comparable 
to the particulates from other clinically used modalities, he also states that the 
clinical studies in humans show that this treatment can be used safely and 
effectively for peripheral angioplasty [2]. 
In an effort to discover the optimal amplitudes of vibration at distal tip for 
carrying out ultrasonic angioplasty on atherosclerotically occluded arteries, 
Chikada describes the use of an ultrasonic device for ultrasonic angioplasty of 
human cadaveric arteries [72]. A 2.5 mm diameter 5 cm long hollow probe was 
used which could deliver amplitudes of 210 µm at 100% power input. This 
operated at 24 kHz. Effective removal of the lesion is reported at distal tip 
amplitudes of vibration for soft atheroma (90-110 µm), mild atherosclerosis 
(110-130 µm) and calcified lesions (150 µm). 
Fischell et al. experimented with ultrasound at 20 kHz using a ball tipped 
wire probe of 2.0 mm diameter on thoracic arteries from New Zealand white 
rabbits and human cadaver iliofemoral arteries. They performed the tests with 
their device on atherosclerotically occluded (fibrocalcific) arterial segments 
using a 50% pulsed cycle of 30 msec. Saline was infused via the catheter to 
prevent heating of the probe [124] . 
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Siegel et al. describe the initial experiences of using an ultrasonic device 
for occluded coronary arteries (xenografts in canine). The device operated at 
19.5 kHz and delivered amplitudes of vibration between 15 - 30 µm to a 1.7 mm 
diameter ball tipped wire waveguide [2]. Similar operational characteristics 
would later be adopted by the CROSSERTM ultrasonic device [53]. In this paper, 
the forces applied to successfully recanalise the occluded arteries were given. 
Forces between 0.98 - 1.96 N were measured. The adverse effects of the 
ultrasonic probe in contact with the healthy canine arterial tissue were also 
observed as part of this study [72]. Incidences of restenosis in both short and 
long term outcomes were reported. It was found that higher distal tip 
amplitudes of vibration resulted in higher rates of restenosis.  
 
2.4.2  In vivo 
2.4.2.1 Ultrasonic thrombolysis 
Studies in vivo suggest that catheter delivered ultrasound can be used for 
thrombolytic therapy without injuring the surrounding vessel wall [125]. In the 
mid 1990s clinical studies using catheter delivered ultrasound were performed 
on human coronary and peripheral arteries, Hamm et al. 1994 first published 
their successful treatment of intra-coronary thrombolysis using this method 
[126]. Later in 1997 Hamm et al. and Rosenschein et al. [127, 128] conducted a 
study on a number of patients for mechanical thrombolysis, although both these 
results were positive, they were not significantly better than the standard 
available treatment, balloon angioplasty [129]. 
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2.4.2.2 Plaque disruption and ablation 
A number of investigators had shown that this technique can be used 
safely and effectively for peripheral artery angioplasty in vivo [80, 86, 87, 130]. 
In 1989, Siegel et al. published their results on their initial clinical experience of 
a percutaneous catheter-delivered arterial recanalisation of human peripheral 
arteries. They used an ultrasonic probe operating at 20 kHz with a power output 
at transducer of 20-35 W/cm2 [130]. The aim of the ultrasonic device was to 
reduce the degree of stenosis so that a follow up balloon device could be put 
into place and inflated, dilating the artery further. Three of four total occlusions 
were recanalised in 120 s or less. The results of this experiment were extremely 
positive, with no arterial emboli, dissection, spasm or arterial perforation 
observed.  However Siegel concludes that one of the major limitations of this 
ultrasound system is difficulty of steering from lack of flexibility.  
One of the largest clinical trial of ultrasonic angioplasty was conducted 
between 1993 and 1995 in Europe. This was known as CRUSADE (Coronary 
Revascularisation Ultrasound Angioplasty Device Evaluation) and it involved a 
total of 229 patients with 234 coronary lesions [120]. The ultrasonic 
angioplasty device operated at 19.5 kHz with 1.2 mm and 1.7 mm ball tips. A 
range of atherosclerotic lesion stages were treated and 82% of lesions were 
successfully crossed. 92% of these were then treated by adjunctive balloon 
angioplasty [120].  
In an effort to examine the long term effects of this new procedure, Siegel 
et al. conducted a study which was intended to present follow-up data as well as 
short-term results on a larger clinical series of patients undergoing ultrasonic 
angioplasty [80]. The tests were carried out on peripheral arteries using a 2.0 
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mm or 3.0 mm ball tip. This operated at a frequency of 19.5 kHz; the device 
configuration is shown in Figure 2-16. It was reported that this method is useful 
for recanalisation of fibrous, calcific and thrombotic arterial occlusions and 
reduces arterial stenoses.  
 
 
Figure 2-16 : 2.0 and 3.0 mm ball tipped titanium wire waveguide from Siegel et 
al. [80]. 
Drobinski et al. also published results of experiments carried out on total 
peripheral artery occlusions [86]. Clinical tests were conducted on coronary and 
peripheral arteries using a 130 cm long wire waveguide (0.8 mm wire with 2.0 
mm ball distal tip) and show that up to 70% of the blockage can be removed by 
this method [86]. Crossing the occlusion was achieved in 6 minutes or less, with 
occlusion length ranging from 5-10 cm, feedrate (if continuous) < 17 mm/min, 
the amplitudes of vibration at wire waveguide distal tip are 50 µm.  
More recently, up to and following the approval of the CROSSERTM system, 
studies have been conducted using the clinically approved device. According to 
the manufactures specification, the CROSSERTM system operates at 20 kHz 
approximately which delivers stroke depths of 20 µm [4, 44, 53]. They describe 
that the high frequency, low amplitude, longitudinal stroke pulverizes a channel 
through the CTO by mechanical impact [53].  
Wire waveguide 
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In this study they describe some necessary design changes which had to be 
made to the wire waveguide in order to access the lesion site [53]. The aims of 
this study were to first access the safety of the device and identify any possible 
opportunities for device improvement. The initial wire was a feasibility stage 
wire design (1.3 mm diameter uncoated wire) which was then reduced to a 
hydrophilically coated 1.1 mm diameter wire waveguide which dramatically 
improved deliverability. They reported an increase in clinical success from 40-
76% as a result.  Another study using the CROSSERTM system highlighted that it 
was effective with ostial and distal lesions, tapered and abrupt lesion 
morphologies [4]. Recent clinical trials (CENTRAL), completed in 2011, using 
the CROSSERTM system investigates the efficacy of the device to navigate 
through the central lumen [131]. 
 
2.4.3 Additional benefits of using ultrasonic angioplasty 
Episodes of arterial spasm resulting in myocardial infarction have been 
encountered when using balloon angioplasty [132], however it was found that 
the ultrasonic energy induces smooth muscle relaxation, a secondary effect 
which may improve safety of arterial recanalisation by reducing vaso-
constriction during catheterisation. Fischell et al. suggested that air bubble 
stimulation generated by the ultrasound could be the mechanism behind the 
beneficial vaso-relaxation they observed [124]. This phenomenon was also 
observed by Chokshi et al. [133]. In a study conducted by Demer et al.  on follow 
up balloon dilation of the artery after ultrasound wire waveguide treatment, 
incidences of increased distensibility of calcific atherosclerotic arteries after 
treatment using the ultrasound are reported [5].  
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2.4.4 Summary of clinical and experimental studies using ultrasonic wire 
waveguides 
 
 The wire waveguide devices typically operate in the low ultrasonic 
frequency range (20 - 50 kHz) and deliver longitudinal amplitudes of 
vibration at the wire waveguide distal tip between 0- 60 µm. The wire 
waveguides shafts are typically slender (0.35 – 2.0 mm) but are often 
tipped with enlarged spheres 1- 2.5 mm in diameter. A review of the 
operating parameters is shown in Table 2-1. 
 The forces required to recanalise occluded arteries is given by Siegel et 
al. [2] as 0.98 – 1.96 N using amplitudes of vibration between 15 – 30 µm 
with a 1.7 mm wire waveguide ball distal tip. These operating 
parameters are similar to the CROSSERTM catheter. 
 The EU and FDA approved device for CTOs, the CROSSERTM, delivers 
amplitudes of vibration in the region of 20 µm to a distal tip of 1.1 or 1.5 
mm in diameter.  
 CTOs are associated with increased risk of arterial perforation, possibly a 
result of the guidewire being deflected towards the arterial wall.  
 Recent clinical trials (CENTRAL) are investigating the efficacy of the 
CROSSERTM device to navigate through the central lumen. The purpose of 
the trial may be a response to the risk of arterial perforation in the 
treatment of CTOs generally. 
 To date there has been no study on the effects, if any, of the wire 
waveguide on perforation of the artery wall. 
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Description Frequency 
(kHz) 
Distal tip 
amplitude of 
vibration (µm) 
Wire waveguide 
details 
Investigator 
Thrombolysis 
In vitro 
26.5 25-30 Hollow wire 
210-290 mm length 
Trubestein [73] 
 
Thrombolysis  
In vitro 
20 63.5 – 111 Titanium wire 
0.72 mm shaft, 2.0 
mm ball tip 
Ariani et al. [71] 
Atherosclerotic 
lesion 
In vitro 
20 50± 25 Titanium wire 
0.5 mm with 2.0 mm 
ball tip 
Demer et al. [5] 
Atherosclerotic 
lesion 
In vitro 
22.5 130/200 Titanium wire 
1.98/2.46 mm ball 
tip 
Makin et al. [7] 
Atherosclerotic 
lesion 
In vitro 
19.5 15-30 1.7 mm ball tip Siegel et al. [2] 
Atherosclerotic 
lesion 
In vitro 
24 90 – 150 Titanium 
2.5 mm hollow wire 
Chikada [72] 
Atherosclerotic 
lesion 
In vitro 
20 N/A Titanium 
2.0 mm wire tip 
Fischell et al. 
[124] 
Atherosclerotic 
lesion 
In vivo 
20 150± 25 Aluminium alloy 
1.6 mm wire tip 
Rosenschein et 
al. [6] 
Atherosclerotic 
lesion 
In vivo 
20 10 1.1 – 1.7 mm wire tip CROSSERTM 
System [75] 
Atherosclerotic 
lesion 
In vivo 
19.5 55.5 Titanium 
2.0 - 3.0 mm wire tip 
Siegel et al. [80] 
Atherosclerotic 
lesion 
In vivo 
N/A 50 Titanium 
0.8 mm shaft, 2.0/2.5 
mm ball tipped wire 
Drobinski et al. 
[86] 
Table 2-1 : Review of operating parameters for thrombolysis and angioplasty, in 
vitro and in vivo. 
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2.5 Performance evaluation of the devices 
  While some investigators examine the efficacy of their device in terms of 
clinical outcomes [4, 131], other investigators investigate the fundamentals of 
the device operation. This includes:  
 
i. Wire waveguide materials and mechanics. 
ii. Acoustic pressure field generated by the wire waveguide distal tip. 
 
2.5.1 Wire waveguides materials and mechanics 
Titanium and Nickel Titanium alloys (Nitinol) and high mechanical Q 
Aluminium were traditionally used as wire waveguide material because of their 
super elastic strength [87].  The mechanical quality factor (Q) of the wire 
waveguide material is proportional to the ratio of stored energy dissipated per 
unit material volume per cycle of vibration. A reduction in the quantity of the 
energy dissipated as thermal energy is associated with high material Q values. 
High Q values are also associated with lower attenuation of the ultrasound per 
unit length of wire waveguide [87]. In comparison, Aluminium has Q values in 
the region of 50,000 while Titanium has roughly half (24,000) [87].  
The wire waveguide performance has been analysed experimentally by a 
number of investigators [71, 134]. Ariani et al. describe a method of measuring 
the amplitudes of vibration at the distal tip of the wire waveguide for power 
input settings by means of an optical microscope [71]. This method of distal tip 
amplitude of vibration measurement was also performed by Gavin et al. for a 
similar ultrasonic apparatus [134]. Other methods using a LASER measurement 
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system has also been investigated.  In terms of accuracy, however,  both 
methods yield very similar results [135]. 
 
2.5.2 Acoustic pressure field (theoretical) 
The vibrating wire in a fluid causes an oscillating acoustic pressure field 
around the distal tip. This field is caused by compression/rarefaction waves 
radiating from the source which produce sinusoidal forces on the surrounding 
tissue. Variations in density in the acoustic medium through which the wave 
propagates can cause reflection. The reflected wave may combine with the 
incident wave to produce a standing wave structure.  Standing waves in tissue 
can cause free moving cells to gather at the nodes of the wave structure. In 
blood, this effect may cause it to coagulate at these locations [108].  Assuming 
linear wave propagation, for an incompressible fluid with no mean flow, and 
neglecting shear stresses, the lossless acoustic wave equation (Equation 2) can 
be written as [136]: 
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The speed of sound in the medium, c, can be calculated using Equation 3: 
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Where the bulk modulus of the material is given by k and material density is 
given by ρ. The spatial-average-temporal-average acoustic intensity at the 
waveguide radiating face, ISATA, can be derived from the measurement of 
acoustic pressure under the assumption of plane progressive wave propagation 
(a situation in which particle velocity and acoustic pressure are in phase). Under 
these assumptions, the peak intensity can be calculated using Equation 4 [91]: 
 
      
    
 
   
                                                                                                              Equation 4 
 
 
It should be noted that the above wave equation is a linear approximation. Wave 
velocity is a function of the particle velocity (or acoustic pressure). High 
pressure components of the wave travel more quickly than the lower pressure 
regions, eventually overtaking them and generating a shock front, a non-linear 
effect [137]. 
 
2.5.3 Reflection of the acoustic wave 
Standing waves in the acoustic field are caused by the reflection which 
occurs at the interface of layers/materials of different acoustic impedances. For 
therapeutic ultrasound the reflected sound power for various tissue types and 
the tissue-air interface encountered in vivo can be calculated. The sound power 
reflection coefficient (αr) is given in Equation 5 [138]: 
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Thus, assuming no energy loss, the total reflection of the incident energy must 
correspond to a unity value of reflection coefficient. The speed of sound for air 
and blood/tissue was taken as 340 m/s and 1580 m/s respectively and with 
densities of 1.2 kg/m3 and 1050 kg/m3 respectively [100]. Using Equation 5 and 
the material properties given, the sound power reflection can be calculated to 
be 99.9% at a tissue-air interface. 
 
2.5.4 Flat vibrating wire tip in a fluid 
Also applicable to this work is the solution for the pressure, Pmax, at a small 
piston source (circular radiating face) from Wu and Nyborg [106]. This closely 
represents experimental waveguides/transducers with flat circular radiating 
faces. Figure 2-17 shows a diagram of a radiating piston which illustrated the 
parameters used in Equation 6. Where the amplitude of displacement is given 
by ξ0.  
 
       
                                                                                                        Equation 6 
  
 
 
Figure 2-17: Illustration of parameters used in calculation of acoustic pressures 
and acoustic intensities. 
R 
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2.5.5 Radiused vibrating wire tip in a fluid 
Analytical solutions for the acoustic pressures for a pulsating sphere in a 
fluid and the more representative oscillating sphere in a fluid also exist. The 
analytical solution proposed by Morse [139] for the pressure field near an 
oscillating sphere in a fluid is given in Equation 7 and associated Figure 2-18. 
Although this linear solution is limited to a simple geometry, it has been 
suggested by Nyborg [136] as a useful approximation to predict pressure 
amplitudes and subsequent cavitation associated with the frequencies and 
conditions encountered in ultrasound angioplasty. 
 
       
        
  |    |
  
                                                                            Equation 7 
 
 
Where the radius of the sphere is given by R, the radial distance from centre of 
sphere is given by r and the angle between the direction of oscillation and 
radius-vector is given by θ.  
2R
θ
P
r
Direction of 
motion  
Figure 2-18: Idealised model of waveguide spherical tip. 
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2.5.6 Acoustic pressure field (experimental) 
The significance of the pressure amplitude at the waveguide tip, the role it 
plays in cavitation and pressures developed in surrounding fluids and tissues 
has led a number of researchers to investigate this phenomenon experimentally 
[7, 123, 140]. 
Makin and Everbach investigated the acoustic pressures developed by an 
ultrasonically vibrating wire waveguide submerged in a liquid with acoustic 
properties similar to that of blood [7]. The experiment consisted of a 2.46 mm 
diameter spherical tipped wire waveguide oscillating in a cylinder of fluid 
(peripheral arterial phantom) at 22.5 kHz. Their experiment comprised of an 
ultrasonic emitter-receiver submerged in a tube within a 355 mm high acrylic 
tank with an internal diameter of 203 mm. The tank was filled with water or a 
glycerine-water mix. The experiment was described as having a 355 mm high 
tank filled to 345 mm with fluid (i.e. 10 mm of air at top of cylinder). A 
schematic of this experimental set up is shown in Figure 2-19. 
Fluid level
Hydrophone
Inner tube 
(Polyurethane)
Wire waveguide 
source
Water
 
Figure 2-19 : Schematic of experimental set up by Makin and Everbach. 
345mm 
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Pressures were measured in the range of 12-250 mm from the vibrating tip 
using an acoustic hydrophone; measurements in the vicinity of the tip were 
restricted due to the limitations of their measuring equipment (potentially 
damaging their sensor).  Their results demonstrate two important effects of the 
ultrasound: 
 
i. Despite not being able to directly measure pressures at the wire 
waveguide distal tip, the authors were able to measure cavitation activity 
with a 20 MHz focused transducer. They concluded that not only was 
cavitation evident, but that the amount of cavitation was related to distal 
tip amplitude of vibration and also to the tip geometry.  
ii. Their results also showed a standing wave in the acoustic domain of 
significant amplitude. They concluded that because the acrylic walls 
were acoustically transparent at the frequency used this standing wave 
was caused by an impedance mismatch between the liquid 
representative of blood and the surrounding air.  
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2.5.7 Summary of performance evaluation of these devices 
 
 The distal tip amplitudes of vibration are a function of wire waveguide 
length, input displacement and losses in the wire waveguide. Nodes and 
anti-nodes exist along the wire waveguide. The amplitudes of vibration 
at the wire waveguide distal tip can be determined both experimentally 
(microscope, image capture software) and analytically. 
 The maximum acoustic pressures and the Spatial-Average-Temporal-
Average acoustic intensities can be analytically determined for a flat and 
radiused wire waveguide distal tip. Analytical solutions given in this 
chapter do not account for non-linearity of the ultrasonic sound 
propagation or complex geometries of the wire waveguide and are, 
therefore, limited. 
 In vivo, complex acoustic conditions exist because of the impedance 
mismatch between tissue and fluids. Surrounding tissues such as bone 
can cause high sound power reflection. Indeed, the tissue-air interface 
from the body and surrounding air atmosphere can act to reflect as much 
as 99.9 % of the sound power. 
 It is possible to experimentally measure the pressure in the acoustic field 
generated by a wire waveguide distal tip using a hydrophone but 
pressures in regions < 12 mm to the distal tip cannot be measured by 
this experimentally. High pressures and cavitation in this proximity can 
critically damage the hydrophone. 
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2.6 Computational numerical analysis 
 
2.6.1 Finite Element Analysis  
Finite Element Analysis (FEA) is a numerical method of solving partial 
differential equations to determine approximate solutions for field variables, 
such as pressure, strain, temperature, electromagnetism etc. This technique is 
used to simulate an object or system (static and dynamic analysis) by 
representing a geometrically similar model. This method divides the model into 
discrete elements or finite elements (i.e. a mesh). Material properties, structures 
and loads are then applied to these elements. A finer mesh will act to improve 
resolution but subsequently increases computational effort. FEA can be 
advantageous over experimental methods as it can model complex geometries 
and be used to recover results where experimental methods cannot.  Numerical 
models are often simplified representations of actual systems and are limited by 
adequate knowledge of material properties and response, input parameters etc. 
Many commercially available FEA packages offer extensive post processing 
options, allowing for the analysis of many different aspects of the solved model.  
 
2.6.2 FEA for ultrasonic applications 
It is possible to apply this numerical method to examine certain aspects of 
ultrasound and its propagation through media such as blood and tissue. Some 
investigators have attempted to model some of the effects of ultrasound, such as 
acoustic streaming and heating [141-144]. Other research has been performed 
on modelling the operation of the ultrasonic angioplasty devices, i.e. 
piezoelectric effect and wire waveguide motion [145, 146]. There is some work 
70 
on the effects of dynamic loading due to high frequency mechanical impact on 
the tissue. Some acoustic models have been created in biological media using 
FEA, but generally these are at sonic or subsonic levels [147, 148]. 
 
2.6.3 Linearity 
Ultrasound is fundamentally a non-linear propagation of sound waves 
[149]. A non-linear partial differential equation is used to describe an ultrasonic 
wave propagating in biological tissue. This derives from the non-linear 
pressure-density relationship and variance in speed of sound with pressure 
amplitude during compression/rarefaction cycles which has a greater influence 
at higher frequencies and at greater intensities.  In high frequency ultrasonics, 
there are some non-linear material properties which also need to be taken into 
account for tissues. These include the amplitude dependent attenuation, 
harmonic generation, increased energy dissipation, acoustic saturation and 
waveform distortion [150].  Some work has been done on soft tissue response to 
low ultrasonic frequencies by Palmeri [151]. It is stated that at the low 
ultrasonic frequencies (<100 kHz), soft tissues can be also be considered and 
modelled as linear elastic, isotropic solids [151] . Since the applied frequencies 
used in this work are in the sub 100 kHz range the properties of the media are 
modelled using linear assumptions.    
The propagation speed of the wave as it passes through the medium is a 
function of the particle velocity of the tissue (medium). When the amplitude is 
infinitesimally small, the ultrasound propagation can be considered as a linear 
phenomenon [152]. When the pressure amplitude becomes significantly large 
this linear approximation no longer holds [152].  The application of the linear 
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material properties and assumption of linear wave propagation greatly reduces 
the computational time and power substantially.  
  
2.6.4 Mesh density in ultrasonic acoustics 
The accuracy of the model is related to the density of the mesh, i.e. the 
spatial resolution. Sufficient element density is required to avoid aliasing data 
between nodes and to capture the small perturbations in the high frequency 
acoustic field, as can be seen in Figure 2-20.  In acoustics, the mesh density is 
often described as Elements Per Wavelength (EPW). Wavelength is inversely 
proportional to the frequency, so higher frequency ultrasonics requires more 
elements and therefore greater computational power. 
There is some data on the EPW which should be used to accurately predict 
ultrasonic transmission from emitters and propagation through elastic media, 
such as tissue. EPWs of anywhere from 8-20 for ultrasonic transducers and 
waveguides are described in the literature [146, 153-155]. Information on the 
EPW for acoustic models for low frequency ultrasonics is sparse. Lewis et al. did 
some initial work on FEA acoustic modelling of ultrasonic cleaning baths with a 
mesh density of 20 EPW [156]. This value was taken from Mosser’s modelling 
protocol of modelling of mechanical waves in wire waveguides, not the acoustic 
field [153].  
In ultrasonic acoustics, more complex acoustic conditions exist and, 
therefore, more elements may be required to capture high frequency wave 
interactions. Model mesh convergence is typically applied to the models to 
ensure that the correct mesh density has been applied. A sensitivity analysis 
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may then be performed to ensure that the mesh density is accurate for a range 
of input parameters (i.e. frequency). 
  
 
 
Figure 2-20: Effects of mesh density on resolution [157]. 
 
2.6.5 Acoustic FEA of ultrasound angioplasty 
Previous FEA of ultrasonic wire waveguides has focussed on modelling 
how the wire waveguide transmits the ultrasonic waves to the distal tip. Gavin 
performed a modal and harmonic analysis to determine wire waveguide 
resonant characteristics, damping and stresses [13]. The same authors also 
modelled the pressure field in the fluid and the effect the presence of fluid had 
on the resonant response of waveguides.  This FEA, however, did not perform a 
mesh density analysis of the acoustic domain and therefore may be subject to 
inaccuracies. 
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Local conditions at the wire waveguide distal tip make it extremely 
difficult if not impossible to measure the acoustic pressure field immediately at 
the vibrating wire distal tip. Makin et al., describe their attempt to 
experimentally measure the acoustic pressures at the wire tip but state that 
measurements closer than 12 mm were not possible with their hydrophone [7]. 
High pressures and cavitation can critically damage the hydrophone so caution 
must be exercised. FEA offers an insight to the acoustic pressures both at the 
wire distal tip and indeed the entire acoustic field. 
By creating models to determine the acoustic activity, the onset of 
cavitation can be predicted. These are areas in which pressures are sufficiently 
low to cause cavitation can be identified throughout the acoustic field. Complex 
geometries and multiple fluids can also be considered. 
Relatively speaking, ultrasonic angioplasty is still in its infancy and 
through design and testing, improvements can be made. FEA is an ideal method 
for design improvements, acoustic FEA of the ultrasonic device can be used to 
examine the effects of the following on the acoustic field: 
 
i. Frequency 
ii. Amplitude of vibration 
iii. Distal tip geometries 
iv. Fluid and tissue properties 
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2.6.6 Summary of computational numerical analysis 
 
 Ultrasound is a non-linear propagation of high frequency pressure 
waves. But for low ultrasonic frequency operation (<100 kHz), using 
linear assumptions FEA may provide accurate results. 
 Acoustic FEA can be used to predict the pressures generated by a 
vibrating wire waveguide. If adequate mesh densities (Elements Per 
Wavelength (EPW)) are applied, these models may then be used to 
numerically solve the entire acoustic field, providing data which cannot 
be obtained experimentally.  
 The correct mesh densities (EPW) for modelling the acoustic field 
generated by ultrasonic angioplasty devices at typical operating 
parameters have not yet been investigated. More complex acoustic 
conditions exist and, therefore, more elements are required to capture 
the high frequency wave interactions, especially in regions where there 
is high acoustic activity, i.e. reflection. 
 Using the FEA with an inertial cavitation threshold for the acoustic 
medium, it is possible to determine the operating conditions necessary to 
generate cavitation. The region (spatial) in which cavitation occurs can 
also be determined.  
 With a verified and validated model, this method can, therefore, be used 
to examine the effects of distal tip geometry, acoustic frequencies, tissue 
properties and amplitudes of vibration on the acoustic field. 
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2.7 Project outline 
Using the background information established from the literature review, 
a method of approach to answering the research question, as outlined in 
Chapter 1, is presented. 
To determine if the ultrasonically energised wire waveguide permits perforation of soft 
arterial tissue at lower forces
Use FEA as a design tool. 
Determine acoustic 
pressure field
Modify an ultrasonic 
apparatus with similar 
operating parameters to 
clinical devices
Test the ultrasonic 
apparatus on 
cardiovascular tissue 
using a test rig
Create and verify FEA 
model using linear 
acoustic assumptions
Assess current ultrasonic 
apparatus
Improve ultrasonic 
apparatus wire waveguide 
design and housing
Validate FEA model 
against experimental data
Ph 1 tissue testing.
Pilot study examine effects 
of US wire waveguide on 
soft tissue perforation
Ph 2 tissue testing.
Examine perforation 
forces and energy in more 
detail. Histological 
analysis
Use FEA model as design 
tool for wire waveguides
Design and manufacture 
test rig and measurement 
devices
Ph 3 tissue testing.
Examine effects of 
feedrate and angle on 
forces & temp’
Characterise ultrasonic 
apparatus with design 
changes
Objectives
 
Figure 2-21 : Research aim and objectives. 
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CHAPTER 
3 NUMERICAL ANALYSIS 
3.1 Introduction 
The goal of this work is to refine and extend the Finite Element Analysis 
(FEA) methodology, previously used by Gavin [13] to predict the waveguide 
mechanics and ultrasound transmission into the fluid, to simulate reflection at 
tissue interfaces and then compare these predictions with reference to 
experimental data from the literature. The method is then also applied to the 
prediction of ultrasound transmission for proposed new distal tip geometries. 
The acoustic FEA is capable of predicting distal tip acoustic pressures and the 
onset of cavitation, with the inclusion of an adequate threshold value. 
FEA is used to model wire waveguide distal tip conditions in an effort to 
establish operating parameters for an ultrasonic apparatus modified as part of 
this work in a tissue testing programme.  The modelling approach is conducted 
in three stages, also illustrated in Figure 3-2: 
 
i. Determination of adequate mesh densities for the frequency range and 
amplitudes of vibration of interest by comparing the results with Morse’s 
analytical solution for pressures generated by a vibrating sphere [139].  
ii. Using this verified model, the pressures near the distal tip of the 
waveguide for proposed distal tip design improvements are predicted 
with the goal of understanding the effects of tip geometry, amplitude of 
vibration and frequency on the onset of cavitation. 
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iii. Finally, the model is validated against experimental results reported in 
the literature in peripheral arterial phantom [7].  
 
3.2 Theoretical background 
Ultrasound is a non-linear propagation of sound which is above the human 
hearing threshold. This derives from the non-linear pressure density 
relationship and variance in speed of sound with pressure amplitude. This has a 
greater effect at higher frequencies and at greater acoustic intensities.  
For solving finite element acoustic fluid-structure interaction models, the 
Navier-Stokes equations of fluid momentum and the flow continuity equation 
must be considered along with the structural dynamics equation. Assuming 
linear wave propagation, for an incompressible fluid with no mean flow, and 
neglecting shear stresses, the lossless acoustic wave equation can be written as: 
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For a harmonically varying pressure: 
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tjeP                                                                                                                      Equation 10 
 
 
Where: P Pressure amplitude 
  
f 2  
  
1j  
  f = Frequency of oscillation of the pressure 
 
Equation 8 reduces to the Helmholtz equation: 
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This governing equation for acoustic wave propagation can be discretized 
taking into account the coupling of acoustic pressure and structural motion at 
the fluid-structure interface [158].  
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 = the 2nd derivative of nodal pressure and nodal pressure 
respectively and [R] = a coupling matrix that represents effective area 
associated with each node. 
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The equations given in Equation 12 and 13 can be combined into a single 
relationship that describes load quantities at all locations in the fluid and 
structure as shown in Equation 14. 
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3.3 Methodology 
The general methodology for the FEA is outlined in Figure 3-2. 
Computational models were developed using a commercially available finite 
element package (ANSYS). Acoustic Fluid29 elements are in the general acoustic 
field and all models were axisymmetric, making use of symmetrical conditions 
generally encountered in wire waveguide design. The Fluid29 2-D elements 
have four corner nodes with three degrees of freedom per node, x, y directions 
and pressure and are governed by the lossless wave equation. The model 
required the inclusion of an infinite absorbing boundary layer to define the 
outer limit of the acoustic model. An infinite acoustic boundary using fluid 
elements Fluid129 is set up along the model boundary according to the 
following defined conditions i.e. this absorbing boundary must lie on an arc of 
radius greater than 0.2λ [158]. Where λ = c/f is the dominant wavelength. The 
acoustic properties of the fluid elements representing the blood was given as c = 
1580m/s and ρ = 1050 kg/m3 [100].  
A Fluid-Structure Interface (FSI) defined where the wire waveguide distal 
tip and fluid meet. The interaction of the fluid nodes and structural nodes at the 
fluid-structure interface is such that the pressure in the acoustic field exerts an 
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applied force on the structural elements which produce an effective fluid load. 
The governing equations for both the fluid nodes and structural nodes are 
shown in Equation 14. Figure 3-1 shows an example of the model geometry and 
mesh. All models are solved for a harmonically varying distal tip displacement 
on the FSI. It has been shown by Gavin that is not necessary to include the wire 
waveguide structural elements [13]. The input displacement on the FSI specified 
the amplitude of vibration of the distal tip. A frequency sweep is also performed 
for a range of frequencies of interest. Pressure plots were then generated.  
 
 
Figure 3-1 : Model geometry and mesh structure. 
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Figure 3-2 : FEA methodology. 
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3.3.1 Model verification: mesh density analysis 
Understanding the effect of the mesh density on the model’s ability to 
resolve the ultrasonic waves and pressures near the distal tip is critical. A 
simple acoustic axisymmetric model of the ultrasonic wire waveguide was 
developed that can predict the pressure field around the vibrating tip.  A model 
was created of a spherical tipped wire waveguide vibrating in a fluid, which 
represented blood [100].  
For controlled meshing the model geometry was created manually by 
assigning areas to connecting lines. Each line of known length is split according 
to the mesh density and subsequently meshed. The lines are split according to 
the wavelength for the frequency which is to be modelled. The model was 
meshed manually for each frequency of operation. The aim of this meshing 
technique is to create quadrilateral elements shapes with 1:1 aspect ratios.  
 A mesh density study was performed in which the number of elements 
per wavelength (EPW) was increased until the model correlated with the 
analytical solution for a oscillating spherical sphere [139]. Since the wavelength 
is frequency dependent, a range of frequencies and distal tip amplitudes of 
vibrations were modelled to verify that the models are still accurate in 
predicting acoustic pressures using this EPW count for the typical settings 
encountered using ultrasound angioplasty.  
 
3.3.1.1 Model verification and mesh density analysis results 
The mesh density analysis results are shown in Figure 3-3 and Table 3-1. 
The results clearly show the effects of insufficient mesh density when trying to 
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accurately predict the pressure amplitudes at the distal tip of the waveguide and 
in the acoustic field around the waveguide.  The model was initially meshed 
with 20 EPW as reported by others in similar applications to be sufficient [146, 
148, 155, 156] and then increased until a good correlation was achieved with 
the pressures directly ahead of the spherical ball tip as determined from the 
analytical solution. This was shown to amount to at least 140 EPW for the 
conditions of interest.  
 
Figure 3-3 : Mesh density analysis for verification model. Pressure versus 
distance for a 2.0 mm diameter ball tip (amplitude of vibration of 25 µm) at 22.5 
kHz and increasing EPW count (20-300 EPW). 
 
For 20 EPW, the predicted maximum pressure at the distal tip was 
approximately 270 kPa, significantly lower than the distal tip pressure of 
approximately 600 kPa given by the analytical solution. 140 EPW were required 
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to closely predict the analytical pressures. These results highlight how 
suboptimum meshing can render models prone to errors and inaccuracies. The 
magnitude of the discrepancies between the Morse’s analytical solution and FEA 
model for maximum pressures at the spherical ball tip surface can be seen in 
Table 3-1. It also shows that a percentage difference of approximately 2.5% can 
be achieved when compared with the analytical solution for an element count of 
140 EPW. For increasing of the mesh density from 140 – 300 EPW a 0.5 % 
discrepancy exists in the difference between the FEA and the analytical solution. 
For the additional computational power required for increasing this mesh 
density, this discrepancy is agreeable. 
 
EPW 20 40 60 80 100 120 140 300 
FEA max pressure at 
tip (kPa) 
269.5 402.2 471.1 509.5 532.6 547.2 587.0 589.5 
% difference from 
analytical solution 
53 29.7 17.7 11 7 4.5 -2.4 -2.9 
 
Table 3-1 : Percentage difference of maximum pressure at distal tip versus 
pressures calculated by analytical solution (Morse [139]). 
 
Since these devices are often used over a range of frequencies (20-50 kHz) 
and at distal tip amplitudes of vibration (≈ 0- 60 µm), a number of models were 
created using the upper range of distal tip amplitudes of vibration (40 µm), for a 
range of different frequencies, using the 140 EPW established from previous 
results. The results are shown in Figure 3-4. The purpose of this model was to 
examine the effects of frequency and distal tip amplitudes on the accuracy of the 
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model using the 140 EPW. This study also showed that 140 EPW produced 
pressure profiles with close agreement to the Morse analytical solution for the 
frequencies and distal tip displacements modelled. 
 
22.5 KHz FEA 
22.5 KHz Morse
35 KHz Morse
45 KHz Morse
50 KHz Morse
40 KHz Morse
30 KHz Morse
45 KHz FEA 
40 KHz FEA 
35 KHz FEA 
30 KHz FEA 
50 KHz FEA 
 
 
Figure 3-4 : Pressure versus distance from FEA model of 1.0 mm diameter 
radiused distal tip with 140 EPW and distal tip amplitudes of vibration of 40 µm 
for a range of frequencies vs. analytical solution (Morse [139]). 
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3.3.2 Model validation: In vivo model in a peripheral artery 
Since both methods (FEA and analytical) do not account for the non-linear 
wave propagation of ultrasound, validation of the model was necessary. To 
validate the acoustic FEA for this application and to further understand the 
effects of the acoustic pressures during ultrasonic angioplasty, a model 
representative of Makin and Everbach’s experimental study using a 22.5 kHz 
wire waveguide device is created [7], this is shown in Figure 3-5. 
 This is representative of a peripheral artery with an acoustic tissue-air 
interface typically encountered in vivo. Their experiment involved an ultrasonic 
emitter (wire waveguide, ball tipped 2.46 mm Ø) and receiver (hydrophone) 
submerged in a liquid glycerine/water blood acoustic analogue. The aim of this 
experiment was to measure the pressures over a number of distances from the 
vibrating wire waveguide. The pressures over this distance were then plotted. 
The surrounding air interface created a standing wave in the acoustic field plot.  
A geometric representation of this experiment was created. The inner 
dimensions of the cylindrical tank which contained the liquid medium were 
developed by creating areas from connecting lines. The lines could then be split 
and meshed according to the mesh density (140 EPW). Fluid29 elements were 
used for the liquid environment. These elements were assigned to have linear 
acoustic material properties (c = 1580m/s and ρ = 1050 kg/m3). The FSI was 
created along the nodes where the wire waveguide and liquid meet. Again no 
structural elements were created to represent the wire waveguide since the 
displacement on the nodes of the FSI would suffice. Fluid129 infinite acoustic 
boundary layer was also included in the model. 
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Where the previous FEA verification model focused on single fluid fields, 
the validation model required other complexities such as a liquid/air interface. 
The model incorporated liquid (blood) and air properties, geometries based on 
Makin and Everbach’s experiment and frequency of operation. Makin and 
Everbach specified maximum amplitude of vibration of their wire waveguide 
distal tip of 65 µm at 100% power input but applied very low power inputs for 
their experiment.  Based on similar equipment and set-ups the amplitude of 
vibration applied to the distal tip for the FEA is inferred to be 10% of total 
output ≈ 6.5 µm amplitude of vibration. These displacements were then applied 
to the nodes along the FSI in the y-direction.  
The aim of this FEA was to examine if one could accurately predict the 
pressures recorded but also predict the standing wave (nodes and amplitudes) 
generated in Makin’s experiment using linear assumptions. This would validate 
the mesh density study and examine whether or not ultrasound at these low 
acoustic intensities can be solved accurately by assuming linear acoustic 
relationships. 
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Figure 3-5 : a) Schematic of Makin and Everbach’s experimental set up. b) 
Interpretation of the FEA acoustic model of Makin’s experiment. 
3.3.2.1 Model validation: In vivo model in a peripheral artery results 
Using the mesh density of 140 EPW established by the verification model, 
the validation model shows a close correlation between the experimentally 
measured pressure data from the Makin experiment and the pressures 
predicted by the FEA model of this experiment. The results are plotted in Figure 
3-6. The standing wave nodal locations show a very close correlation but some 
discrepancies exist in the pressure amplitudes. The pressure amplitude 
variations in the model may be due to a number of factors, including, 
inaccuracies of the inputted material acoustic properties (local variations) or 
non-linear effects. 
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Pressures presented here are at a distance 12 mm from the wire 
waveguide and are very small in comparison to the maximum pressures at the 
waveguide distal tip (1200 Pa Vs. 90 kPa). The largest deviation in pressure 
amplitude from the experimental and FEA is ≈ 400 Pa. In comparison to a model 
with a pressure range 0 – 90 kPa this amount of discrepancy is deemed 
agreeable for determining the critical pressures.   
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6 : Comparison of experimentally determined standing wave and 
predicted standing wave from FEA. 
 
3.3.3 Acoustic pressure field versus waveguide parameters 
Using the verified model with the appropriate mesh density, as 
determined from the above methodology, a number of tip geometries similar to 
those reported in the literature were modelled. The acoustic pressure field 
associated with each wire waveguide distal tip design was assessed for a range 
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of amplitudes of vibration based on those input settings commonly reported. 
The frequency of 22.5 kHz is applied to these models as this was the frequency 
used by Makin et al. The distal tip geometries modelled (diagrams included in 
figures) were: 
i. Spherical ball tip, used for model verification 
ii. Radiused tip (1.0 mm diameter) 
iii. Flat tip (1.0 mm and 2.0 mm diameter) 
iv.  Inverted dome (1.0 mm diameter)  
3.3.3.1 Acoustic pressure field versus wire waveguide distal tip geometry 
results 
Using the verified model mesh density (i.e. 140 EPW), the pressures 
created by different wire waveguide distal tip geometries could now be 
investigated using FEA. Operating at a frequency of 22.5 kHz, the following 
results were achieved for the distal tip geometries modelled. Figure 3-7 shows 
the pressure results for the 1.0 mm radiused tip for a range of wire waveguide 
distal tip amplitude of vibrations (0 – 60 µm). The predicted pressures show 
clearly the effect that increasing distal tip displacement has on the waveguide 
performance. With the inclusion of a cavitation threshold relevant to the in vivo 
conditions, the onset of this critical event may be predicted. Assuming suitable 
gas nuclei present, according to Nyborg, cavitation is observed above pressures 
in the range of 0.1 – 0.2 MPa [136]. 
Figure 3-8 shows the predicted pressures for a 1.0 mm flat distal tip. For 
the 1.0 mm radiused distal tip, the maximum pressure is approximately 270 kPa 
(amplitudes of vibration of 60 µm). For the same amplitudes of vibration, a 1.0 
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mm flat distal tip produces nearly 550 kPa. The 1.0 mm inverted dome for the 
same amplitudes of vibration, as shown in Figure 3-9 produces nearly 1,100 
kPa, an increase of close to 300% when compared to that of the 1.0 mm 
radiused wire for the same amplitude of vibration.  
The effect of distal tip size was also assessed. For flat distal tips, doubling 
the diameter of the wire waveguide will have a proportionate effect on the 
pressure; with the 2.0 mm flat distal tip wire generating 1,100 kPa, as shown in 
Figure 3-10. Of interest, also, is that the wire distal tip geometry produces 
characteristic acoustic pressure decay profiles. Ideally, for the purpose of 
ablation of the diseased material directly ahead of the distal tip, it is desirable to 
project the maximum pressures directly ahead as opposed to latterly, where 
they may damage the surrounding healthy tissue. The walls of arteries may also 
harbour nuclei that could generate undesirable cavitation within the healthy 
artery wall; therefore, these pressures should be kept to a minimum.  
The inverted dome results in a higher pressure distribution, with the walls 
of the dome acting as a barrier to the adjacent healthy artery wall where 
pressures are lower. Also, this shape acts to intensify the pressure by a focal 
mechanism. The spherical and radiused configurations display a wide dipole-
like pressure distribution in all directions, spatially ‘wasting’ some of the 
acoustic power that could be used to ablate the diseased material ahead. Any 
geometry, however, is limited by surgical interventional constraints, flexibility, 
risk of arterial perforation and, therefore, some wire waveguide distal tips may 
be associated with additional drawbacks. 
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Figure 3-7 : Pressure versus distance of 1.0 mm radiused distal tip with 140 
EPW at 22.5 kHz for amplitudes of vibrations 16 – 60 µm. 
 
Figure 3-8 : Pressure versus distance of 1.0 mm flat distal tip with 140 EPW at 
22.5 kHz for amplitudes of vibrations 16 – 60 µm. 
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Figure 3-9 : Pressure versus distance of 1.0 mm inverted dome distal tip with 
140 EPW at 22.5 kHz for amplitudes of vibrations 16 – 60 µm. 
Figure 3-10 : Pressure versus distance of 2.0 mm flat distal tip with 140 EPW at 
22.5 kHz for amplitudes of vibrations 16 – 60 µm. 
Potential 
cavitation 
threshold 
Potential 
cavitation 
threshold 
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3.4 Conclusions 
A linear acoustic fluid-structure model can be used in the prediction of the 
pressure profiles and cavitation using ultrasonically vibrating wire waveguides. 
The model compared favourably with the analytical solution provided an 
adequate mesh density was utilised. This was determined to be approximately 
140 EPW for the frequencies and amplitudes modelled here and encountered 
during use of these devices. 
The model showed the relationship between distal tip amplitude of 
vibration, frequency and pressures developed. Increasing the frequency does 
increase the pressure substantially; however, the intensities to cause cavitation 
also increase. Most devices operate in the region up to 50 kHz and the EPW 
count was shown to be sufficient over the range.  Unlike the analytical solution, 
the model was not restricted to simplified geometries.  
The acoustic pressure results for the range of distal tips modelled showed 
that the geometries not only affected the distal tip surface pressure but also 
altered the overall acoustic profile around the distal tip, i.e. the pressure decay 
distance. This may play a critical role as it can be used to alleviate lateral 
pressures that may adversely affect healthy arterial tissue.  
The model of the Makin and Everbach’s experiment demonstrated that a 
linear acoustic modelling approach may be useful in the design of wire 
waveguide distal tip geometries and could be used to predict acoustic pressure 
profiles in relatively complex environments with tissue-air interfaces, such as 
the peripheral artery as demonstrated here.  
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The shape of the wire waveguide distal tip end-effectors plays a significant role 
in tissue tip interaction. Using the acoustic FEA as a design tool, the pressures 
created by a vibrating wire waveguide for a range of amplitudes of vibration for 
different distal tip geometries can be predicted. Using the cavitation threshold 
of 0.1 – 0.2 MPa, the wire waveguides and ultrasonic apparatus parameters 
which can achieve these pressures can be designed.  
While a robust design methodology for predicting acoustic pressures and 
cavitation has been advanced, soft tissue interactions are not well understood 
and require careful experimental investigation. Chapter 4 introduces an 
ultrasonic apparatus and test rig designed to determine ultrasonic wire 
waveguide and tissue interaction perforation forces and heating. Tissue tests 
are then conducted using this apparatus and test rig. 
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CHAPTER 
4 ULTRASONIC APPARATUS AND TEST 
RIG DEVELOPMENT 
 
4.1 Introduction 
An existing ultrasonic apparatus with similar operating parameters to 
clinical devices and other experimental ultrasonic wire waveguide devices was 
modified and further developed as part of this research for tissue testing. The 
apparatus was developed from an ultrasonic device previously used in other 
research by Gavin [13]. Gavin’s research focused on wire waveguide mechanics. 
This ultrasonic apparatus was examined for its suitability in the tissue testing 
programme. An adaptation of this original apparatus was then developed and 
characterised for later use in the tissue testing programme (see Chapter 5). 
Some of the major changes to this original device include improved wire 
waveguide attachment methods and a new custom housing for additional wire 
waveguide support; this will be explained in further detail in Section 4.4.  
This apparatus was used to study the waveguide distal tip and tissue 
interaction by replicating the following parameters commonly reported in the 
literature: 
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i. Operational frequency.  
ii. Wire waveguide distal tip geometry. 
iii. Amplitudes of vibration of wire waveguide distal tip.  
 
The ultrasonic apparatus was incorporated into a bench top test rig. This would 
advance the apparatus at a specific feedrate and could measure forces and 
temperature rise in the tissue as the wire waveguide perforates the tissue. The 
test rig is also designed to accommodate a hydrophone for acoustic field 
pressure measurements. This system will be used then for cavitation detection. 
The development stages of both the ultrasonic apparatus and the test rig are 
shown in Figure 4-1. Existing work is shown in green; all other colours 
represent new work. The end objective was to have an ultrasonic apparatus and 
a test rig with known operational characteristics that could be used for the 
tissue testing programme.  
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Figure 4-1: Development and design stages for ultrasonic apparatus and test rig. 
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4.1.1 Ultrasonic apparatus design requirements 
The requirements for the ultrasonic apparatus which are to be used for 
tissue testing are outlined below.  This was aimed to highlight key parameters 
required for the tissue testing but to also examine the current device for its 
suitability in the tissue testing programme. The requirements for the design of 
the ultrasonic apparatus are described in terms of functional, performance, 
design and operational requirements. The terms “shall”, “should” and “may” are 
used respectively to depict mandatory requirements, those that are to be 
considered but are not seen as mandatory and requirements that will be 
considered when all other requirements are satisfied. 
 
 Functional requirements 
F.1. The apparatus shall be capable of transmitting ultrasonic frequency 
mechanical vibrations through wire waveguides. 
F.2. The input power settings to the transducer shall be variable and allow 
for a range of wire waveguide distal tip amplitudes of vibrations. 
F.3. The waveguides shall operate for a duration such that tissue testing can 
be performed. 
F.4. The apparatus shall allow for the attachment and testing of a range of 
wire waveguides with different wire waveguide distal tip geometries. 
F.5. The system should operate similar to that of the approved CROSSERTM 
device and other experimental ultrasonic wire waveguide devices for 
ultrasonic angioplasty as outlined in the literature review. 
 
Table 4-1 : Functional requirements for ultrasonic apparatus design. 
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 Performance requirements 
P.1. The apparatus shall transmit energy at a single fixed frequency between 
20- 50 kHz. Response to F.5 
P.2. The apparatus should be capable of using wire waveguides between 1.0 -
2.0 mm, both flat and round distal tips. Response to F.5. 
P.3. The apparatus shall be capable of transmitting ultrasonic mechanical 
vibrations to the wire waveguide distal tip for longer than 20 sec. 
Response to F.3. 
P.4. The apparatus shall be capable of delivering amplitudes of vibration 
between 0- 60 µm. Response to F.5. 
P.5. The wire waveguides should perform both above and below inertial 
cavitation threshold. Response to F.3. 
P.6. The energised apparatus (including waveguides) should be capable of 
performing no less than 100 tissue tests. Response to F.3. 
 
Table 4-2 : Performance requirements for ultrasonic apparatus design. 
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 Design requirements 
D.1. The wire waveguides should be manufactured in such a way that the 
waveguides performance is repeatable. Response to F.3. 
D.2. The apparatus may allow for quick and easy replacement of the wire 
waveguide. Response to F.4. 
D.3. The apparatus shall be designed in such a way that it can be integrated 
to a test rig. Response to F.3. 
D.4. The apparatus should also be handheld and mobile. Response to F.3 & F.5. 
 
Table 4-3 : Design requirements for ultrasonic apparatus design. 
 Operational requirements 
O.1. The apparatus shall be safely handled by the operator. Response to D4. 
O.2. Activation and sonification of the apparatus shall not harm or damage 
the operator or others in close proximity. 
O.3. The cost of developing the apparatus and manufacturing multiple wire 
waveguides should be within the budget for this project. 
 
Table 4-4 : Operational requirements for ultrasonic apparatus design. 
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4.2 Ultrasound generation 
The ultrasonic apparatus used for this research was an adapted BransonTM 
Ultrasonic Sonifier model 150DTM system previously developed by Gavin and is 
shown in Figure 4-2. Gavin describes the selection of the sonifier for adaptation 
because of its operating frequency, variable power output and the system’s 
ability to auto tune to the systems resonant frequency [13]. The system 
comprised of a portable generator and transducer package. This sonifier is 
designed to be used in chemical and biological processes to disrupt cells, 
homogenise or emulsify materials, disperse or mix compounds and accelerate 
reactions by means of ultrasonic energy transmitted via an acoustic horn. The 
operating frequency of the sonifier (as specified by the manufacturer) operated 
at the low ultrasonic frequency of 22.5 kHz (nom) [159]. The generator has an 
analogue dial which ranges from 1 – 10 and this is related to power output. 
These units are arbitrary units and the suffix “au” will be used to describe the 
power input settings in this document from here on. 
 
 
Figure 4-2 : BransonTM sonifier generator. 
Power dial Display 
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4.2.1.1 Sonifier (transducer) 
The ultrasonic apparatus uses a piezoelectric transducer (Lead Zirconate 
Titanate) internal stack structure to produce longitudinal displacements. The 
piezoelectric effect was created by delivering a sinusoidal voltage input (950 
Vrms) to the piezoelectric stack, converting electrical energy to high frequency 
mechanical vibrations [159]. The ultrasonic vibrations are then amplified by 
attaching an acoustic horn to the distal end of the transducer, as can be seen in 
Figure 4-3. The auto tuning function can perform a frequency sweep and find 
the resonant frequency of the system (converter and horn) and load (liquid 
environment). 
 
 
 
 
 
 
 
 
 
Figure 4-3 : Ultrasonic transducer and acoustic horn. 
4.2.1.2 Acoustic horn 
The acoustic horn, shown in Figure 4-3 above, screws into to the distal end 
of the ultrasonic transducer. The acoustic horn allows for amplification of the 
ultrasonic vibrations produced by the transducer. The output of the acoustic 
Transducer 
Acoustic horn 
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horn (amplitude of vibration) will, therefore, be the input to the attached wire 
waveguide. Of the acoustic horns available, a Titanium alloy horn (BransonTM 
Microtip 5.0 mm series, pt #: 101-148-069) was most suited. This is an acoustic 
horn with a step and linear taper and was chosen as it has a specified maximum 
output amplitude of vibration of approximately 30-150 µm for setting 1 and 7 
au respectively at the resonant frequency of 22.5 kHz when connected to the 
piezoelectric converter [160]. The acoustic horn can only be operated in a liquid 
environment, as the liquid acts to both cool and load the wire waveguide distal 
tip once energised. Operating the ultrasonic apparatus outside of a liquid 
environment will cause the ultrasonic apparatus to stall and may otherwise 
cause damage to the transducer [159]. 
 
4.2.1.3 Wire waveguide coupling to acoustic horn 
Attaching a wire waveguide, essentially a mass, to the acoustic horn can 
affect the system’s performance. The horns are finely tuned instruments, 
manufactured to high tolerances and altering their shape can cause the system 
to stall or under perform. However, with the use of short wire waveguide 
lengths, of relatively negligible mass, the auto tuning function of the ultrasonic 
transducer can still find system resonance. Short wire waveguide lengths also 
allowed for integration of the ultrasonic apparatus to the bench top test rig. The 
wire waveguides are much shorter than waveguides which are used in clinical 
surgery but for the investigation of the wire waveguide distal tip and tissue 
interaction, longer waveguides were not required, since only the amplitude of 
vibration was of interest. 
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Methods of attaching a wire waveguide to the distal end of the acoustic 
horn are available in the literature and in patent data sheets [13, 78, 161, 162]. 
Most methods rely on either a friction fit, crimp fit or heat shrunk interference 
fit between a female end screw and the male wire waveguide, as shown in 
Figure 4-4. 
 
 
Female 
end-screw
Wire waveguide 
proximal end
Acoustic horn
 
Figure 4-4 : Female end screw and wire waveguide coupling method. 
 
The initial approach to manufacturing the wire waveguides was based on 
crimping the larger female screw radially around the male proximal end of the 
wire waveguide, as proposed by Gavin [13].  The wire waveguides were inserted 
approximately 6-8.0 mm into the female M3 grub screw and crimped, this was 
then screwed into the distal end of the acoustic horn. This technique produced 
low transmission success rates and short transmission periods before failure (if 
Direction of travel 
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the wire waveguides were successful in transmitting the ultrasonic vibrations). 
Failure generally occurred at the point where the wire waveguide and female 
screw were compressed by the crimping. The wire waveguide was still held in 
the female screw. However, it had snapped just as it protruded from the female 
screw. This may have been a result of stress concentration from damage to the 
wire waveguide at this point from crimping.  
As part of this present work, in an effort to increase time to failure, a new 
wire waveguide manufacturing technique was developed. To avoid crimping the 
wire, a friction interference fit was employed. Testing using this method proved 
most satisfactory. If the interference fit was managed correctly, wires 
transmitted without failure for extended periods of time, ideal for tissue testing. 
The procedure for manufacturing the friction interference fit wire waveguides 
for 1.0 mm diameter wire, are as follows:  
 
i. M3 Stainless Steel (SS) screws were placed in a radial clamp and centre 
drilled at high speed on a milling machine to a depth of 6-8.0 mm using a 
0.95 mm jobber drill bit. These are now the female screw. 
 
ii. Wire waveguides were cut in 200 mm length sections. The proximal end 
of the wire waveguides were then ground sharp, 45 degree radially, 
approximately 2-3.0 mm from the end.  
 
iii. The wire waveguides were then placed vertically in a bench top vice, 
sharp side up, with approximately 10 mm of wire protruding. 
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iv. The M3 0.95 mm female screw was placed on top on the male wire 
waveguide, the sharp edge provided a lead in. This was then press fitted. 
 
v. The waveguide could now be screwed into the acoustic horn using the 
female screw, as shown in Figure 4-5. 
 
vi. It was found that crimping reduced contact surface area and resulted in 
premature failure of the wire waveguides at the crimping point. 
Waveguides would emit a high pitch singing moments before failure. 
 
 
 
Figure 4-5 : Wire waveguide manufacture, (left) wire waveguide in M3 grub 
screw, (right) wire waveguide screwed into distal end of acoustic horn. 
 
4.3 Wire waveguides design and performance 
 
4.3.1 Materials 
The medical grade surgical wire chosen for the wire waveguide material 
was a Nickel-Titanium (NiTi) alloy (Nitinol). This particular Nitinol alloy 
consists of 54.5 – 57 % Wt Nickel with balance % Wt Titanium, with some other 
Acoustic 
horn 
3.0 mm Ø 
1.0 mm Ø 
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trace elements. It was chosen because of its super-elastic behaviour and proven 
success in this field as wire waveguide material [6, 13]. The wire waveguide 
material for tissue testing was obtained from EUROFLEX GmbH (Kaiser-
Friedrich-Str. 7, D-75172 Pforzheim) in 1.0, 1.5 and 2.0 mm diameters. These 
wire diameters were chosen because the acoustic pressure profile for each 
diameter was previously established using FEA in Chapter 3. 
 
4.3.2 Wire waveguide length 
The nature of the energy transmission creates a standing wave with nodes 
and anti-nodes along the wire waveguide length (i.e. resonance and anti-
resonance lengths)[13]. The maximum amplitudes of vibration at wire 
waveguide distal tip occur at a length of wire which terminates at a resonant 
length (i.e. the input from the acoustic horn is amplified). An anti-resonance 
length provides no amplification at the distal tip from the input at the acoustic 
horn. A schematic of the input and output of the wire waveguide is shown in 
Figure 4-6 [13, 163]. The resonant and anti-resonant lengths are a function of 
frequency and acoustic speed and can be calculated by using Equation 16. 
l
X
U(t) = b sin ω(t)
 
Figure 4-6: Diagram of a uniform rod, of length l, with an input displacement. 
Acoustic 
horn 
(input) 
Distal tip 
(output) 
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  )                                                   Equation 15 
 
 
The resonant response of the wire waveguide can also be derived from the 
above solution and is shown in Equation 16. nf  denotes the resonant 
frequencies of longitudinal vibration for a rod of length l . The speed of sound 
the rod material is given by c.  
 
      
  
  
                                                         Equation 16                                                 
 
Typically, the ultrasonic devices operate at a constant frequency. Based on this 
assumption, for fixed frequency transmission, the wire waveguide lengths for 
which resonance occurs (n = 1, 3, 5, 7….) and the lengths for which anti-
resonance occurs (n = 0, 2, 4, 6, 8….) can be calculated using Equation 17. 
 
      
  
  
                                                                                                       Equation 17 
 
 
Using the material properties for the wire waveguide, the acoustic speed can be 
determined by using Hooke’s Law in Equation 18. 
 
   √
 
 
                                                                                                                  Equation 18 
 
Where E is the young’s modulus of the wire material (75 GPa) and ρ is the 
density (6500 kg/m3) of the medium. For the NiTi wire waveguides, c = 3396.83 
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m/s, therefore, the resonance lengths (n = 1, 3, 5, 7…) and anti-resonance 
lengths (n = 2, 4, 6, 8…) are as follows: 
 
Node # 
 
Position  of node along wire 
waveguide (mm) 
(f = 22,500 Hz) 
1 37.7 
2 75.48 
3 113.2 
4 150.9 
5 188.7 
6 226.4 
 
Table 4-5 : Wire waveguide lengths of resonance and anti-resonance. 
 
It was necessary to use lengths of wire which could produce the required wire 
waveguide distal tip amplitudes of vibrations but would also be of suitable 
length for test rig integration and tissue tests (transmit energy for sufficient 
periods of time for a number of tests). The wire waveguide material fatigue 
strength greatly influences the maximum achievable amplitudes of vibration at 
the distal tip and also time to failure. The wire waveguide was prone to failure if 
the amplitudes of vibration were too great at the distal tip. 
 Initially wire waveguides of anti-resonant length of 150.9 mm were 
tested. Wires at this length had short periods of transmission time and failed 
within a matter of seconds. Wire length ± 2-3.0 mm from 150.9 mm caused 
system stall or intermittent transmission.  
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In previous work by Gavin, 144 mm wire waveguide length was used. The 
distal tip amplitude of vibration for power input was also characterised by 
Gavin for this wire waveguide length. Initial tissue tests were conducted using 
this length of wire waveguide but transmission and time to failure was also poor 
which prevented testing of large sample sizes using the same wire waveguide. 
For this wire waveguide material, optimum lengths for consistent and 
reliable energy transmission were found to occur at lengths between resonance 
and anti-resonance lengths. For this apparatus and with test rig constraints, 132 
mm was most suited. This length of wire waveguide was also favourable as it 
produced a range of amplitudes of vibration across the cavitation threshold, this 
will be elaborated on further in the cavitation detection section 4.8. The 
remaining tissue tests were, therefore, carried out using a 132 mm wire 
waveguide. A wire waveguide and acoustic horn can be seen in Figure 4-7. 
 
 
Figure 4-7 : Acoustic horn and 132 mm wire waveguide. 
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4.3.3 Wire waveguide distal tip 
Wire waveguides for ablation and disruption of cardiovascular tissue, as 
described in the literature, often comprise of slender shafts which have larger 
distal tip finishes, such as sphere tip; they may be then supported by a catheter 
as shown in Figure 4-8. The objective of tissue testing was to examine the effects 
of the wire waveguide distal tip-tissue interaction. The wire waveguides used 
for tissue testing did not have a slender shaft, they replicated the wire 
waveguide distal tip, i.e. the shaft and distal tip diameter was constant. The wire 
waveguide distal tips for tissue testing were either ground flat or radiused. 
 
 
 
Figure 4-8 :(Left), wire waveguide in catheter with enlarged ball distal 
tip and slender shaft. (Right), wire waveguides used for testing 
representative of the enlarged ball distal tip. 
 
Catheter 
supporting  
wire waveguide 
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4.3.3.1 Radiused 
Radiused wire waveguide distal tips were machined and ground from the 
NiTi wires. They have the appearance of a dome tip (i.e. edges have been 
filleted) so they are not ground to a constant radius. To achieve this finish on the 
wire waveguides the following was performed. This process is illustrated in 
Figure 4-9 :  
 
i. Large sand stone grinding bits (12 mm diameter) were drilled using 
a 1.0 mm ball nose jobber drill bit (A). This gave an internal form for 
the wire tip to be ground. 
 
ii. The sand stone bit was secured in a Dremel high speed cutter. The 
Dremel was then held vertically in a vice.  
 
iii. The Dremel was powered and set to maximum speed. The wires 
were fed into the drilled hole and the wire waveguide distal tip was 
ground as a result (B). The resulting distal tip finish is shown in 
Figure 4-10. 
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Figure 4-9 : Method for rounding wire waveguide distal tips. 
 
 
Figure 4-10 : Radiused wire waveguide distal tip. 
4.3.3.2 Flat 
Flat wire waveguide distal tips, which were also required, were 
manufactured from the NiTi wire, as shown in Figure 4-11 and Figure 4-12. The 
wire waveguide distal tips were ground flat using a high speed rotating grinding 
stone. This form gave constant and highly repeatable geometries.  
 
A B 
Grinding stone 
Drill bit 
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Figure 4-11 : Grinding wire waveguide distal tip flat. 
 
Figure 4-12 : Flat wire waveguide distal tip. 
 
4.4 Housing for acoustic horn and wire waveguide 
The housing for the ultrasonic apparatus was custom designed and built to 
hold the acoustic horn and transducer in a lightweight casing which protects the 
user from contact with the transducer and acoustic horn. It also encloses the 
horn in a liquid environment, essential for operation. This can be seen in Figure 
4-13.  
For ease of access and replacement of wire waveguides, the housing was 
manufactured as two split halves which could then be bolted together through 
holes incorporated into the design at mid section and also at the neck of the 
housing. One side of the housing was designed with a 1.0 mm ridge along the 
Flat wire waveguide 
distal tip 
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inside of the shell wall. This could then be slotted into the opposite half which 
had a recessed 1.0 mm cut out, also seen in Figure 4-13. The housing was made 
from Acrylonitrile Butadiene Styrene (ABS) thermosetting plastic and 
manufactured on a Rapid Prototype Machine (RPM) creating a Fused Deposition 
Model (FDM). This was designed on SolidEdge CAD package and an STL file 
format was created which could be transferred to the RPM. The RPM finished 
product is a porous material. Since this is to contain a liquid, a sealer was 
impregnated into the plastic. This was then coated with polyester glass fibre 
filler (Isopon), formed and painted. 
 
 
 
Figure 4-13 : ABS apparatus housing manufactured by RPM. 
 
Liquid chamber 
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4.4.1 Assembly  
The wire waveguides are screwed into the acoustic horn, which then exit 
the housing through a number of seals, as seen in Figure 4-14. A seal was 
installed on the acoustic horn where it enters the sealed liquid chamber. 
Another two seals were installed at the opposite end of the housing where the 
wire waveguides protrude. The seals act to reduce leakages at the point of 
protrusion but also act to support the wire waveguide at a number of points 
along its length, reducing lateral movement and increasing the time to failure of 
the wire waveguides. Larger wire waveguides may also be accommodated in 
this ultrasonic apparatus by increasing the internal seal diameter in the housing. 
If necessary, one can also accommodate a medical grade catheter at the 
ultrasonic housing tip by attaching it to the female connector lure located at the 
distal section of the housing where the wire waveguide emerges as seen in 
Figure 4-15.  
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Figure 4-14 : Assembled housing and ultrasonic apparatus. 
 
 
Figure 4-15 : Assembled ultrasonic apparatus (section view). 
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4.5 Test rig design 
A test rig was designed and manufactured to advance the ultrasonic 
apparatus towards tissue samples and to control and measure a number of 
parameters. The design requirements for the test rig are also described in terms 
of functional, performance, design and operational requirements. 
 
4.5.1 Test rig requirements 
 
 Functional requirements  
F.1. The test rig shall allow for tissue testing using the ultrasonic apparatus. 
F.2. The test rig shall be capable of advancing the ultrasonic apparatus 
towards tissue samples in a controlled manner. 
F.3. The test rig shall have a thermostatic liquid tank incorporated 
F.4. The test rig shall provide force feedback of the tissue perforation. 
F.5. The test rig shall provide temperature measurement of the tissue when 
it is perforated by the ultrasonic wire waveguide. 
F.6 The test rig shall incorporate a miniature hydrophone which is capable 
of detecting cavitation. 
F7. The test rig shall accommodate all sensing devices simultaneously and 
be interfaced and controlled using a Data Acquisition (DAq) system and 
CPU. 
 
Table 4-6 : Functional requirements for test rig design. 
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 Performance requirements 
P.1. The test rig should be capable to performing over 200 tissue tests 
(energised and non-energised, i.e. no ultrasound). Response to F.1. 
P.2. The test rig should be capable of advancing the ultrasonic apparatus at 
feedrates between 0- 100 mm/min. Response to F.2. 
P.3. The test rig shall be able to advance the ultrasonic apparatus in the Z-
axis, moving up and down, with a stroke length of 200 mm. Response to 
F.2. 
P.4. Thermostatic tank shall maintain the liquid environment at the core 
human body temperature of 37 oC ± 0.5. Response to F.3. 
P.5. The force feedback shall be capable of measuring up to 15 N ± 0.01. 
Response to F.4. 
P.6. The force feedback should be capable of measuring at a sample rate of 
1k. Response to F.4. 
P.7. Thermocouple should be sensitive to 0.1 oC. Response to F.5. 
P.8. The hydrophone shall be capable of operating at a minimum frequency 
of 50 kHz. Response to F.6. 
 
Table 4-7 : Performance requirements for test rig design. 
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 Design requirements  
D.1 The ultrasonic apparatus should be held vertically (z-axis) in a bench top 
frame which masses no more than 20 Kg and is less than 1.5 m in height. 
D.2. The test rig should allow for quick and easy access to changing the 
attached ultrasonic apparatus. Response to F.1. 
D.3. The thermostatic tank shall fit beneath the ultrasonic apparatus and be 
capable of accommodating all sensing devices. Response to F.7. 
D.4. The test rig should allow for easy filling/draining and removal of 
thermostatic tank. 
D.5. The tissue sample holder cantilever beam should be capable of holding 
soft tissue samples in thickness no greater than 6.0 mm. Response to F.4. 
D.6. The cantilever tissue holder may be designed so that the tissue can be 
interchanged quickly between tests.  
D.7. The tissue sample holder cantilever beam shall accommodate a 
thermocouple which can take measurements less than 3.5 mm from the 
wire waveguide point of entry to the tissue. Response to F.2, F.4 and F.5. 
D.9. The hydrophone shall be capable of operation in a liquid tank at 37 0C. 
An armature should hold the hydrophone and place it in the tank 
orthogonally at a fixed position relative to the wire waveguide. Response 
to F.6. 
D.10. The Data Acquisition (DAq) system shall allow for multiple sensing 
devices to be operated simultaneously. Response to F.7. 
 
Table 4-8 : Design requirements for test rig design. 
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 Operational requirements  
O.1. The test rig should be designed to be mobilised and carried by one 
person. 
O.2. It shall be possible for one operator to safely handle all parts of 
assembly and conduct tissue testing using the test rig. Response to D5. 
O.3. Activation and sonification of the apparatus shall not harm or damage 
the operator. 
O.4. The electronics and CPU should be safely situated so that water from the 
tank cannot make contact. 
0.5. The cost of manufacturing the test rig shall fall within the budget for this 
project. 
 
Table 4-9 : Operational requirements for test rig design. 
4.5.2 Experimental test rig 
A schematic of the test rig is shown in Figure 4-16. The main design 
features include, accommodation of the ultrasonic apparatus to a vertical 
motorised lead screw assembly and a tissue sample holder capable of 
measuring the forces generated by an advancing ultrasonically energised wire 
waveguide. The rig was also extended to include hydrophone pressure 
measurement and temperature measurement. This assembly, including sensors 
were designed to be held in liquid at ≈ 37 0 C.  
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Figure 4-16 : Schematic of experimental rig with ultrasonic angioplasty 
apparatus, cantilever arrangement, strain gauge (SG), thermocouple (TC) 
thermostatic tank and DAq system. 
 
4.5.2.1 Primary structure and lead screw assembly 
The primary structure of the test rig was manufactured from extruded 
aluminium sections (ITEM). This is shown in Figure 4-17. The ultrasonic 
apparatus was attached to a linear lead screw system located vertically in the 
centre of the test rig structure. This was driven by a high torque stepper motor 
located above the lead screw assembly, behind the blue electronics box, which 
housed the stepper motor driver board (Uni-polar stepper driver board, 2 A, 
Greenwich Instruments Ltd, Kent, UK).  
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Figure 4-17 : Experimental test rig with ultrasonic apparatus attached. 
 
4.5.2.2 Lead screw motor and thermostatic tank 
A high torque motor (Hybrid stepping motor, 440-458, Radionics Ltd) 
with a step angle of 1.80 ±5 % was used. The speed of the motor was controlled 
by an adjustable onboard clock installed on the motor driver board. A flexible 
coupling from the stepper motor was used to drive the lead screw, as seen in 
Figure 4-18 . The pitch of the lead screw was such that one revolution gave 1.0 
mm of travel. A pulse counter from the stepper motor drive card (one pulse per 
1.80) was used to determine the distance travelled of the lead screw. This 
system was found to be capable of travelling between feedrates of 10 - 140 
mm/min. The rig also incorporated a stainless steel thermostatic tank (Clifton 
1000 Watt, model NE1B-14), with internal dimensions of 325 x 300 x 150 mm. 
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This tank was filled with tap water and saline. The temperature was held at 
370C, this was found to be accurate to ± 0.20C. This tank would allow for the 
submersion of tissue samples and a strain-based force measurement sensor 
during tissue testing. 
 
 
Figure 4-18 : Linear lead screw. 
4.5.2.3 Cantilever tissue sample holder 
The cantilever beam force measurement device was designed to hold 
tissue samples for testing. The beam had two plates which are bolted to the top 
and bottom of the cantilever. The lower plate contains the tissue in a guide slot 
(approximately 1.5 mm deep), as seen in Figure 4-19 (top).  
The lower plate also includes a 3.0 mm diameter hole to allow for the wire 
waveguide to fully perforate the tissue. The upper plate which bolts to the top of 
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coupling 
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attachment 
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the cantilever beam supports the thermocouple, it also has a pilot hole for the 
wire waveguide to enter. This can be seen in Figure 4-19 (bottom left and right) 
also. 
  The cantilever beam assembly included strain gauges (KFG N10C2, 
Kyowa Electronic Instruments, Co, Ltd, Japan) and was calibrated to provide 
force feedback. A half-bridge temperature compensation strain gauge 
arrangement was used. This arrangement was then sealed using epoxy resin 
(Araldite, Huntsman Advanced Materials, USA).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-19 : Picture of cantilever beam tissue holder and strain gauge 
arrangement. 
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4.5.2.4 Calibration 
Weights (masses) of known values were placed at the end of the beam 
where the tissue samples were to be held and tested. The strain reading (change 
in electrical resistance) for the range of weights could then be graphed and a 
constant conversion scale factor could be extrapolated. This factor was applied 
to all strain measurements to give force output. The gauge was then tested in 
the heated thermostatic tank to ensure that effects of temperature and 
buoyancy did not skew results. During calibration, the beam deflection, δbeam, 
was determined via the force-deflection equation for the beam. i.e., for a given 
force, the beam deflection could be measured using a dial gauge, as shown in 
Figure 4-20. The force-deflection relationship proved to be approximately linear 
over the force range of interest (linear fit, R2 = 0.99). This test was conducted six 
times (n = 6) and a mean linear fit of y = 2.505x was recorded for forces of 0 - 10 
N. The values are plotted in Figure 4-21. 
 
 
 
 
128 
 
 
Figure 4-20 : Beam deflection measurement using dial gauge. 
 
Figure 4-21 : Cantilever beam deflection versus force. 
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4.5.2.5 Mechanics of the cantilever tissue holder measurements 
This dynamic system was designed to represent in vivo conditions, where 
the vessel would be allowed to extend somewhat before perforation. The 
cantilever beam essentially acts as a spring which produces an equal and 
opposite force acting against the wire waveguide as it perforates the tissue.  
Results from the force measurement can be plotted as force versus time, 
however, by using the waveguide travel, δtip can also be calculated by converting 
time to distance using the constant feedrate (mm/min). By relating the force (or 
drop in force) to a deflection distance of the beam (mm), it was also possible to 
subtract the beam deflection from the distance travelled to give the wire 
waveguide indentation into the tissue, δi as seen in Figure 4-22. This provides 
more information than a static load cell system alone. Each time the tissue 
partially fails this has to be accounted for, as it results in a drop in applied force 
on the tissue and hence the beam, as shown in Figure 4-22.  The wire waveguide 
indentation into tissue, δi, is given in Equation 19. Indeed, an additional benefit 
of this arrangement is the detection and quantifying of tissue failure depth in 
multiple stage tissue failure, as shown in Figure 4-23. 
 
δi  = δtip – δbeam- ∑δfail                                                                                           Equation 19 
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Figure 4-22 : Close up diagram of cantilever beam and tissue with displacement 
references. Note: the beam deflection in the diagram is exaggerated for visual 
purposes and does not exceed 4 degrees in practice. 
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Figure 4-23 : Acquiring tissue deflection with respect to beam from tissue and 
beam deflection measurement, example of a two stage tissue failure. Tissue 
failure depth also illustrated. 
 
4.5.3 Temperature measurement  
The cantilever beam tissue holder allowed for the placement of two 
thermocouples close to the point of entry of the wire waveguide. They could be 
located 3.0 mm (centre to centre) from the pilot hole for the wire waveguide, 
and then placed 2.0 mm apart, as seen in Figure 4-24. A rapid response pot 
sealed 1.0 mm diameter, custom made K-Type mineral insulated thermocouple 
was used (TC Direct, Uxbridge, UK).  
δfail 
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The Data Acquisition (DAq) system and thermocouple module has an 
onboard thermistor for cold-junction compensation for self calibration of the 
thermocouple. The thermocouples were also calibrated using the ice water 
technique outlined in ASTM E220-86 [164], to verify the cold junction accuracy. 
 
 
Figure 4-24 : Cantilever top plate with two thermocouples. 
 
4.5.4 Hydrophone acoustic measurement system 
The tank was fitted with a miniature hydrophone (Model B/200, Neptune 
Sonar Limited, Kelk Lake, East Yorkshire, United Kingdom, 9.0 mm diameter, 
unfocused), as seen in Figure 4-25. This hydrophone has a flat response up to 
180 kHz and a resonant frequency of 240 kHz. The acoustic pressures generated 
by the vibrating wire waveguide distal tip in an open tank were measured using 
the hydrophone and charge amplifier (Brüel & Kjær, Charge amplifier Type 
2635).  
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The charge conditioning amplifier (Brüel & Kjær, Charge amplifier Type 
2635) was used to amplify the voltage signal from the hydrophone. This 
performs a time integration of the electric current, thus measuring the total 
electric charge, this was calibrated to 1 Pa = 1 mV. This voltage signal was then 
transmitted to an analogue port on the Data Acquisition (DAq) system for 
measurement. Sound and Vibration tool kit (National Instruments) was used to 
process and display the data, the sampling rate was 80 kHz. 
 
 
 
  
 
 
 
 
 
 
 
Figure 4-25 : (Bottom left) Charge amplifier. (Top left and right). Hydrophone 
and hydrophone assembly. 
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4.5.5 Data acquisition 
The programming environment and hardware used to control the various 
instruments and Data Acquisition (DAq) was LabVIEW and National 
Instruments© PCI-6221 acquisition board and connector terminal block SCC-
68. A Graphic User Interface (GUI) was created to allow easy control and 
measurement of all devices on the DAq system. The stepper motor was 
controlled using a driver board. Switching and control was performed using a 
LabVIEW function. The feedrate of the ultrasonic device, force feedback of the 
tissue-wire waveguide interaction and temperature increase in the tissue could 
be controlled and displayed on the monitor through LabVIEW. A screen shot of 
this graphical interface is shown in Figure 4-26. For strain measurement, a 
strain gauge module from National Instruments was used. This was module 
SCC-SG03 (half-bridge). Each channel of the SCC-SG module includes an 
instrumentation amplifier, a 1.6 kHz low-pass filter, and a potentiometer for 
bridge-offset nulling. Each SCC-SG module also includes a single 2.5 V excitation 
source. 
Thermocouple modules (SCC-TC01) for temperature measurements could 
also be placed into the DAq. It also includes a 2 Hz low-pass noise filter and 
instrumentation amplifier with a gain of 100.  The input circuitry of the SCC-
TC01 modules also includes high-impedance bias resistors for open-
thermocouple detection, as well as handling both floating and ground-
referenced thermocouples. 
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Figure 4-26 : (Top) GUI for DAq. (Bottom) Wiring diagram. 
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4.6 Characterisation of ultrasonic apparatus 
 
4.6.1 Waveguide amplitude of vibration for power input 
To ensure that the wire waveguide manufacturing technique and the seals 
in the housing did not affect the performance of the waveguides, 
characterisation of the waveguide distal tip amplitude of vibration for power 
input was carried out. The wire waveguide distal tip amplitudes of vibration 
were measured using an optical microscope and camera (Olympus BX60M, 
frame rate <90) and vision analysis software (Infinity Analyze). The high 
frequency vibration (22.5 kHz) is seen as a streak (maxima and minima) on the 
vision software. Measuring the distance between these two points gave the peak 
to peak displacement (i.e. amplitude of vibration x 2). It was also possible to 
measure streaks created by visible artefacts on the wire waveguide as datum 
points. A schematic representation of this measurement is shown below in 
Figure 4-27. 
 
Figure 4-27: (Top) Maxima and minima at wire waveguide distal tip, 
(Bottom) artefact datum point creating a streak. 
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4.6.2 Methodology 
 For this test, the apparatus was held horizontally as shown in Figure 
4-28. Visco-elastic foam was placed under the wire to stabilise the wire 
waveguide, thus making the optical measurements possible. The power input 
for settings 1-8 au were tested and the resulting wire waveguide distal tip 
displacements were measured. Using multiple 132 mm wires, no less than six 
tests (n = 6) were carried out for each power setting. Power settings greater 
than 5 au often resulted in premature failure of the wire waveguides, in that, the 
amplitudes of vibration were too great for the material to withstand.  
 
 
 
 
Figure 4-28 :  Experimental set-up for characterisation of power input for 
wire waveguide distal tip amplitude of vibration. 
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4.6.3 Results 
An image of the stationary wire waveguide distal tip is shown in Figure 
4-29. A number of datum points which appear as distinct white dots are 
identified. The energised wire is shown in Figure 4-30. The points on the wire 
now appear as streaks which can be measured using the image analysis 
software. The results are plotted Figure 4-31. The acoustic intensity is also 
calculated and given in Table 4-10. The results display an approximate linear 
relationship in terms of input/output (i.e. power input/amplitude of vibration). 
Settings above 5 au are excluded from these results as they were deemed too 
unstable for tissue testing. From setting 0-1 au no power is transmitted and it 
was often the case that setting 1 au produced intermittent transmission. For 
tissue testing, setting 1 au was also excluded. 
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Figure 4-29 : Non-energised waveguide. 
 
 
 
 
 
 
 
 
 
Figure 4-30 : (Top), energised wire waveguide with datum points. (Bottom) 
,schematic of energised wire waveguide with datum points. 
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Figure 4-31 : Amplitude of vibration at wire waveguide distal tip for a 
given power input setting. 
 
Power setting 
(au) 
Amplitude of vibration  
(mean) (µm) 
Acoustic 
Intensity (mean) 
(W/cm2) 
1 17.8 (σ = 1.19) 1.03 
2 22.5 (σ = 1.5) 1.65 
3 27.8 (σ =  1.43) 2.51 
4 31.4 (σ =1.45 ) 3.21 
5 34.3 (σ = 1.58) 3.83 
 
Table 4-10 : Amplitude of vibration at wire waveguide distal tip and 
acoustic intensity for a given power input setting. 
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4.7 Fundamental frequency of operation measurement 
The operational frequency of the ultrasonic transducer, as specified by the 
manufacturer, is 22.5 KHz. Since this sonifier has been altered by the addition of 
wire waveguides and the apparatus housing (seals), it was deemed necessary to 
experimentally verify if this was operating at this specified frequency. Using the 
hydrophone, a Fast Fourier Transform (FFT) on the acoustic spectrum was 
performed. Using this data, the fundamental frequency could then be 
determined. 
 
4.7.1 Methodology 
The ultrasonic apparatus (Flat 1.0 mm distal tip, 132 mm length) was 
attached to the test rig. This was then lowered into the thermostatic tank to a 
depth of approximately 50 mm. The tank was filled with tap water, heated to ≈ 
37 0C and fitted with the miniature hydrophone which was lowered into the 
tank using a retort stand. This was situated orthogonally to the wire waveguide, 
approximately 30 mm deep into the water at a distance of 140 mm from the 
wire waveguide.  A schematic of this experiment is shown below in Figure 4-32. 
 
 
142 
Ultrasonic 
generator Hydrophone 
and charge 
amplifier
CPU
Tank and cantilever with 
tissue
Ultrasonic apparatus 
and lead screw 
assembly
 
Figure 4-32 : Schematic of experiment for cavitation detection. 
 
The ultrasonic generator was powered on but no energy was transmitted to the 
transducer (i.e. setting 0 au, no amplitude of vibration at wire waveguide distal 
tip). The signal from the hydrophone was conditioned via the charge amplifier 
and recorded as an analogue input to the data acquisition card and then to the 
CPU via the PCI bus. National Instruments Sound and Vibration tool kit was used 
to interrogate the input signal. An FFT was performed on the acoustic spectrum 
which is used to establish the peak amplitude at the dominant driving 
frequency. The sampling rate was 80 kHz. To reduce the spectral leakage, a 
Hanning window was applied to the FFT signal. This acts to minimise non-
harmonic sinusoids of the fundamental and gives a better representation of the 
dominant frequency.  
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4.7.2 Results 
When the generator was powered on, the FFT of the acoustic spectra 
revealed a spectral peak at the operating frequency of 22.5 kHz, as can be seen 
in Figure 4-33. The vibration from the generator at 22.5 kHz was received by the 
hydrophone in the liquid filled tank. This was most likely caused by the 
vibrations being transmitted through the bench top to the water tank. A peak at 
50 Hz was also measured, a result of the surrounding electrical interference 
from the mains voltage signal.  
 
 
Figure 4-33 : FFT of acoustic spectrum, with peak at fundamental 22.5 kHz. 
 
Fundamental 22.5 kHz 
144 
4.8 Cavitation detection using hydrophone 
Cavitation can be measured as a secondary source of sound. By using a 
hydrophone placed in the tank but away from the cavitating region, one can 
determine if cavitation is present in the acoustic field. This method is commonly 
known as Passive Cavitation Detection (PCD). The goal of this experiment was 
to determine if the wire waveguides could produce sufficient pressures from the 
vibrating wire waveguide distal tip to cause stable and inertial cavitation.  
Based on reports by others, characteristic markers of stable cavitation 
include sub (e.g. f/2), super (e.g. 2f) and ultra (e.g. 3f/2) harmonic peaks of the 
fundamental frequency (measured at 22.5 kHz) in the FFT spectrum [93, 99, 
165, 166]. For inertial cavitation detection, a frequency band within the FFT 
signal absent of significant harmonics should be analysed. An increase and a 
levelling of the broadband noise (saturation) suggest operation in the inertial 
cavitation region [98, 167].  
 
4.8.1 Methodology 
The ultrasonic apparatus (Flat 1.0 mm distal tip, 132 mm length) was 
attached to the test rig. This was then lowered into the thermostatic tank to a 
depth of approximately 50 mm. The tank was filled with tap water, heated to ≈ 
37 0C and fitted with the miniature hydrophone. This was lowered into the tank 
using a retort stand and was situated orthogonally to the wire waveguide, 
approximately 30 mm deep into the water at a distance of 140 mm from the 
wire waveguide. 
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The acoustic pressures generated by the vibrating wire waveguide distal 
tip in the open tank were measured using the hydrophone and charge amplifier. 
The power settings (au) were then increased from setting 1 – 8, corresponding 
amplitudes of vibration 0 - 40.8 µm.  The majority of wire waveguides failed 
above amplitudes of vibration greater than 34.3 µm and for this reason there 
are a reduced number of test samples. For wire waveguides operating up to 34.3 
µm, six test samples (n = 6) were recorded. For cavitation detection a Fast 
Fourier Transform (FFT) of the acoustic time signal was conducted. For stable 
cavitation detection, the entire acoustic spectrum was analysed at each setting. 
For inertial cavitation, a frequency band absent of any significant harmonics 
was extracted from the spectrum and analysed for indicators of inertial 
cavitation.  
 
4.8.2 Results 
Figure 4-34 shows an example FFT plot of the acoustic spectrum produced 
by an energised 1.0 mm flat wire waveguide distal tip with amplitude of 
vibration of 22.5 µm. The FFT of all acoustic spectra revealed a spectral peak at 
the operating frequency of 22.5 kHz.  At all amplitudes of vibrations tested, 
harmonic peaks are evident, indicating that stable cavitation was present for all 
power settings. A number of frequency bands were extracted and examined for 
inertial cavitation. The frequency band of 16.5-17 kHz (a band absent of 
significant harmonics) is presented in Figure 4-35. The wire waveguide 
amplitude of vibration was increased and the noise power in this frequency 
band was recorded. This can be seen in Figure 4-36. An initial increase in 
broadband noise was first recorded as the wire waveguide was energised. This 
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noise power level reached saturation for values of amplitude of vibration 
greater than 31.4 µm (acoustic intensity of 3.21 W/cm2) despite the fact that the 
wire waveguide distal tip amplitudes of vibration were still increasing. This is 
an indicator of operation in the inertial cavitation region. All bandwidths 
examined displayed this trend at amplitudes of vibration greater than 31.4 µm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-34 : FFT of acoustic spectrum. Wire waveguide delivering 22.5 µm 
amplitude of vibration. 
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Figure 4-35 : FFT of acoustic spectrum with 1.0 mm wire waveguide energised, 
bandwidth 16.5 – 17 kHz extracted. 
 
Figure 4-36 : Broadband noise power in frequency band 16.5-17 kHz. 
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4.9 Cavitation detection using diagnostic ultrasonic imaging device 
To further validate the onset of cavitation (inertial), a B-mode ultrasonic 
imaging device (Philips ATL HDI 5000, L74 transducer) operating between 4-7 
MHz was used to visualise the cavitation for amplitudes of vibration of 0 – 34.3 
µm.   
4.9.1 Methodology 
The ultrasonic apparatus was held vertically using a retort stand and the 
flat 1.0 mm distal tip, 132 mm length wire waveguide was inserted into a length 
of PVC tubing of 15 mm internal diameter. This was then filled with tap water, 
37 0C approximately. The B-mode emitter/receiver was coated with copious 
amounts of ultrasonic transmission gel and placed in contact with the PVC 
tubing at a height where the centre focus of the ultrasonic imaging device was 
focused on the wire waveguide distal tip, as shown in Figure 4-37. The 
ultrasonic generator was powered on and for each setting (1 - 5 au, 17.8 – 34.3 
µm), a still image from the ultrasonic imaging device was recorded. 
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Figure 4-37 : Detection of cavitation using a B-mode ultrasonic imaging device. 
 
4.9.2 Results 
A schematic of the ultrasonic imaging display is shown in Figure 4-38. The 
wire waveguide distal tip is displayed in black. The PVC tubing of which the wire 
waveguide is inserted into is displayed in grey. No bubble activity was observed 
visually using the B-mode scanner for amplitudes of vibration of 0- 27.8 µm. An 
example of a non-cavitating wire waveguide can be seen in Figure 4-39. 
Cavitation activity was observed at amplitudes of vibration greater than 
31.4 µm and is shown in Figure 4-40.  Dense bubble clouds are seen emanating 
from the wire waveguide distal tip at high velocities. Interference is also seen on 
the B-mode scanning image. The bubble stream direction was directly ahead of 
the wire waveguide distal tip for 3 - 4 mm approximately, this then coalesced on 
one side of the PVC tubing. The path of the bubble streaming is similar for all 
cavitating settings. Post sonification, the liquid was seen to have a number of 
bubbles which had not collapsed and were murky in appearance. 
B-mode 
emitter/receiver 
Wire 
waveguide 
distal tip 
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It was found that, for the 1.0 mm diameter waveguide, the cavitation threshold 
occurred above 31.4 µm amplitude of vibration, corresponding to an 
approximate wire waveguide distal tip acoustic intensity of 3.21 W/cm2. This 
value correlates well with the cavitation threshold acquired via acoustic 
spectrum analysis using the hydrophone, values reported in the literature and 
the FEA results. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-38 : Schematic of the ultrasonic imaging display for cavitation 
detection. 
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Figure 4-39 : B-mode image of wire waveguide, ≈ 20 µm, setting 1.5 au, non-
cavitating. 
 
Figure 4-40 : Wire waveguide causing cavitation. Bubbles and interference 
observed using B-mode ultrasonic imaging, ≈ 33µm, setting 4.5 au. 
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4.10 Summary 
 
 An ultrasonic apparatus  which delivered ultrasonic vibrations through a 
wire waveguide was developed by Gavin [13]. This was an adapted 
sonifer which could deliver ultrasonic amplitudes of vibration to the 
distal tip of a wire waveguide. This ultrasonic apparatus was examined 
for its suitability for tissue testing. 
 For this research, some of the design issues with the original ultrasonic 
device used by Gavin were addressed. A new method of manufacturing 
wire waveguides allowed for longer transmission times. A custom ABS 
housing was also designed and manufactured. This also allowed for 
longer transmission of ultrasound by providing additional support to the 
wire waveguide through a number of seals in the housing. 
 The ultrasonic device operated at 22.5 kHz, as specified by the 
manufacturer. This delivered high frequency voltage to the transducer. 
This then converted the energy to mechanical vibrations. This was then 
amplified by an acoustic horn. The wire waveguides were then attached 
to the distal tip of the acoustic horn. 
 The amplitudes of vibration at the wire waveguide distal tip are a 
function of the waveguide length. It was found that wire waveguides 
which operated between resonance and anti-resonant lengths 
transmitted best.  
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 Flat and radiused wire waveguide distal tip could be manufactured. 
Radiused distal tips were used in phase one testing. However, it was 
difficult to repeatedly produce radiused wire waveguide distal tips. For 
phase two and three tissue testing flat distal tips were chosen for tissue 
testing because of the ability to create a repeatable geometry and 
because they can deliver twice the acoustic pressures (required for 
cavitation) to that of the radiused tip (as shown in FEA, Chapter 3). 
 A test rig was designed which could advance the ultrasonic apparatus 
towards tissue samples which are held in a force measurement 
cantilever. The force measurement cantilever included two 
thermocouples which could be inserted into the tissue. This arrangement 
could then be held in a liquid thermostatic tank. A hydrophone was also 
included in this test rig which could be used for cavitation detection. A 
Data Acquisition (DAq) system and LabVIEW environment was used to 
control and measure the sensing equipment. 
 The cantilever beam tissue holder was designed to provide force 
feedback as the tissue samples are perforated. The beam was calibrated 
and beam displacement for a given force was also measured. Using this 
data the failure depth in multistage tissue failure can be calculated (i.e. 
recoil or reduction in force as the tissue partially fails is known to be a 
beam deflection distance). 
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 The amplitudes of vibration at the distal tip were measured using an 
optical microscope and image analysis software. Tests were conducted 
for power setting 1- 8 au. Artefacts on the wire waveguide were used as 
datum points. The artefacts were captured as streaks as the wire 
waveguide was vibrating. The wire waveguides could sustain amplitudes 
up to 34.3 µm (setting 5 au), after which wire waveguides regularly 
failed in a short period of time. 
 The hydrophone and data processing was used to detect the operational 
frequency of the ultrasonic apparatus (22.5 kHz). The hydrophone was 
also used to detect the onset of cavitation. Stable cavitation occurred at 
all power settings (i.e. amplitudes of vibration). Inertial cavitation was 
deemed to occur above amplitudes of vibration greater than 31.4 µm 
(acoustic intensity 3.21 W/cm2). According to the FEA of the flat wire 
waveguide, this amplitude of vibration produces approximately 0.3 MPa. 
This value was also verified by a B-mode ultrasonic imaging device. 
 The apparatus was characterised for the following: 
 
 Amplitudes of vibration for given power input settings. 
 Operational frequency of the ultrasonic apparatus. 
 Cavitation detection. 
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 It was required that the ultrasonic apparatus operated similar to clinical 
devices. It was also required that the test rig could produce conditions 
suitable for the tissue tests. Some of the main design requirements which 
were verified are included in Table 4-11. 
 
Description Requirement Verified 
Operating frequency 20 – 50 kHz 22.5 kHz 
Wire waveguide diameters (distal tip) 1.0 – 2.0 mm 1.0 mm 
Amplitudes of vibration 0 – 60 µm 0 – 34.3 µm 
Feedrates 0 – 100 mm/min 10 – 140 ± 2 mm/min 
Thermostatic tank temp’ (core human 
body temp’) 
37 ± 0.1 0C 37 ± 0.2 0C 
Hydrophone DAq sampling rate 
(suitable for cavitation analysis) 
 ≈ 50 kHz 80 kHz 
Cavitation threshold 
1.0 mm flat distal tip 
Yes amplitudes of vibration 
greater than 31.4 µm  
 
Table 4-11 : Main design requirements for ultrasonic apparatus, test rig and 
sensing equipment.  
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CHAPTER  
5 EXPERIMENTAL TISSUE TESTING 
5.1 Introduction 
Using the characterised ultrasonic apparatus, the test rig and sensing 
equipment, a suite of tissue tests were performed. The aim of the tissue tests 
was to examine the following: 
 
i. The effect of the energised ultrasonically vibrating wire waveguide on 
soft arterial tissue perforation forces. 
ii. The effect of increasing amplitudes of vibration at distal tip of the wire 
waveguide on soft arterial tissue perforation forces. 
iii. The effect of cavitation at the wire waveguide distal tip on soft arterial 
tissue perforation forces. 
iv. The effects of the increase of feedrate of the wire waveguide on soft 
arterial tissue perforation forces. 
v. The effects of angled entry of the wire waveguide on soft arterial tissue 
perforation forces. 
vi. The effects of the increase of wire waveguide distal tip amplitude of 
vibration on temperature elevation in the tissue. 
vii. The effects of the increase of feedrate of the wire waveguide on 
temperature elevation in the tissue. 
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The experimental configuration is comparable to that of arterial perforation by 
an ultrasonically vibrating wire waveguide used for angioplasty, thrombolysis 
or other soft tissue cutting. For all tissue tests a 1.0 mm diameter wire 
waveguide was used, both radiused and flat distal tip.  
Tissue testing was conducted in three phases. Based on initial testing and 
results from phase one, phase two and phase three experiments were then 
designed and conducted. Phase two and phase three experiments were aimed at 
examining the waveguide and tissue interaction in more detail, answering some 
of the questions resulting from phase one. The test phases are shown in Figure 
5-1 and the test conditions are shown in Table 5-1. 
 
 Phase one – The operating conditions of the ultrasonic apparatus were 
designed to act similar to that of devices used for thrombolysis and 
angioplasty. It was not yet known the effects, if any, of the ultrasonic wire 
waveguide on the healthy soft arterial tissue. This pilot tissue test phase 
was performed to examine if the ultrasonic apparatus and test rig 
performed as designed during tissue tests. It was important to establish 
if the ultrasonic apparatus had the ability to continually transmit 
ultrasonic vibrations under loading for the entire duration of the tissue 
test. Phase one testing was used to examine the maximum forces for 
complete tissue perforation using a non-energised and energised 
radiused distal tip wire waveguide (144 mm length) with increasing 
amplitudes of vibration (in the range of common distal tip amplitudes of 
vibration). The feedrate used for this test phase was 34 ± 2 mm/min. The 
158 
standard deviation from these results was then used for sample size 
estimation for phase two tissue tests. 
 
 Phase two – Based on results from phase one, phase two experiments 
were then designed. Phase one testing displayed results which required 
further investigation (i.e. multistage tissue failure). Design of 
experiments, including sample size estimation, randomisation of 
experiments and statistical analysis (ANOVA) were employed during this 
phase using Minitab Statistical Software Package. Processing and 
manipulation of the resulting force data in phase two was also improved 
upon in an effort to extract more information from the force profile. The 
force profile was decomposed to describe stages of the tissue failure 
process (perforation initiation force, the force required for initial tissue 
failure). This was thought to be more representative of arterial failure 
whereby the elastic limit of the arterial wall was exceeded and a cut was 
initiated (i.e. irreversible damage). Perforation initiation energy and total 
energy for tissue perforation are also presented in phase two. The effects 
of cavitation on perforation force were also examined in phase two. 
Histological examination of tissue post perforation was applied to 
examine the tissue fibre damage and determine the cause of the 
multistage tissue failure. Initial thermal tests were also performed and 
recorded during this phase. Wire waveguide lengths of 132 mm were 
used for this suite of tests as they proved to be more reliable and were 
able to transmit the ultrasonic energy for long periods of time. All tissue 
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tests hereafter used 132 mm wire waveguide length. Feedrates of 38 ±2 
mm/min were used during this phase. 
 
 Phase three – These tests were designed to examine the effects of 
feedrate on perforation forces at constant power (amplitude of 
vibration) in conditions closer to that of clinical situations. A new tissue 
sample holder design facilitated angled entry approach to the tissue. The 
thermal effects of the wire waveguide over a range of power levels 
(amplitudes of vibration) were also examined. The ΔT and thermal 
profile were recorded and analysed from these test results. 
 
 
Table 5-1 : Summary of conditions used for tissue testing. 
22.5 
kHz 
Waveguide 
Ø(mm) 
Distal tip 
finish 
Waveguide 
lengths 
(mm) 
Amplitude of 
vibration 
(µm) 
Cavitation 
threshold 
Feedrate 
(mm/min) 
Ph 1 1.0 mm Radiused 144  16 – 40  N/A 34 ±2  
Ph 2 1.0 mm Flat 132  22.5–34.3  > 31.4 µm 38 ±2  
Ph 3 1.0 mm Flat 132  22.5–34.3  > 31.4 µm 19-95 ±2 
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Figure 5-1 : Phases for experimental testing of the ultrasonic apparatus and soft 
arterial tissue. 
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5.2 Tissue preparation 
For all tests healthy porcine vascular tissue was used as it is a close 
analogue to human vascular tissue [168]. Multiple porcine subjects were 
obtained from an abattoir and delivered within 24 hours after death. Tissue was 
stored and refrigerated in water until this point. Approximately 250 mm length 
of the descending thoracic aorta was extracted.  Connective tissue was removed 
and 10 x 20 mm radial sections were cut from the tissue sample indicated in 
Figure 5-2. Sections which included branched arteries were rejected.  
Sample tissue thickness ranged between 2.5 - 3.5 mm. Tissue sections 
were then stored in a 0.9 % refrigerated saline solution before testing 
(approximately 1-2 hours prior).  In order for the tissue temperature to equalise 
with the liquid tank temperature of 370C ± 0.2, tissue samples were placed in a 
sealed container and lowered into the thermostatic tank. For each test, the aorta 
sections were then spread flat and clamped in the cantilever beam tissue holder 
(inner endothelium uppermost to represent an inside-out wire perforation) and 
submerged in the thermostatic tank.  
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≈ 20-30 mm
 
Figure 5-2 : Cutting of tissue test samples from porcine aorta sections. 
 
5.3 Phase one tissue tests 
 
5.3.1 Effects of amplitudes of vibration on tissue perforation forces 
The ultrasonic apparatus was designed to act similar to that of devices 
used for thrombolysis and angioplasty. It was not yet known the effects, if any, 
of the ultrasonic wire waveguide on the healthy soft arterial tissue. It was also 
important to establish if the ultrasonic apparatus had the ability to constantly 
transmit ultrasonic vibrations under loading for the entire duration of the tissue 
test.  
This comparative study was undertaken to examine the forces required to 
completely perforate the arterial tissue using a non-energised (no ultrasound) 
Wire waveguide 
direction of travel 
Porcine aorta 
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and energised wire waveguide with a radiused 1.0 mm distal tip.  With the 
energised wire waveguide, the effects of increasing distal tip amplitudes of 
vibration on tissue perforation were also examined. 
 
5.3.1.1 Methodology 
The tissue preparation protocol, as outlined in Section 5.2, was applied for 
these tests. 12 tissue samples were prepared, three tissue (n = 3) per amplitude 
of vibration (0, 16, 25 and 40 µm). Where 0 µm refers to a non-energised wire 
waveguide. A 1.0 mm radiused wire waveguide distal tip, 144 mm in length was 
used. 
Each tissue sample was placed in the cantilever and submerged in the 
thermostatic tank which was filled with tap water and held at a temperature of 
approximately at 37 0C. The wire waveguide was advanced towards the tissue 
samples at a feedrate of 34 ± 2 mm/min. The ultrasound was operated in 
continuous mode at 22.5 kHz. For all tests the wire waveguide was advanced 
until arterial perforation occurred. This could be determined by monitoring the 
real time force profile data.     
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5.3.1.2 Results 
5.3.1.2.1 Perforation force profile 
Figure 5-3 shows examples of the perforation profiles achieved for the 
non-energised wire waveguide and for the energised wire waveguide for three 
distal tip amplitudes of vibration (16 µm, 25 µm and 40 µm). The force profile 
data has been filtered to exclude high frequency noise components 
superimposed on the force profile (> 100 Hz). For clarity, the force profiles are 
spread over the x -axis (time) so that each profile can be distinguished easily. 
The force profile for the tissue perforation with a non-energised wire 
waveguide exhibits only one peak, i.e. single failure. A reduction in perforation 
force and multistage failure was evident when the wire waveguide was 
energised. It is also evident that when the waveguide is non-energised, there is a 
net reactive force on the waveguide after perforation due to contact friction 
between the wire waveguide and the tissue. This force is less in the tests with 
the ultrasound applied. The initial hypothesis, deduced from Figure 5-3, may be 
described as follows: 
 
i. An initial rise in force as the wire waveguide contacts the tissue sample 
ii. Peak one: This initial maximum peak force is thought to represent 
perforation of the intima-media layer (samples were set up so the 
internal arterial wall was penetrated, simulating the in vivo scenario).  
iii. A secondary rise in force as the waveguide contacts the adventitia layer 
iv. Peak two: Perforation of the adventitia layer and an associated reduction 
in force to a negligible value. 
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Figure 5-3 : Perforation force profiles with no ultrasound applied (0 µm, No 
ultrasound (US)) and for ultrasonic wire waveguide distal tip displacement of 
16, 25 and 40 µm. 
 
5.3.1.2.2 Maximum cutting force 
The results of the maximum perforation force in all 12 experiments are 
shown in Figure 5-4. It was found that a force exceeding 3.8 N resulted in 
perforation of the healthy arterial tissue with a non-energised 1.0 mm radiused 
distal tip wire waveguide. The energised wire waveguide with increasing distal 
tip amplitude of vibration resulted in a lower force required to completely 
perforate the artery wall. A 30% reduction in mean perforation force (3.96 N vs. 
2.67 N) was measured when the wire waveguide was energised at the lowest 
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ultrasonic power setting (16 µm).  With the highest ultrasonic amplitudes of 
vibration tested here (40 µm), the perforation force was reduced to 2 N (σ = 
0.1).  It should be noted that in multistage failures of the tissue, the maximum 
force was not always the force first peak. 
 
Figure 5-4 Maximum perforation force required with no ultrasound and with 
ultrasound at amplitudes of vibration of 16, 25 and 40 µm.  
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5.3.2 Conclusion of phase one tissue tests 
Most work to date using therapeutic ultrasound has focused on high 
intensity applications in excess of 400 W/cm2. This work focused on how low 
acoustic intensities, less than 4 W/cm2 affect soft tissue perforation.  
 
The results from the preliminary study indicate the following: 
 
 There is a reduction in the force required (compared to a non-
energised wire waveguide) to perforate the healthy elastic arterial 
wall at the wire waveguide amplitudes of vibration typically used to 
ablate and disrupt atherosclerotic plaques and thrombus.   
 Multistage failure was evident when the wire waveguide was 
energised. By analysing the force profile for multistage failure, one 
may also partially perforate the tissue.  
 The maximum force displayed in Figure 5-4 in some cases was the 
second peak. Initial failure of the tissue is a critical point of failure, 
i.e. the first force profile peak, so this should be examined in more 
detail. 
 The sample size (n = 3) used for this test was low and deemed 
inadequate for statistically significant data. Larger samples would 
be needed for phase two tissue testing. 
 
 
 
  
168 
5.4 Phase two tissue tests 
 
5.4.1 Examination of tissue failure forces using flat distal tip 
This suite of tests (phase two) was designed to further examine the tissue 
perforation force profile in closer detail.  A shorter wire waveguide (132 mm) 
was used for this suite of tests. This had a 1.0 mm diameter flat wire waveguide 
distal tip which could be easily and consistently replicated. It was also 
established through FEA (Chapter 3) that the flat distal tip can produce higher 
pressures than that of the 1.0 mm diameter radiused distal tip wire waveguide 
counterpart for the same amplitudes of vibration. 
The amplitudes of vibration at wire waveguide distal tip for power input 
were experimentally measured, see Chapter 4. This length of wire waveguide 
was shown to be operating in the inertial cavitation region above amplitudes of 
vibration of 31.4 µm (mean). Due to tissue availability and storage, this phase of 
tissue testing was conducted over a number of weeks. The run order of tests 
was, therefore, randomised to mitigate the influence from any uncontrolled 
variables. The aims of this suite of tests were to:  
 
 Examine the forces and energies for initial and total perforation. 
 
 Examine the effects of cavitation on the perforation forces. 
 
 Determine the cause of multiple failures in tissue via histological 
examination. 
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5.4.1.1 Methodology 
For this test six tissue samples (n = 6) per amplitude of vibration (0, 22.5, 
27.8, 31.4 and 34.3 µm) were prepared using the tissue preparation protocol as 
outlined in Section 5.2 (30 tissue samples in total). For each test, the tissue 
sample was secured in the cantilever and submerged in the thermostatic tank. 
The ultrasonic wire waveguide was advanced towards the tissue samples at a 
constant feedrate of 38 ± 2 mm/min for all tests. The ultrasound was 
transmitted in continuous mode at 22.5 kHz.  The wire waveguides were 
advanced through the tissue samples until complete perforation occurred. The 
force profile and visual observation was used as an indicator that the tissue had 
been perforated fully.  
The perforation initiation force was measured and refers to the first peaks 
(F1 and F2) as shown in Figure 5-5 for their respective profiles. While the 
perforation initiation forces (F1 and F2) are extremely informative they do not 
take the wire waveguide tissue indentation depth (δi) into account. The energy 
to initiate perforation (Ei) and totally perforate the artery wall (Et) was 
therefore considered also. 
The energy was calculated using Equation 1 from Chapter 2. The 
perforation initiation energy is represented by the shaded region in Figure 5-5. 
This method was also applied to the entire force profile to determine the total 
perforation energy. 
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Figure 5-5 : Deriving perforation initiation energy from force and distance 
travelled. 
5.4.1.2 Results 
5.4.1.2.1 Perforation force profile versus waveguide indentation 
Figure 5-6 shows examples of the tissue perforation force profile versus 
distal tip indentation into the tissue for each of the amplitudes of vibration (0 – 
34.3 µm). The deflection of the cantilever beam has been subtracted from the 
overall deflection of the system (beam and tissue) to give waveguide 
indentation into tissue (δi). This was then used to calculate perforation energy. 
Generally, the force profiles can be described as having a number of features: 
 
i. An initial rise in force up to a threshold value whereby the tissue fails 
and perforation of the tissue begins, the perforation initiation force, Fi. 
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The area under the curve up to this initial failure point represents the 
work done to initiate perforation, the perforation initiation energy, Ei, 
using the method similar to McCarthy et al. [28]. The total energy for 
perforation was also calculated from the force profile data by calculating 
the area under the entire curve. In the case of the non-energised wire all 
samples failed in a single stage. It should be noted that the magnitude of 
the perforation initiation force was not always the greatest force 
encountered during the perforation; in some cases the second or third 
peak was greater.  
ii. With activation of the wire waveguide and, in particular, at higher 
amplitudes of vibration a multi-stage failure was evident. It was found 
that with amplitudes of vibration of 22.5 µm and greater, failure of the 
tissue occurs in multiple stages (two-three stages identified).  
 
The results show a reduction in the perforation initiation force and energy 
required to initially perforate the tissue with increasing amplitudes of vibration. 
No more than three peaks were detected for any test. To ensure that the wire 
waveguide has contacted the tissue, a threshold of 0.3 N is allocated as the 
contact point, the data has also been decimated (50 points) to provide a clearer 
representation of the force profile, as seen in Figure 5-6. 
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Figure 5-6 : Force versus distal tip indentation into tissue, δi, profiles for 
individual tests for a range of amplitude of vibrations. “x” indicates failure. Note: 
Non-energised is depicted as 0 μm. 
 
5.4.1.2.2 Perforation initiation force 
Figure 5-7 shows the results for the perforation initiation force for all tests 
(six tests per amplitude of vibration (n = 6), 30 runs in total). With the non-
energised wire waveguide, the perforation initiation force is 6.13 N (mean, σ = 
0.60 N). At the lowest amplitude of vibration of 22.5 μm, the perforation 
initiation force is reduced to 2.46 N (mean, σ = 0.49 N). The perforation 
initiation force is further reduced to 1.26 N (mean, σ = 0.14 N) with an 
energised wire waveguide while with the highest amplitude of vibration of 34.3 
μm, an 80% reduction in force compared with the non-energised waveguide 
was found. The perforation initiation forces for amplitudes of vibration at 27.8 
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µm and above were not significantly different (CI = 0.95). There was also no 
significant reduction in the perforation initiation force when the wire 
waveguide was operating above the cavitation threshold amplitude of vibration 
of 31.4 µm. Standard deviation was lowest (both σ = 0.135 N) for the higher 
amplitudes of vibrations tested (31.4 µm and 34.3 µm). In comparison for a non-
energised wire waveguide the deviation was much greater (σ = 0.60 N) 
 
 
Figure 5-7 : Perforation initiation force (Fi) for a range of amplitudes of 
vibrations. 
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5.4.1.2.3 Perforation initiation energy 
The resulting perforation initiation energy, Ei, was calculated and plotted 
in Figure 5-8. The energy for perforation initiation for a non-energised wire was 
7.75 mJ (mean, σ = 1.41 mJ). This reduced to 2.38 mJ (mean, σ = 0.71 mJ) at the 
lowest amplitude of vibration of 22.5 µm. The minimum perforation initiation 
energy was measured as 1.02 mJ (mean, σ = 0.46 mJ) at the highest amplitude of 
vibration of 34.3 µm. The lowest standard deviation (σ = 0.22 mJ) was measured 
at amplitude of vibration of 27.8 µm, this increased for the higher amplitudes of 
vibration (31.4 µm, σ = 0.33 mJ and 34.3 µm, σ = 0.46 mJ).  
 
Figure 5-8 : Perforation initiation energy (Ei) for a range of amplitudes of 
vibration. 
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5.4.1.2.4 Total perforation energy 
The total perforation energy (Et) versus amplitude of vibration is plotted 
in Figure 5-9. For a non-energised wire waveguide, the total perforation energy 
was 7.75 mJ (mean, σ = 1.41 mJ, note: same as perforation initiation energy as 
failure occurred in one stage for all tests). This was reduced to 3.07 mJ (mean, σ 
= 1.49 mJ) at an amplitude of vibration of setting 22.5 µm. The energy required 
to completely perforate the tissue at the highest amplitude of vibration (34.3 
µm) was reduced to 1.45 (mean, σ = 0.52 mJ). The perforation initiation force, 
energy and total perforation energy are also presented in Table 5-2. 
 
 
 
Figure 5-9 : Total perforation energy (Et) for a range of amplitudes of vibration. 
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Table 5-2 : Perforation initiation force (Fi), perforation initiation energy (Ei) and 
total perforation energy (Et) for all amplitudes of vibration/acoustic intensities 
using a 1.0 mm flat distal tip wire waveguide at 22.5 kHz. 
 
 
 
 
 
TISSUE PERFORATION FORCE AND ENERGY 
Amplitude of  
Vibration  
(µm) 
Acoustic 
intensity 
(W/cm2) 
Perforation  
initiation 
force, Fi (N) 
Perforation  
initiation energy, 
Ei (mJ) 
Total perforation 
energy, Et (mJ) 
0 0 6.13  
(mean, σ = 
0.60) 
7.75  
(mean, σ = 1.41) 
7.75  
(mean, σ = 1.41) 
22.5 1.65 2.46  
(mean, σ = 
0.49) 
2.38  
(mean, σ = 0.71) 
3.07  
(mean, σ = 1.49) 
27.8 2.51 1.59  
(mean, σ = 
0.25) 
1.23  
(mean, σ = 0.22) 
2.13  
(mean, σ = 0.60) 
31.4 3.21 1.48  
(mean, σ = 
0.13) 
1.14  
(mean, σ = 0.33) 
1.75  
(mean, σ = 0.71) 
34.3 3.83 1.26  
(mean, σ = 
0.14) 
1.02  
(mean, σ = 0.46) 
1.45  
(mean, σ = 0.52) 
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5.4.2 Histological analysis of tissue failure 
Histological analysis was employed to answer some of the fundamental 
questions surrounding the perforation of the tissue with an ultrasonically 
energised wire waveguide. Before the tissue was subjected to testing, 
microscopic analysis was used to determine the composition of the porcine 
artery wall samples (intima, media and adventitia).  A comparative analysis of 
tissue which was perforated by a non-energised and energised wire waveguide 
was also performed. Tissue samples were viewed at point of entry (plan view) 
and along the perforated hole (section view) as shown in Figure 5-10. 
 
Section view
Plan view
Point of entry
 
Figure 5-10 : Plan view (top) and section view (right) of tissue samples for 
histology. 
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5.4.2.1 Methodology 
For this analysis, three different sets of tissue samples were histologically 
examined, as outlined below. 
 
i. Negative controls (processed tissue but not perforated with any wire 
waveguide). 
ii. Tissue sample perforated with a non-energised wire waveguide.   
iii. Tissue samples perforated with an energised wire waveguide which 
exhibited multiple failures. 
 
All tissues sample were stored in 10 % buffered formalin solution. The tissue 
was then processed to wax over a 12 hour period and is illustrated in the 
flowchart in Figure 5-11 . Water constituents were removed by alcohol, i.e. 
dehydration by ethanol. A hydrophobic clearing agent (Xylene) was then used to 
remove the alcohol and the tissue was finally infiltrated by molten paraffin wax. 
The hard wax tissue samples were then embedded in wax cassettes, top down 
for plan view and sideways for section view. The samples were then trimmed 
(20 µm) on a rotary microtome until the sections of interest were exposed. The 
cassette was then placed in an ice bath to cool. 
For section view cuts it was important to get a representation of the cut 
approximately half way through the diameter of the hole. To achieve this several 
levels were taken. For each level, three to four 5 µm sections were cut and 
placed on a microscopic glass slide. The wax block was then trimmed for 
approximately 10 cuts of 20 µm. The next level of 5 µm sections was then cut. 
Up to seven levels were taken for some tissue samples.  
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For the plan view, the wax block was trimmed (20 µm) until section 
samples represented the point of entry at the upper tissue layer. One level of 
three to four 5 µm sections were then cut and placed on the microscopic glass 
slide. These samples were then de-waxed and stained using Haematoxylin and 
Eason (H&E) and Millers Elastic staining protocols. Samples could then viewed 
using light microscopy. 
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Histological process
Remove water 
(dehydrate)
Remove Ethanol  Xylene infiltration
Add Ethanol
Add 
hydrophobic 
clearing agent
Process to wax
Infiltrate with 
paraffin wax
Embed in cassette 
(block)
Trim (20 µm)
Cut section levels 
(5 µm)
Cover slip on glass 
slide
Set and bake on 
slides
Rehydrate to spirit
Apply staining 
protocol
Dehydrate 
Microscope
 
Figure 5-11 : Histological processing. 
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5.4.2.2 Results 
 
5.4.2.2.1 Negative control tissue samples 
A tissue sample which was prepared for testing but not tested on (control) 
was stained using Miller Elastic protocol is shown in Figure 5-12. The section 
view of the artery shows elastin fibres stained blue and collagen in the 
adventitia stained pink. Relatively thin adventitia layer is present surrounding 
the circumference of the tissue. The cut end of this artery section is also shown 
in Figure 5-13. The end section was dissected using a scalpel. The effects of this 
cut can be seen at where the fibres terminate. The fibres are sheared but are not 
de-bundled. This is an example of the shear failure. 
 
 
 
Figure 5-12 : Millers Elastic stain of artery wall, section view, 20x. 
Adventitia (pink) 
300 µm 
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Figure 5-13 : End of artery section, 20x. 
 
5.4.2.2.2 Non-energised wire waveguide perforation 
Tissue samples which were perforated with a non-energised wire 
waveguide are shown in Figure 5-14. The plan view of the wire waveguide point 
of entry, stained with H&E, is shown Figure 5-14 (B). The 1.0 mm diameter wire 
waveguide does not produce a perfect circular entry hole; rather, the grain of 
the fibres has split in opposite points along the circumference of the hole. The 
forces to perforate the tissue using the non-energised wire waveguide are larger 
than that of the force when using an energised wire waveguide. The larger 
forces may cause more tissue damage akin to that of perforation by blunt 
trauma. Single tissue failures were seen on the force profile when the non-
energised wire waveguides perforated the tissue. This single failure was also 
evident in the section view H&E tissue samples. Again the large forces seem to 
split the tissue (shear dissection) with minimal tissue removal when the wire 
waveguide is non-energised. The image of the shearing at points of tissue failure 
300 µm 
Sheared fibres 
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in Figure 5-14 are in some respects comparable to Figure 5-13 where the tissue 
has been dissected by a scalpel. It should be noted that, due to the processing, 
some artefacts may get included on the slide or the tissue may get moved 
slightly by the addition of the cover slip. 
 
 
 
Figure 5-14 :  A) Section view of tissue which was perforated by a non-energised 
wire waveguide, 20x, H&E stain. B) Plan view of point of entry of non-energised 
wire waveguide perforation, 4x, H&E stain. 
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5.4.2.2.3 Energised wire waveguide perforation 
Tissue samples which were perforated with an energised wire waveguide 
operating with amplitudes of vibration of 27.8 µm are shown in Figure 5-15.   A 
Haematoxylin and Eason stain was applied. The cross sectional profile of the 
hole parallel to the cut direction (A) clearly shows multistage tissue perforation. 
Three stage perforation was observed corresponding to the force profile data 
from the tissue test where three force peaks was measured. The histology 
images present strong evidence of tissue removal; the perforated hole remains 
after waveguide removal. At the tissue failure locations it can also be seen that 
the tissue has become striated and compressed or fused, with evidence of de-
lamination in the vicinity. When the high frequency vibrations are applied to the 
wire waveguide, a well defined entry hole is created in the tissue (B). There is 
also evidence to suggest that lateral damage occurs away from the point of 
entry, this is shown in Figure 5-16. Similar de-striation of the fibres is seen, 
although no shearing of the fibres occurs. 
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Figure 5-15 : A) Perforation of artery with energised wire waveguide, 
amplitudes of vibration of 27.8 µm, 20x. B) Plan view of point of entry, 4x. 
 
 
Figure 5-16 : Section cut from peripheral of point of entry. Lateral damage from 
a three stage perforation, 20x. 
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5.4.3 Conclusion of phase two tissue tests 
 
 The phase two tissue tests show that the energised wire waveguide 
perforate the artery with lower forces than a non-energised wire 
waveguide. An increase in the wire waveguide distal tip amplitudes of 
vibration results in lower perforation forces.  
 A significant reduction in perforation initiation force, perforation 
initiation energy and total perforation energy is measured with the 
energised wire waveguide at the lower amplitudes of vibration (< 27.8 
μm). Increasing the amplitudes of vibration above this may not yield 
significantly lower perforation forces and energies. 
 Inertial cavitation and its effects on the perforation forces were 
examined here. Operation of the waveguide in the inertial cavitation 
region appears to have no significant effect on the perforation force and 
energy. This ablation mechanism may however have a greater affect on 
hard brittle tissues, but for soft tissues, such as the aorta wall, direct 
mechanical contact between waveguide and tissue appear to be the 
primary tissue disruption mechanism. 
 Histological examination of the tissue revealed a relatively thin 
adventitia layer in the porcine aorta when compared with the media 
layer. As a result, it was evident that there were multiple distinct failures 
within the media layer alone, ruling out the possibility that failure 
occurred at the boundaries between arterial layers 
(intima/media/adventitia), contrary to the initial hypothesis from phase 
one test results. 
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 When no ultrasound is applied, tissue fibres appear sheared. The forces 
applied by the wire waveguide may build up to a point where the elastic 
limit of the tissue is compromised and sudden failure occurs. These large 
forces appear to be great enough to then fully perforate the tissue.  
 Histological examination show evidence of tissue removal when the 
tissue is perforated with an energised wire waveguide. 
 Large variance in perforation force and energy is seen when the wire 
waveguide is non-energised. This may be attributed to the heterogeneity 
of the tissue samples. The standard deviation from the mean forces and 
energies are lower when the waveguide is ultrasonically energised. The 
lowest standard deviation occurring at amplitudes of vibration of 27.8 
µm. This may suggest that, despite the tissues heterogeneity, the 
energised waveguide is performing a controlled cutting action, reaching 
its most efficient at amplitudes of vibration of 27.8 µm.  
 With an energised wire waveguide, a more controlled cutting action 
appears to be occurring. Locally, the tissue may be failing from high 
strain rates and fatigue caused by the high frequency mechanical 
vibrations. The high frequency cyclic impact may be pounding and 
compressing the tissue until failure occurs.  
 Although perforation occurs at lower forces with the energised wire 
waveguide when compared to the non-energised wire waveguide, tissue 
damage and removal both seem greater. Compression of the fibres is 
most evident with the second perforation stage, as seen in Figure 5-15. 
One possible explanation of this may be as follows. 
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i. Wire waveguide distal tip perforates the tissue initially. The first 
perforation initiation stage in then complete.  
 
ii. As this fails the cantilever recoils upward and the second stage 
perforation begins. At this point the wire waveguide is now 
subject to loading both directly ahead and laterally (friction by 
tissue at sides of waveguide). This may impede the cutting action 
of the wire waveguide and cause larger forces for the second 
perforation. The compression of the fibres at this point is an 
indicator of this. It appears also that tissue removal is most 
evident in the initial perforation, whereas, the second and third 
perforation stages appear to have less tissue removal. 
 
 This work shows that when high frequency vibrations are applied to 
waveguides, the range of forces and energy to perforate the tissue are 
more predictable. This may allow for greater control of tissue removal. 
The results may aid device design and power selection during precision 
tissue removal applications. 
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5.5 Phase three tissue tests 
This tissue testing phase was designed to more closely represent in vivo 
conditions, whereby a range of feedrates and angle of approach would be more 
applicable. Phase three examines the following: 
 
i. Effects of feedrate on tissue perforation forces. 
ii. Effects of angled entry on perforation forces. 
iii. Effects of feedrate and wire waveguide distal tip amplitudes of 
vibration on tissue temperature rise (ΔT). 
 
5.5.1 Effects of feedrate on tissue perforation forces  
Tissue failure is caused by a combination of the wire waveguide being 
driven into the tissue by the motor and lead screw but also by the cyclic impact 
from the vibrating wire waveguide distal tip. To this point, only the effects of 
ultrasound for a range of distal tip amplitudes of vibration on perforation force 
and energy at a fixed feedrate have been examined. This test is designed to 
examine the effects of feedrate on the perforation forces.  
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5.5.1.1 Methodology 
For this experiment three different distal tip amplitudes of vibration were 
examined (0, 27.8 and 34.3 µm). For these three amplitudes of vibration settings 
the effects of a range of feedrates on perforation initiation force were examined 
(19, 38, 57, 76 and 95 ±0.2 mm/min), i.e. multiples of 19 mm/min. For each test 
run, six tissue samples (n = 6) were used. In total 90 tissue samples were tested, 
30 samples per amplitude of vibration. Tissue samples for this test were 
processed according to the tissue preparation protocol outlined in Section 5.2 
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5.5.1.2 Results 
5.5.1.2.1 No ultrasound, non-energised wire waveguide, 0 µm 
The effects of the range of feedrates for a non-energised wire waveguide 
show no statistical difference in perforation initiation force (CI = 0.95). The 
results are plotted in Figure 5-17. The largest mean perforation initiation force 
and largest standard deviation (6.95 N, σ = 1.47 N) is seen with the slowest 
feedrate (19 mm/min), but it is not statistically different from all other 
feedrates (CI = 0.95). The mean perforation initiation force reduces by 1.7 N for 
the faster feedrate of 38 mm/min. For all other feedrates above 38 mm/min the 
mean value does not deviate by more than 0.4 N. The lowest standard deviation 
occurs at feedrates of 76 mm/min (σ = 0.72 N). 
 
Figure 5-17 : Perforation initiation force for a range of feedrates (19-95 
mm/min) for a non-energised wire waveguide. 
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5.5.1.2.2 Energised wire waveguide with amplitudes of vibration of 27.8 
µm 
With the energised wire waveguide producing amplitudes of vibration of 
27.8 µm at the distal tip, the perforation initiation force for the range of 
feedrates (19- 95 mm/min) is shown in Figure 5-18.  The perforation initiation 
force for the feedrate of 19 mm/min is statistically different from the 
perforation initiation force at 76 mm/min (CI = 0.95). Higher mean perforation 
forces (3.07 N mean, σ = 0.39 N) were again seen at the slowest feedrate of 19 
mm/min. The lowest perforation initiation force and standard deviation (2.08 
N, σ = 0.3 N) was seen at a feedrate of 76 mm/min.  A 1 N (30%) reduction is 
measured between the highest and lowest mean perforation forces.  
Figure 5-18 : Perforation initiation force for a range of feedrates (19-95 
mm/min) for an energised wire waveguide with amplitude of vibration of 27.8 
µm. 
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5.5.1.2.3 Energised wire waveguide with amplitudes of vibration of 34.3 
µm 
A reduction in perforation initiation force is observed for all feedrates, as 
expected, with the higher amplitude of vibration of 34.3 µm. No statistical 
difference was seen in the perforation initiation force for the range of feedrates, 
as can be seen in Figure 5-19 (CI = 0.95). The lowest mean perforation force and 
standard deviation occurred at a feedrate of 38 mm/min (1.26 N, σ = 0.1368). 
The greatest mean perforation initiation force (1.63 N, σ = 0.1871 N) was 
experienced at the higher feedrates of 95 mm/min.   
 
 
Figure 5-19 : Perforation initiation force for a range of feedrates (19-95 
mm/min) for an energised wire waveguide with amplitude of vibration of 34.3 
µm. 
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5.5.2 Effects of angled entry on perforation forces 
The aim of this suite of tests was to examine the effects of angled entry on 
the perforation initiation force. This scenario may be more applicable to in vivo 
conditions whereby the wire waveguide may not approach the artery wall at 90 
degrees. For this experiment a 45 degree angle of approach was examined, 
eccentric lesions may cause of such an approach. An illustration of this scenario 
is shown in Figure 5-20. One challenge for this test was to get the wire 
waveguide to engage the tissue at this angle rather than deflecting parallel to 
the wall and sliding along the inner lumen. 
 
Figure 5-20 : 45 degree angle of approach. 
 
5.5.2.1 Methodology 
For this test, a tissue holder attachment was designed and manufactured 
which could be used with the current cantilever force measurement device. This 
is a 45 degree compensator. A schematic of this arrangement is shown in Figure 
5-21. The cantilever strain gauge arrangement was re-calibrated to include the 
additional mass of this attachment. Tissue samples were placed in an 8.0 mm 
deep slot and were then secured by an upper plate. This attachment block and 
450 
Wire 
waveguide 
Eccentric CTO 
Artery wall 
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the upper plate allowed for complete perforation of the tissue. An image of the 
cantilever with the 450 compensator is shown in Figure 5-22. The tissue was 
clamped by the upper plate in such a manner that it could not slip or be pushed 
from its position. To examine the effects of angled entry on the perforation 
initiation force, three amplitudes of vibration (0, 27.8 and 34.3 µm) were 
examined at a constant feedrate of 38 mm/min. Six tissue samples were tested 
(n = 6) for 45 degree and 90 degree. 36 test runs in total. 
 
 
 
Figure 5-21 : Schematic of cantilever beam force measurement device with 45 
degree angle compensator. 
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Figure 5-22 : Image of cantilever beam force measurement device with 45 
degree angle compensator. 
5.5.2.2 Results 
Figure 5-23 shows the perforation initiation forces for the angled entry 
test for amplitudes of vibration of 0, 27.7 and 34.3 µm. For each set of amplitude 
of vibration, tests were carried out at a 45 degree and 90 degree angle of 
approach. The results for each set are contained in a red box.  
In any case, the forces required for perforation initiation for both 45 and 
90 degrees were not statistically different (CI = 0.95); the maximum difference 
in  mean perforation initiation force for 90 degree and 45 degree differed by no 
more than 28 % (measured at 27.8 µm).  For 0 µm and 27.8 µm the mean value 
for perforation initiation force was lower for 45 degrees (5.43 and 2.06 N 
respectively) than for the 90 degree angle of approach (6.1 N and 2.88 N). For 
tests using amplitudes of vibration of 34.3 µm, mean perforation initiation 
Wire waveguide 
Cantilever with 450 compensator 
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forces were lower for the 90 degree angle of approach. The difference between 
the mean perforation initiation forces for 45 and 90 degrees at amplitudes of 
vibration of 34.3 µm was the smallest for all three distal tip settings (1.37 and 
1.26 N, respectively). 
The largest standard deviation (45 degree, δ = 0.59 and 90 degree, δ = 
0.66) is present with 0µm (i.e. no ultrasound) and this may be related to the 
heterogeneity of the tissue. With ultrasound, the standard deviation is lowest, as 
can be seen with 34.3 µm (45 degree, δ = 0.29 and 90 degree, δ = 0.13).  
0 µm 
450
0 µm 
900
27.8 µm 
450
27.8 µm 
900
34.3 µm 
450
34.3 µm 
900
Amplitude of vibration
Angle
 
Figure 5-23 : Perforation initiation force for 0, 27.8 and 34.3 µm for 45 degree 
and 90 degree angle of approach to tissue. 
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5.5.3 Effects of feedrate and wire waveguide distal tip amplitudes of 
vibration on tissue temperature rise (ΔT) 
Heating of tissue when using ultrasonic devices in medicine is commonly 
described. The aims of the thermal testing were to examine the temperature rise 
and its relationship with wire waveguide amplitudes of vibration and feedrates.  
 
Tissue heating may be a result of: 
 
i. Attenuation of the ultrasonic wave: For the higher intensity ultrasound, 
heating is often attributed to attenuation of the acoustic wave, depositing 
thermal energy as it passes through the medium. The high temperatures 
commonly observed are closely related to exposure time and operation 
duty.  
 
ii. Wire waveguide internal friction: For the low frequency ultrasonic 
apparatus used for these tests, the emitter, the wire waveguide may also 
act as a heat source. The mechanical to thermal energy conversion 
caused by the high cyclic vibrations in the NiTi wire waveguide can cause 
the wire waveguide material to heat. 
 
iii. Wire waveguide - tissue contact friction: Friction between the vibrating 
wire waveguide and surrounding tissue which is in contact with it can 
cause temperature increase which may be sufficient for cell and tissue 
necrosis.  
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Figure 5-24 : Heating sources using ultrasonically vibrating wire waveguide. (A) 
Heating due to attenuation. (B) Wire waveguide as heat source. (C) Wire 
waveguide – tissue frictional heating.  
 
5.5.3.1 Methodology 
The measurements for the thermal tests were taken during the tissue 
perforation tests (phase two). A thermocouple was embedded into the surface 
of the tissue approximately 3.0 mm from the point of entry of the wire 
waveguide. Tissue samples were prepared according to the tissue preparation 
protocol outlined in Section 5-2; they were then placed in a container and held 
at thermostatic tank temperature (≈ 37 0C). It should be noted that the 
temperature measurement from the thermocouple lags behind the true 
temperature at the source as it is placed a few millimetres from the point of 
entry. For all tests, maximum temperatures are measured a few seconds after 
perforation. A drop in temperature was also used as an indicator that the 
maximum possible temperature had been reached. 
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5.5.3.1.1 Effects of amplitude of vibration on temperature 
For this test, the temperature elevation (ΔT) was measured for a range of 
amplitude of vibrations (22.5, 27.8, 31.4 and 34.3 μm). The 1.0 mm flat distal tip 
wire waveguide was advanced at a constant feedrate of 38 ± 2 mm/min until the 
tissue was perforated. The ambient temperature (T1) and maximum 
temperature during perforation (T2) were measured. Six tissue samples were 
tested for each feedrate (n = 6), 24 tissue samples in total. 
 
5.5.3.1.2 Effects of feedrate on temperature 
For a constant amplitude of vibration (27.8 μm), the effects of feedrate on 
temperature rise (ΔT) were also examined. For this test, a range of feedrates 
were tested (19, 38, 57, 76, 95 ± 2 mm/min) using a 1.0 mm flat distal tip wire 
waveguide. Six tissue samples were tested for each feedrate (n = 6), 30 tissue 
samples in total. 
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5.5.4 Results 
5.5.4.1 Effects of amplitude of vibration on temperature 
The increase of amplitude of vibration at the wire waveguide distal tip 
resulted in an increase in ΔT. For a constant feedrate the maximum ΔT was 
measured at the largest amplitude of vibration of 34.3 µm. This mean value of 
the temperature increase was 1.8 0C (σ = 1.363).  The lowest mean value 
temperature increase was measured with the lowest amplitude of vibration, this 
was 0.775 0C (σ = 0.48). The mean temperature increase (ΔT) doubled (0.8520C, 
σ = 0.351 to 1.57 0C, σ = 0.68) from amplitudes of vibration of 27.8 µm to 31.4, 
respectively. 
 
Figure 5-25 : Effects of amplitude of vibration on temperature elevation (ΔT), 
constant feedrate of 38 mm/min. 
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5.5.4.2 Effects of feedrate on temperature 
The effects of feedrate on temperature are shown in Figure 5-26. The 
slowest feedrate of 19 ±2 mm/min resulted in the highest temperature increase 
of 1.7 0C (σ = 1.33, maximum 3.9 0C). Temperature increase values at 38 ±2 
mm/min and 57 ±2 mm/min were very similar despite an increase in feedrate, 
the measurements were 0.830C (σ =1.33) and 0.880C (σ = 1.98). The lowest 
temperature increase was recorded at the fastest feedrate (95±2 mm/min), this 
was 0.437 0C (σ = 0.188).  The temperature profile and force profile for a 
feedrate of 57 mm/min and amplitude of vibration of 27.8 µm are shown in 
Figure 5-27. In this example, the force and temperature profiles are closely 
matched. The force and temperature are related here. The multistage failure in 
the force profile is also evident in the temperature profile. 
 
Figure 5-26 : Effects of feedrate on temperature elevation (ΔT), constant 
amplitude of vibration (27.8 μm). 
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Figure 5-27 : Temperature profile and force profile example for feedrate of 57 
mm/min and amplitude of vibration of 27.8 µm. 
5.5.5 Conclusion of phase three tissue tests 
5.5.5.1 Effects of feedrate on tissue perforation forces 
A combination of feedrate and amplitude of vibration at distal tip may 
offer the most optimum cutting action, where efficient cutting can be attributed 
to lower perforation initiation forces. From these results, low perforation forces 
are associated with high amplitudes of vibration and slow feedrates. For 
amplitudes of vibration of 27. 8 µm the feedrate for lowest perforation initiation 
force is 76 mm/min. For tests using 34.3 µm the feedrate for lowest mean 
perforation initiation force has been reduced to 38 mm/min. This may suggest 
that at larger amplitudes of vibration at the wire waveguide distal tip the 
feedrate must be slower to achieve low perforation forces. 
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5.5.5.2 Effects of angled entry on perforation forces 
No significant difference in perforation initiation force is seen with the 
angled point of entry. This may be explained by the soft elastic nature of the 
artery wall and the geometry which is perforating it. At some point, as the 
waveguide distal tip approaches and contacts the tissue at the 45 degree angle, 
one side of the distal tip will contact the tissue first and cause a stress 
concentration. Locally, because of the distal tip geometry, this has the effect of 
aligning the tissue towards the cutting face of the flat distal tip, as shown Figure 
5-28. In comparison with hard tissue angled contact, the brittle nature of the 
tissue may cause failure at first point of contact providing a true 45 degree angle 
cutting. It is hypothesised that perforation in vivo, not only because of the elastic 
nature of the tissue but its anatomical position (vessel can extend in all 
directions) may be also well represented by a 90 degree angle entry when using 
flat tip wire waveguides.  
 
Figure 5-28 : Mechanics of soft tissue interaction with angled entry. 
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5.5.5.3 Effects of amplitude of vibration on temperature 
It was evident that an increase in amplitude of vibration resulted in an 
increase in temperature of the tissue. The temperatures are not likely to cause 
thermal tissue damage. The temperature rose significantly after amplitudes of 
vibration of 27.8 µm. The temperature rise after may be attributed to cavitation 
heating. This form of additional heating is described in the application of phaco-
emulsification. The adverse effect of this heating coupled with the force data 
from phase two testing may suggest that operating with amplitudes of vibration 
above this may not be significantly beneficial. No significant drop in perforation 
force is seen above 27.8 µm but there is a significant temperature increase. 
Since the frequency of operation is constant but amplitude of vibration is 
increasing, one may proffer that the temperature increase is most likely caused 
by lateral friction between the wire waveguide and tissue.   
 
5.5.5.4 Effects of feedrate on temperature 
For constant wire waveguide distal tip amplitude of vibration, slower 
feedrates resulted in a higher temperature rise. This would suggest that the 
temperature rise is a function of wire waveguide tissue contact time. A 
significant difference was seen at the slowest feedrate of 19 mm/min. For 
feedrates after this, the temperature increase remained relatively constant. 
When comparing the perforation initiation force for the same range of feedrates 
with the temperature data, one may offer the conclusion that heating is also 
closely related to the contact forces, this is evident in the force profile and 
temperature profile comparison, shown in Figure 5-27.  
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CHAPTER  
6 CONCLUSION 
6.1 Summary of results 
The modified ultrasonic apparatus used in this research for tissue testing 
operates at a fixed frequency of 22.5 kHz and is capable of delivering ultrasonic 
amplitudes of vibration to a radiused and flat 1.0 mm wire waveguide distal tip 
for the extended periods of time required for tissues testing.  Tests were 
conducted with a non-energised wire waveguide (0µm) and with an energised 
wire waveguide at four set amplitudes of vibration (22.5, 27.8, 31.4 and 34.3 
µm). For feedrate tests the feedrates were 19, 38, 57, 76 and 95 mm/min. Over 
222 arterial aortic tissue samples were tested in these studies. The aorta was 
extracted from over 30 porcine cadavers. The objectives set out in Figure 2-21 
have all been achieved. 
 
6.1.1 Tissue perforation force profile  
 
 The force required to perforate the artery wall using a radiused distal 
tipped non-energised wire waveguide is 3.8 N mean, by ultrasonically 
energising the wire waveguide at low amplitudes of vibration (16 µm) 
the perforation force is reduced to 2.66 N mean (i.e. a 30 % reduction in 
force). Subsequent increasing of distal tip amplitudes of vibration results 
in no significant reduction in perforation force. 
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 The force required to perforate the artery wall using a 1.0 mm flat distal 
tipped non-energised wire waveguide is 6.13 N, mean. A 60 % reduction 
in perforation initiation force (3.67 N) is measured when the wire 
waveguide is ultrasonically energised at low amplitudes of vibration 
(22.5 µm). A further 35 % reduction in perforation initiation force can be 
achieved by increasing the amplitude of vibration by only 5.3 µm to 27.8 
µm.  Increasing the wire waveguide distal tip amplitudes of vibration 
further to 31.4 µm only results in a 7 % decrease in mean perforation 
initiation force. 
 For all tests the largest standard deviation in perforation forces is 
measured when the wire waveguide is not energised (σ = 0.60 N). The 
lowest standard deviation in perforation initiation forces occurs with 
wire waveguide distal tip amplitudes of vibrations of 31.4 µm (σ = 0.13 
N).  The lowest standard deviation in perforation energy occurs with 
distal tip amplitudes of vibration of 27.8 µm (σ = 0.22 mJ). 
 
6.1.2 The effect of feedrate on tissue perforation forces  
 
 The perforation forces for a range of feedrates (19 - 95 mm/min) were 
measured for a non-energised wire waveguide and an ultrasonically 
vibrating wire waveguide (27.8 µm and 34.3µm).  
 The lowest mean perforation forces with the non-energised wire were at 
a feedrate of 38 mm/min (5.25 N, mean). The perforation forces for the 
range of feedrates, however, were not statistically different (CI = 0.95). 
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 For an ultrasonically vibrating wire waveguide with distal tip amplitudes 
of vibration of 27.8 µm the lowest perforation initiation force is 
measured at a feedrate of 76 mm/min (2.08 N mean). This perforation 
initiation force is 30 % lower than the highest perforation initiation force 
(3.07 N, mean) measured for this range of feedrates and is statistically 
different from all other feedrates (CI = 0.95). 
 For an ultrasonically vibrating wire waveguide with distal tip amplitudes 
of vibration of 34.3 µm the lowest perforation initiation force is 
measured at a feedrate of 38 mm/min (1.26 N mean). The highest 
perforation initiation force is measured at the fastest feedrate of 95 
mm/min (1.63 N, mean). The perforation initiation forces across the 
range of feedrates are not statistically different (CI = 0.95). 
 
6.1.3 The effect of cavitation on the tissue perforation forces 
 
 Using a 1.0 mm diameter flat wire waveguide distal tip, inertial cavitation 
for the ultrasonic apparatus used in tissue testing occurs with 
amplitudes of vibrations greater than 31.4 μm. According to the FEA, for 
a flat wire waveguide distal this is predicted to be ≈ 0.3 MPa. This 
correlates well with the cavitation threshold from the literature. 
 There is no statistically significant change in the perforation forces and 
energy above this cavitation threshold (CI = 0.95). There is an increase in 
temperature above the cavitation threshold, the mean temperature 
doubled (0.85 0C to 1.57 0C). 
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6.1.4 The effect of angled entry on tissue perforation forces 
 
 Initially the artery was perforated at a 90 degree angle. No statistically 
different data was measured in the perforation initiation force when this 
angle was reduced to 45 degrees (CI = 0.95).  
 For a non-energised wire waveguide the perforation initiation force is 
largest for 90 degree angle of approach (6.1 N, mean). The perforation 
initiation force reduced by 11% for the 45 degree angle of approach (5.4 
N, mean). 
 A 28% reduction in mean perforation initiation force was measured with 
wire waveguide distal tip amplitudes of vibration of 27.8 µm when 
angled at 45 degrees (from 2.88 N to 2.06 N).  
 An 8% increase in mean perforation initiation force was measured with 
wire waveguide distal tip amplitudes of vibration of 34.3 µm when 
angled at 45 degrees (from 1.26 N to 1.37 N). 
 
6.1.5 The effects of wire waveguide distal tip amplitudes of vibration on 
temperature  
 
 The largest mean temperature increase (ΔT) was measured at the 
greatest amplitude of vibration (34.3 µm). This was 1.8 0C (mean). The 
largest ΔT measured at this amplitude of vibration was 3.8 0C. The lowest 
temperature rise (ΔT) was measured with the lowest wire waveguide 
distal tip amplitude of vibration (22.5 µm).  
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 Increasing the amplitude of vibration to 27.8 µm results in only a mean 
ΔT increase of 10%. Increasing the distal tip amplitudes of vibration 
further to 31.4 µm results in a mean ΔT increase of 45%. Increasing the 
amplitudes of vibration to 34.3 µm results in a mean ΔT increase of only 
12 %. 
 
6.1.6 The effects of feedrate and wire waveguide distal tip amplitudes of 
vibration on temperature 
 
 The effects of feedrate on temperature increase, ΔT, were also examined. 
The feedrates tested were 19, 38, 57, 76 and 95 mm/min. The largest ΔT 
was measured with the slowest feedrate of 19 mm/min. This was a mean 
ΔT of 1.7 0C. The maximum ΔT was 3.9 0C at this feedrate. There was no 
statistically different ΔT for the range of feedrates 38 – 95 mm/min (CI = 
0.95). 
 
6.1.7 Numerical analysis 
6.1.7.1 Mesh density analysis 
For the frequency range (20 – 50 kHz) and wire waveguide distal tip 
amplitudes of vibration used in clinical and experiment testing of the ultrasonic 
wire waveguides (0 – 60 µm), the pressure profile was predicted and compared 
to an analytical solution for simple distal tip geometries. The mesh density 
required to model these devices was found to be 140 Elements Per Wavelength 
(EPW). 
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6.1.7.2 Effects of wire waveguide distal tip 
 
 For a fixed frequency and wire waveguide distal tip amplitude of 
vibration a 1.0 mm flat wire waveguide distal tip produces double the 
maximum pressures which can be achieved by a 1.0 mm radiused distal 
tip. Increasing the diameter of the flat wire waveguide from 1.0 mm to 
2.0 mm produces double the maximum pressure at the distal tip. 
 For a fixed frequency of 22.5 kHz, the maximum wire waveguide distal 
tip pressure for a 1.0 mm radiused distal tip can be as high as 350 kPa at 
amplitudes of vibration of 60 µm. With a cavitation threshold of 0.1 – 0.2 
MPa, this wire waveguide will cause cavitation at amplitudes of vibration 
≈ 25 – 40 µm. 
 For a fixed frequency of 22.5 kHz, the maximum wire waveguide distal 
tip pressure for a 1.0 mm flat distal tip can be as high as 550 kPa at 
amplitudes of vibration of 60 µm. With a cavitation threshold of 0.1 – 0.2 
MPa, this wire waveguide will generate cavitation at amplitudes of 
vibration ≈ 10 – 25 µm.  
 Experimental data for the 1.0 mm diameter flat distal tip wire waveguide 
for the same frequency of operation (22.5 kHz) shows the inertial 
cavitation occurring above amplitudes of vibration of 31.4 µm. The FEA 
model predicts that this amplitude of vibration for these conditions 
produces maximum pressures of ≈ 0.3 MPa at the wire waveguide distal 
tip. 
 Using 140 EPW the FEA model could accurately predict the standing 
wave amplitude of vibrations and nodes which were measured 
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experimentally by others. This model could account for wave 
interactions created by an air interface.   
 
6.2 Conclusions from this work 
 
 Ultrasonically energised vibrating wire waveguides can perforate the 
artery at lower forces than non-energised wires. 
 Increasing wire waveguide distal tip amplitude of vibration results in 
decreasing perforation forces. There is a significant decrease in 
perforation force at low distal tip amplitudes of vibration but no 
significant drop in perforation force is seen above amplitudes of 27.8 
µm. The additional power will not reduce the perforation force but 
does cause heating which, over longer periods of time, can cause 
tissue damage. 
 Single event failure of the artery wall occurs with non-energised 
wire waveguides. Ultrasonically energised wire waveguides produce 
multiple sequential failures in the media layer of the artery wall 
during perforation suggesting that the tissue is failing locally. This is 
evident in both the force profile and histological examination. 
 Operation of the wire waveguide in the cavitation region does not 
seem to play a primary role in perforation force and energy 
reduction. It may however contribute to heating. Further 
investigation on its effects in temperature increase and residual 
tissue damage is therefore required. 
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 Pushing and probing of the ultrasonically energised wire waveguide 
over a range of feedrates is also more applicable to in vivo 
conditions. For the range of feedrates examined here (19 – 95 
mm/min) there is no significant change in the artery wall 
perforation forces for both the non-energised and ultrasonically 
energised wire waveguide. A trend of low mean perforation forces 
for a particular feedrate may be observed from the data, more tests 
are required to establish significant changes in the perforation force.  
Generally, for non-energised and ultrasonically energised wire 
waveguides higher perforation forces are measured with lower 
feedrates (19 mm/min). 
 Histological analysis of aortic tissue, which have been perforated by 
the ultrasonically energised wire waveguide, show tissue removal. 
Non-energised wire waveguide shear the tissue fibres and do not 
appear to remove tissue. 
 When using non-energised wire waveguides there is a large standard 
deviation in the perforation forces. The standard deviation in the 
perforation forces is reduced when the wire waveguide is 
ultrasonically energised at all settings.  
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 There is a temperature rise in the tissue when the artery is 
perforated by the ultrasonically energised wire waveguide. 
Increasing amplitudes of vibration and decreasing feedrate results in 
greater temperature increase of the tissue at the wire waveguide 
point of entry. There is also a doubling of the mean temperature rise 
as the device operates across the inertial cavitation threshold. It is 
not obvious whether this is a result of the increase of distal tip 
amplitude of vibration or the presence of cavitation.  
 The temperature rise (ΔT) measured for increasing wire waveguide 
distal tip amplitudes of vibration over a range of feedrates for the 
duration of contact time is not sufficient to cause thermal tissue 
damage (< 4 0C).  
 Given the low acoustic intensity and low attenuation values for 
conditions encountered during use of ultrasonically energised wire 
waveguides on tissue, the temperature increase is most likely due to 
heat generated by frictional forces between the wire waveguide and 
the tissue and not attenuation of the ultrasonic wave. 
 The goal of the experimental tissue testing conducted as part of this 
research is designed to gain insight into the soft tissue-wire 
waveguide interaction. The experiments were designed to represent 
these devices in vivo under clinical conditions but contain some 
generalisations.   This experimental tissue testing is the first of its 
kind and is designed to examine these devices under highly 
controlled and repeatable conditions. Where one or more variable is 
manipulated to determine its effect on a dependent variable. For this 
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reason, the results are limited in terms of a direct comparison with 
what would be expected to occur in vivo.  
 The acoustic Finite Element Analysis (FEA) of the wire waveguide 
distal tip can predict the acoustic pressures generated for typical 
frequencies and amplitudes of vibrations used in wire waveguide 
tissue ablation and disruption. This analysis shows that the FEA 
method can be used to predict the pressures generated by the wire 
waveguide distal tip in simulated in vivo conditions and therefore 
can be used as a design tool for development and improvement of 
these devices. 
 With sufficient mesh densities a linear FEA acoustic model can 
accurately predict the pressures directly at the wire waveguide 
distal tip and can also predict the entire acoustic field, including the 
standing wave structure created by an interface of acoustic media 
with different attenuation properties. The FEA acoustic model is 
shown to accurately predict the pressures measured experimentally 
from a study of a simulated peripheral artery with multiple fluids. 
 Using a cavitation threshold and the pressures predicted by the 
acoustic FEA, the wire waveguide distal tip amplitudes of vibration 
and frequency required to generate the pressures sufficient for 
cavitation can be predicted. 
 The FEA acoustic model is an approximation of the system, the 
resolution of which is determined by the mesh density. The accuracy 
of the model is also highly depended on valid input material 
properties. This model assumed linear acoustic properties of the 
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liquid medium. The liquid medium representative of blood is also 
modelled as a homogenous liquid and does not take into 
consideration that blood is a suspension. Despite these assumptions, 
for the pressure ranges of interest, this FEA method can provide 
accurate solutions useful in the design and improvement of these 
devices. 
 
6.3 Recommended future directions 
 
 The ultrasonic wire waveguide device has been shown to perforate and 
remove soft tissue at lower forces than a non-ultrasonically vibrating 
wire waveguide. An investigation into the design of new MIS cutting 
devices using this technology would be extremely beneficial. This may 
include a new supporting catheter and an investigation into a number of 
new MIS cutting applications for a range of tissue types. 
 Examining the perforation or cutting of thicker soft tissue samples using 
this device and methodology presented in this research may also be 
useful. Tissue fracture toughness for a range of tissue types may be then 
calculated when using the force data from the perforating ultrasonically 
vibrating wire waveguides. Experimental data for the tissue, such as 
fracture properties could then be used in FEA to model the tissue 
perforation. 
 Establishing accurate attenuation coefficients for the acoustic medium 
(i.e. blood) at the low ultrasonic frequencies can also provide important 
data for numerically modelling acoustic streaming and heating. 
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 The failure mechanisms of the soft tissue subjected to ultrasonically 
energised wire waveguide perforation should also be investigated in 
more detail. There is evidence which suggests that cyclic mechanical 
impact of the wire waveguide and the artery may cause the arterial 
tissue to stiffen, an effect of high strain rate, causing fracture and 
removal of tissue fibres by fatigue failure. 
 Testing larger tissue samples or entire sections of vessels would be 
beneficial in determining the perforation forces more representative of 
in vivo conditions. In some cases larger test sample sizes may identify 
acute differences between the perforation forces for the range of test 
variables examined during this research. 
 For assessing the risk of arterial perforation using the ultrasonically 
vibrating wire waveguides in CTO recanalisation, it may be more realistic 
to examine the wire waveguide in a blocked artery with a CTO lesion or 
mock CTO lesion. Bends and bifurcations in the artery may cause the 
ultrasonically vibrating wire waveguide to deflect and contact the artery 
wall; this may also require further investigation. 
 This study shows evidence of soft tissue removal when using 
ultrasonically vibrating wire waveguides; it may be possible to examine 
the particulate or debris size distribution. 
 One MIS field where this knowledge might be useful is Natural Orifice 
Transluminal Endoscopic Surgery (NOTES). NOTES performs surgical 
interventions by accessing anatomical systems through natural orifices 
such as the mouth, ears and anus. The ultrasonically vibrating wire 
waveguides may be used for NOTES as it has been shown that soft vessel 
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walls can be accessed at lower forces. The forces and energies presented 
in this research may also prove useful in future development of robotic 
or haptic surgery using ultrasonically vibrating wire waveguides. 
 Obtaining an accurate inertial cavitation threshold for blood in vivo at the 
frequencies typically used with these devices would help identify when 
cavitation is occurring in clinical applications. This threshold could be 
obtained experimentally using the hydrophone cavitation detection 
system outlined as part of this work. 
 Acoustic streaming was not considered as a contributing mechanism in 
tissue perforation for this research programme. A quantitative analysis 
of the fluid flow velocities and its effects on soft tissue should be 
investigated. 
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8 APPENDIX 
8.1 Histological images (H & E) 
8.1.1 Non-energised wire waveguide perforation 
 
 
Figure 8-1 : Artery perforation with non-energised wire waveguide. 4x. 
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Figure 8-2 : Artery perforation with non-energised wire waveguide. 4x. 
 
Figure 8-3 : Artery perforation with non-energised wire waveguide. 4x. Plan 
view. 
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8.1.2 Energised wire waveguide perforation 
 
 
Figure 8-4 : (Top), magnification of fibre compression, 20x. (Bottom), evidence 
of residual damage with ultrasound.  
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Figure 8-5 : Plan view of point of entry. 27.8 µm amplitude of vibration. 4x. 
 
Figure 8-6 : Plan view of point of entry. 34.3 µm amplitude of vibration.4x. 
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